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Abstract 
Overweight and obesity are increasing at an alarming rate globally, and are quickly becoming one of the 
largest medical problems in the world. Overweight and obesity are risk factors of metabolic diseases such 
as diabetes, cardiovascular diseases and cancer. Obesity is associated with a chronic state of low-grade 
inflammation in the adipose tissues, which involves several factors of the innate immune response having a 
range of systemic effects and which has been implicated in the development of the metabolic syndrome. 
To investigate the impact of obesity and obesity-related diseases good translational animal models are 
needed, and as such pigs have been proposed as relevant models for human obesity-induced inflammation 
as pigs share many genetic, anatomical and physiological features with humans.  
In this project the up- and downregulation of genes and proteins involved in the innate immune response 
to obesity-induced inflammation were examined to define the response and to identify a pig model that 
resembles the human response. Regulation was examined in the liver, two adipose tissues from the 
abdomen (subcutaneous adipose tissue (SAT) from the abdomen or retroperitoneal adipose tissue (RPAT) 
and visceral adipose tissue (VAT)) and one from the neck (neck SAT), as well as in the blood. Three pig 
breeds, all previously used as obesity models, have been examined, namely domestic pigs, Göttingen 
minipigs and Ossabaw minipigs, as well as cloned domestic pigs in an attempt to reduce variation, and thus 
the number of animals to be used in a trial to obtain statistical power. 
For the gene regulation analysis, two platforms for quantitative real-time PCR (qPCR) were employed: The 
Rotor-Gene Q instrument and the microfluidics-based high-throughput Bio-Mark. For the serum protein 
concentrations analysis several enzyme-linked immunosorbent assays (ELISAs) were used on the blood. 
In the clones, both cloning and obesity changed the response of the innate immune genes in the tissues 
and in the blood, as fewer genes were differentially regulated in the clones and in the obese, than in the 
controls and lean pigs. These effects were additive, so that obese, cloned pigs showed the least differential 
gene expression. However, the obese clones showed up-regulation of two serum proteins, namely 
haptoglobin and orosomucoid (ORM), as the only group of domestic pigs. Furthermore, cloning did not 
reduce the inter-individual phenotypic variation between the pigs. This changed expression of the innate 
immune response seen in cloned pigs may have phenotypic effects over time, and should therefore be 
taken into consideration when using cloned pigs for nutritional studies. 
In the Göttingen minipigs, obesity induced extensive changes in gene expression in the tissues as nine 
genes in the liver (out of 35), 12 genes in the VAT, 11 in the RPAT and eight genes in the neck SAT (out of 
33) were significantly differentially regulated in the obese Göttingen minipigs compared to lean. Three 
genes were differentially expressed in all three adipose tissues, namely the proinflammatory CC Chemokine 
ligand 3-like 1 (CCL3L1), the anti-inflammatory CD200 and the anti-inflammatory IL1RN, indicating that 
several factors in the adipose tissues are suppressing the effects of obesity. This response is like the 
response observed in obese humans. However, the obese Göttingen minipigs do not show elevated serum 
protein concentrations, which is observed in obese humans.      
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The obese Ossabaw minipigs did not show significant differential expression in the adipose tissues, 
although this could be an artifact due to small group sizes. However, a number of genes in the liver (six out 
of 26 genes) were down-regulated, which is not like the human response to obesity. 
When comparing the three breeds of porcine obesity-models with regards to the acute phase protein ORM, 
none of the three breeds showed any difference in the gene regulation of ORM between the lean and 
obese pigs. ORM has been found to have anti-inflammatory and immunomodulatory effects and has been 
associated with maintaining the metabolic homeostasis in obesity. Furthermore, no expression differences 
were found between the adipose tissues, which is similar what has been observed in obese humans. In 
obese humans, raised plasma levels of ORM have been found, as was the case for obese Ossabaw minipigs. 
The plasma levels between lean and obese domestic pigs and Göttingen minipigs were unchanged. 
Therefore, with regard to ORM, the obese Ossabaw minipigs respond similarly to obesity as humans. 
In conclusion, none of the investigated breeds of porcine obesity models showed a complete human-like 
response to obesity, under the investigated conditions, though the obese Göttingen minipigs showed a 
response similar to obese humans with regards to gene expression in the adipose tissues, and the obese 
Ossabaw minipigs showed a similar response with regard to serum ORM concentrations. 
  
vi 
 
Sammendrag på dansk 
Overvægt og fedme er stigende i et alarmerende tempo globalt, og er hurtigt ved at blive et af de største 
medicinske problemer i verden. Overvægt og fedme er risikofaktorer for metaboliske sygdomme såsom 
diabetes, hjerte-kar-sygdomme og kræft. Fedme er forbundet med en kronisk tilstand af let inflammation i 
fedtvæv, der involverer flere faktorer af det innate immunrespons med en række systemiske effekter, og 
som er impliceret i udviklingen af det metaboliske syndrom. 
For at undersøge effekten af fedme og fedmerelaterede sygdomme er gode translationelle dyremodeller 
nødvendige, og som sådan er griseblevet foreslået som relevante modeller for human fedme-induceret 
inflammation eftersom, grise deler mange genetiske, anatomiske og fysiologiske ligheder med mennesker. 
I dette projekt blev op- og nedregulering af gener og proteiner involveret i det innate immunrespons mod 
fedme-induceret inflammation undersøgt for at definere responset og for at identificere en grise-model, 
der minder om det humane respons. Reguleringen blev undersøgt i leveren, to fedtvæv fra maven 
(subcutant fedtvæv (SAT) fra abdomen eller retroperitoneal fedtvæv (RPAT) og visceralt fedtvæv (VAT)) 
samt SAT fra halsen (neck SAT), såvel som i blodet. Tre tynde og fede svineracer, som alle tidligere er 
anvendt som fedme-modeller, er blevet undersøgt, nemlig produktionsgrise, Göttingen minigrise og 
Ossabaw minigrise, samt klonede produktionsgrise i et forsøg på at reducere variation, og dermed antallet 
af dyr, der skal anvendes i et studie for at opnå statistisk signifikans. 
I genreguleringsanalyserne blev to platforme til kvantitativ real-time PCR (qPCR) anvendt: Et Rotor-Gene Q 
instrument og en mikrofluid-baseret high-throughput Bio-Mark. Enzym-bundet immunsorbent-assays 
(ELISAs) blev anvendt for at analysere flere serumproteiners koncentrationer i blodet. 
I klonerne blev både klonings- og fedmeresponset fra gener i det innate immunforsvar ændret i væv og i 
blodet, idet færre gener var differentielt reguleret i klonerne og i fede grise, end i kontrollerne og tynde 
grise. Disse virkninger var additive, således at fede, klonede grise viste den mindste differentielle 
genekspression. Dog viste de fede kloner opregulering af to serumproteiner, nemlig haptoglobin og 
orosomucoid (ORM), som den eneste gruppe af produktionsgrise. Desuden reducerede kloning ikke den 
inter-individuelle fænotypiske variation mellem grisene. Dette ændrede respons i det innate immunrespons 
kan have fænotypiske effekter over tid, og derfor bør dette tages i betragtning, når klonede grise bruges til 
ernærings undersøgelser. 
I Göttingen minigrise inducerede fedme omfattende ændringer i genekspressionen i vævene, da ni gener i 
leveren (ud af 35), 12 gener i VAT, 11 i RPAT og otte gener i neck SAT (ud af 33) var signifikant differentielt 
reguleret i de fede Göttingen minigrise i forhold til de tynde. Tre gener blev differentielt udtrykt i alle tre 
fedtvæv, nemlig det proinflammatoriske CC chemokin ligand 3-like 1 (CCL3L1), den antiinflammatoriske 
CD200 og den antiinflammatoriske IL1RN, hvilket indikerer, at flere faktorer i fedtvæv undertrykker 
konsekvenserne af fedme. Denne reaktion er lig det respons der er observeret i fede mennesker. Dog 
udviste de fede Göttingen minigrise ikke forhøjede serum proteinkoncentrationer, der er observeret hos 
fede mennesker. 
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De fede Ossabaw minigrise udviste ikke differentiel ekspression i fedtvævene, selv om dette kan skyldes 
små gruppestørrelser. En række gener i leveren (seks ud af 26 gener) var nedreguleret, hvilket ikke er lig 
menneskers respons på fedme. 
Ved sammenligning af de tre racer af porcine fedme-modeller i forhold til akutfaseproteinet ORM, udviste 
alle tre racer ingen forskel i genreguleringen af ORM mellem de tynde og fede grise. ORM har vist sig at 
have antiinflammatoriske og immunomodulatoriske virkninger, og er blevet forbundet med at opretholde 
metabolisk homøostase under fedme. Endvidere blev ingen ekspressions forskelle fundet mellem 
fedtvævene, hvilket svarer til responset hos fede mennesker. Hos fede mennesker er forhøjede 
plasmaniveauer af ORM blevet fundet, hvilket også var tilfældet for fede Ossabaw minigrise. 
Plasmaniveauerne mellem tynde og fede produktionsgrise og Göttingen minigrise var uændrede. Hvad 
angår ORM, reagerer Ossabaw minigrise altså tilsvarende på fedme som mennesker. 
Som konklusion viste ingen af de undersøgte racer af porcine fedme modeller et fuldstændigt menneske-
lignende respons på fedme, under de undersøgte betingelser. Dog udviste de fede Göttingen minigrise et 
respons svarende til fede menneskers med hensyn til genekspression i fedtvæv, og de fede Ossabaw 
minigrise viste en lignende reaktion med hensyn til serum ORM koncentrationer i blodet. 
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1 Background 
1.1 Obesity-induced low-grade inflammation 
Overweight and obesity are increasing at an alarming rate globally (Figure 1), and are quickly becoming one 
of the largest medical problems in the world (Abelson & Kennedy 2004; Haslam & James 2001). In 2005, it 
was estimated that 937 million adults were overweight and 396 million were obese. Furthermore, obesity 
projections reveal that up to 2.16 billion will be overweight and as many as 1.12 billion people will be obese 
by 2030 (Kelly et al. 2008). As defined by the World Health Organization (WHO), the body mass index (BMI) 
is used as a tool to identify weight problems. The BMI is a person’s weight in kilograms (kg) divided by their 
squared height in meters. Overweight is defined by a BMI=25-29.9 and obesity by a BMI≥30 (source: 
who.int). This is 
important as 
overweight and obesity 
are important risk 
factors of diabetes, 
cardiovascular disease, 
and cancer, and 
therefore increases 
mortality and decreases 
life expectancy (Haslam 
& James 2001). 
In most mammals 
adipose tissue occurs in 
two forms; the brown 
adipose tissue and the 
white adipose tissue 
(WAT) (reviewed in 
(Trayhurn & Beattie 
2001)). Brown adipose 
tissue is found mainly in 
neonates and is important for the regulation of body-temperature through non-shivering thermogenesis. 
WAT has several functions; it is a site for energy storage of fatty acids and it also provides thermal 
insulation. Furthermore, WAT has endocrine functions, releasing so-called adipokines that have both local 
and systemic functions. 
Obesity is associated with a chronic activation of the innate immune system resulting in a systemic low-
grade inflammation of the WAT which has been implicated in the development of obesity-related diseases, 
such as insulin resistance, cardiovascular diseases and hepatic steatosis (Gil et al. 2007; Bastard et al. 2006; 
Federico et al. 2010), and the development of the metabolic syndrome (MetS) (Yudkin et al. 2004). The 
MetS is a cluster of pathologies, of which the main components include insulin resistance, atherosclerotic 
dyslipidaemia, elevated blood pressure, abdominal obesity, and a systemic proinflammatory state. The 
components of MetS differ in criteria defined by different organizations (for example WHO and ATP III), 
Figure 1: Overview of the changes in obesity prevalence in adults in selected countries. Source: 
International Association for the study of Obesity, IASO.org. 
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however, the before mentioned are generally agreed upon (Grundy et al. 2004). At least 3 of these risk 
factors need to be present for a diagnosis of MetS to be made.  
The obesity-induced low-grade inflammation is different from “normal” acute inflammation caused by 
pathogens, where inflammation is a principal response to injuries of the body, with hallmarks that include 
swelling, redness, pain and heat. The acute inflammation response is rapid, robust and transient, with 
important mechanisms for the regulation and resolution of the inflammation (Serhan & Savill 2005; Zhang 
& Spite 2012; Mannick et al. 2001). Acute inflammation involves integration of many complex cellular and 
soluble signals in distinct cells and organs locally and systemically (Gabay & Kushner 1999; Tilg & Moschen 
2006). Most of the cytokines and acute phase proteins (APPs) involved in a normal inflammatory response 
are produced mainly in the liver. In contrast, obesity-induced low-grade inflammation is long-term with 
often only small changes in the pattern of the immune factors involved (Fain 2010) and several proteins 
involved in this process are synthesized and secreted by the adipose tissues as well, such as C-reactive 
protein (CRP), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) (reviewed in (Fain 2010; Fantuzzi 
2005)). Therefore, the low-grade inflammation of the adipose tissues is not only local, but also has systemic 
implications. It is still unknown whether low-grade obesity-induced inflammation is caused by defects in 
the program to resolve inflammation or whether it is induced by a continuous attenuated stimulation of 
inflammation (Zhang & Spite 2012).  
Even though obesity can induce low-grade inflammation, it is not the adiposity in itself, but rather the body 
fat distribution that plays a role in the development of metabolic diseases. Abdominal visceral adipose 
tissue (VAT) is more closely associated with an adverse metabolic risk profile, including cardiovascular 
disease, than subcutaneous adipose tissue (SAT) (Fox et al. 2007) and thigh SAT may even exhibit beneficial 
effects on glucose and lipid levels independent of abdominal adipose tissue (Snijder et al. 2005), whereas 
abdominal SAT seems to have a beneficial effect on triglyceride levels in obese humans (Porter et al. 2009). 
There are two main hypotheses currently, not mutually exclusive,  as to why VAT is more involved in the 
low-grade inflammation than the SAT (Federico et al. 2010; Klein et al. 2007). The first hypothesis proposes 
a direct effect of VAT on insulin resistance, lipoprotein metabolism and blood pressure through secreted 
metabolic products such as free fatty acids. The VAT is drained by the portal vein, which provides direct 
delivery of metabolic products of VAT to the liver, and it has been shown that secretion from the VAT of 
adipokines is associated with systemic inflammation in obese humans (Fontana et al. 2007). The second 
hypothesis, called the ectopic hypothesis, suggests that SAT depots have a limited ability to store excess 
energy, which ultimately leads to overflow of fatty acids to intra-abdominal adipose tissue and ectopic sites 
such as liver, muscle and islets. The excessive ectopic fat then causes metabolic dysfunction in those 
organs, such as insulin resistance and dyslipidemia (Seppälä-Lindroos et al. 2002; Sinha et al. 2002), and a 
correlation between macrophage activation and plasma levels of free fatty acids has been found (Ghanim 
et al. 2004).  
The exact cause(-s) of obesity-induced low-grade inflammation is not known, but there are many theories. 
When exposed to over-nutrition with consequent expansion of adipose tissue (including increase in 
adipocyte size and numbers, as well as adipose tissue proliferation), a number of local physiological 
changes occur in the adipose tissue; alterations in fatty acid metabolism (Suganami et al. 2005; Shi et al. 
2006), vascularisation (Hosogai et al. 2007; Pang et al. 2008), local hypoxia (Hosogai et al. 2007; Ye et al. 
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2007), adipocyte cell death (Strissel et al. 2007), and adipocytes secretion (Skurk et al. 2007; Clément et al. 
2004). These changes are hypothesized to be important for the development of low-grade inflammation.  
The main cell type in adipose tissue is adipocytes, but adipose tissue also consists of preadipocytes, 
vascular endothelial cells, fibroblasts, and immune cells such as lymphocytes and macrophages (Ouchi et al. 
2011). Recently, there has been great focus on the recruitment of macrophages in the adipose tissues as 
contributors to inflammatory and metabolic alterations in obesity (for example reviewed in (Dalmas et al. 
2011; Lumeng 2010)), as the infiltration of macrophages is directly linked to systemic inflammation and 
insulin resistance and is also proportional to adiposity in humans and mice (Weisberg et al. 2003; Xu et al. 
2003). The percentage of macrophages in adipose tissue of lean humans is estimated to be around 10% and 
around 40% in obese humans (Weisberg et al. 2003). Furthermore, the number of macrophages in VAT is 
greater than in the SAT (Bruun et al. 2005) supporting the fact that VAT is more involved in the low-grade 
inflammation than SAT. However, it is still unclear exactly what triggers the infiltration or how it occurs. It is 
still debated how much the infiltrating macrophages contribute to the secretion of adipokines in the WAT 
in obesity, however, there appears to be some overlap in the secretion from macrophages and adipocytes, 
as several of the proteins released by the fat cells are released by the nonfat cells in the adipose tissues as 
well (Fain 2010).  
 
1.1.1 Adipose tissue as an endocrine organ 
Nowadays, the term adipokine covers any protein that can be synthesized and secreted by adipose tissue 
(Trayhurn & Wood 2004). The adipokines released from immune cells and adipocytes make up a complex 
network that orchestrates interactions 
between metabolism and the immune 
system (Figure 2). Elevated serum 
concentrations and adipose tissue 
expression of these adipokines have 
been found in obese individuals (Table 
1). Furthermore, several of the proteins 
shown in Table 1 have been shown to 
have an effect on the development of 
metabolic diseases in obesity, and on the 
predictability of weight gain (Engström et 
al. 2003). There are several adipokines 
that are secreted exclusively by the 
adipose tissues and that exerts great 
effects on the state of inflammation, such 
as leptin, resistin, visfatin and 
adiponectin. Adiponectin is the only adipokine from this group that will be discussed further in this thesis, 
as the main focus will be on innate immune factors. As mentioned and shown in Table 1, the secreted 
adipokines and their effects on metabolic disorders are complex. For this reason only a few adipokines will 
be highlighted in the following sections. 
Figure 2: Local and systemic effects of low-grade inflammation of adipose 
tissue. Source: (Kalupahana et al. 2012) 
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Some of the best studied adipokines in obesity are IL-6 and TNF-α and they have consistently been found to 
be increased by obesity in the serum, WAT or both (see Table 1, reviewed in (Cottam et al. 2004)). The 
adipose tissue secretes about 30% of the circulating IL-6 in obese individuals (Mohamed-Ali et al. 1997) and 
both VAT and SAT secretes IL-6 (Fontana et al. 2007; Mohamed-Ali et al. 1997). The direct secretion of IL-6 
into the portal vein has important metabolic consequences as IL-6 exerts a lot of hepatic effects; it 
stimulates hepatic APP production (Heinrich et al. 1990), including CRP (Fontana et al. 2007), impairs 
insulin-mediated glycogenesis (Senn et al. 2002) and stimulates hepatic gluconeogenesis (Tsigos et al. 
1997). Furthermore, increased IL-6 serum levels are associated with increased risk of type 2 diabetes (with 
CRP) and cardiovascular diseases (Pickup et al. 1997; Pradhan AD 2001; Plutzky 2001). TNF-α has many 
functions in obese individuals; it correlates with the level of dyslipidemia (Chan et al. 2002), inhibit 
lipoprotein lipase (Kern et al. 1995) and increase lipolysis (Grunfeld et al. 1989). However, even though the 
expression of TNF-α is upregulated in the adipose tissue of obese individuals compared to lean (Hotamisligil 
et al. 1995) and the serum levels is higher in obese individuals (Dandona et al. 1998), it has been shown 
that there is no net release of TNF-α from abdominal SAT (Mohamed-Ali et al. 1997). The plasma 
concentrations of TNF-α were similar in the portal vein as in the radial vein, indicating that the upregulated 
expression of TNF-α in the adipose tissue does not have a systemic effect, but rather a local as TNF-α is not 
primarily released into the bloodstream from the adipose tissues (Fontana et al. 2007). It can be 
hypothesized that the elevation in TNF-α serum levels leading to metabolic disorders is due to secretion 
from other tissues. TNF-α has been implicated in the development of insulin resistance (Hotamisligil et al. 
1995) as TNF-α can inhibit intracellular signaling from the insulin receptor (Hotamisligil et al. 1994) and is 
positively associated with cardiovascular risk factors (Mendall et al. 1997). 
Several APPs have been investigated as possible markers of the disturbance of metabolic homeostasis 
during obesity, either secreted from the adipose tissues or secreted from other tissues due to secreted 
adipokines. CRP is mainly a hepatically produced APP, but it is also secreted from adipose tissues (Fain 
2010). The serum levels of CRP are elevated during obesity (Khaodhiar et al. 2004; Esposito et al. 2002; van 
Dielen et al. 2001), and IL-6 is one of the main inducers of hepatic CRP production in most species 
(Weinhold & Rüther 1997) which involves CRP in many of the metabolic disorders IL-6 is involved with. 
Furthermore, CRP has been proposed as a marker of cardiovascular disease. Studies have shown that high-
normal base-line CRP levels are associated with increased risk of coronary events, even in healthy, normal-
weight individuals, with lipid levels below the median levels of the population (Ridker et al. 1998; Ridker et 
al. 2000).   
Serum amyloid A (SAA) is another APP reported to be increased in serum and adipose tissue of obese 
humans (Poitou et al. 2005; van Dielen et al. 2001). Chronic systemic elevation of SAA has been linked to 
metabolic diseases and it is a well-established risk factor for atherosclerosis (Ridker et al. 2000; Fyfe et al. 
1997; Liuzzo et al. 1994). The correlation of gene expression with plasma levels was higher in adipose tissue 
than in the liver, and even though the liver is believed to be the most important organ for SAA secretion in 
the acute phase response, insulin-related human studies have shown that SAA expression is higher in 
adipose tissues than in the liver (Poitou et al. 2006). SAA is induced in primarily by IL-1, TNF-α and IL-6 in 
most species (Gabay & Kushner 1999). 
Adiponectin is highly expressed in adipose tissue and adiponectin plasma levels constitutes 0.01% of 
circulating proteins, making adiponectin one of the most abundant adipokines in plasma (Bastard et al. 
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2006). However, the expression of adiponectin mRNA is dependent on the localization of adipose tissue as 
the expression is higher in abdominal SAT than in VAT (Lihn et al. 2004). Adiponectin differs from other 
adipokines as the circulating levels are decreased in obese humans and in patients with type 2 diabetes and 
coronary heart disease (Kern et al. 2003; Spranger et al. 2003; Weyer et al. 2001; Ouchi et al. 1999). 
Furthermore, there is a strong positive correlation between decreased adiponectin and insulin sensitivity 
(Weyer et al. 2001). As adiponectin has anti-inflammatory effects, it has been suggested that the decreased 
levels of adiponectin in obesity and metabolic diseases are a contributing factor to the low-grade 
inflammation, and that adiponectin has a protective role against insulin resistance and atherosclerosis. One 
of these anti-inflammatory effects is prevention of the formation of so-called foam cells; lipid-repleted 
macrophages, which are a feature of atherosclerosis, and which produce high amounts of proinflammatory 
cytokines (Tian et al. 2012). Another anti-inflammatory effect is the inhibition of expression of different 
vascular adhesion molecules, scavenger receptors and proinflammatory cytokines, such as TNF-α, IL-6 and 
IL-1β in various tissues (Ajuwon & Spurlock 2005; Tsatsanis et al. 2005). Interestingly, adiponectin has also 
been implicated in chronic inflammatory processes, as the expression of adiponectin is elevated in inflamed 
tissues and circulating levels of adiponectin are higher in patients with chronic inflammatory diseases, such 
as inflammatory bowel disease, osteroarthritis and rheumatoid arthritis (Tang et al. 2007; Ehling et al. 
2006; Fayad et al. 2007). Adiponectin has been suggested as a marker for MetS, as plasma levels of 
adiponectin was negatively correlated with many parameters of the MetS, including BMI, triglycerides, 
cholesterol and plasma glucose and insulin (Ryo et al. 2004).  
IL-10 is an interesting adipokine as it seemingly has dual roles. IL-10 is a well-known anti-inflammatory 
protein, and its functions include inhibition of the cytokine synthesis, suppression of macrophage function 
and inhibition of proinflammatory cytokines (Tedgui & Mallat 2001). Furthermore, IL-10 has been shown to 
block the formation and stability of atherosclerotic lesions (Pinderski Oslund et al. 1999). However, IL-10 
also has proinflammatory functions, as discussed in a review by Mocellin and coworkers, as IL-10 promotes 
the activation of NK-cells, stimulates T cells and enhances the expression of cytotoxic molecules (Mocellin 
et al. 2003). Furthermore, when administered to humans with inflammatory disorders intravenously, IL-10 
exhibits proinflammatory effects through release of IFN-γ, among others (Lauw et al. 2000). The circulating 
levels of IL-10 are elevated in obese humans compared to non-obese humans (Esposito et al. 2003; Juge-
Aubry et al. 2005), with a 2 fold-increase in the SAT and a 6-fold increase in the VAT of obese humans when 
compared to the SAT and VAT of lean humans (Juge-Aubry et al. 2005). However, low IL-10 levels are 
detected in both obese and non-obese humans with MetS (Esposito et al. 2003). Low serum levels of IL-10 
have been associated with increased risks of stroke and type 2 diabetes in humans (van Exel et al. 2002a; 
van Exel et al. 2002b). The higher IL-10 levels in obese individuals could be part of a response to inhibit the 
proinflammatory cytokine and chemokine production observed in obesity.   
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Gene 
symbol Gene name 
Change in 
expression 
levels in 
obesity Family Function Reference 
ADIPOQ Adiponectin ↓ Adipokine Modulates several 
metabolic processes 
(Kern et al. 2003; Diez & 
Iglesias 2003) 
AOAH Acyloxyacyl hydrolase N/A Immune 
regulatory 
Phospholipase activity (Munford & Hunter 1992) 
APOA1 Apolipoprotein A-1 ↑ APP Stimulates the innate 
immune response and 
couples cholesterol 
trafficking to inflammation 
(Smoak et al. 2010; Chu et 
al. 2001) 
C3 Complement 
component 3 
↑ APP Part of the complement 
system 
(Gabrielsson et al. 2003) 
CCL2 Chemokine (C-C 
motif) ligand 2 
↑ Chemokine Macrophage recruitment 
into adipose tissues 
(Christiansen et al. 2004; 
Kanda et al. 2006) 
CCL3L1 Chemokine (C-C 
motif) ligand 3-like 1 
↑  
(in mice) 
Chemokine Involved in recruitment and 
activation of 
polymorphonuclear 
leukocytes 
(Wolpe et al. 1989; Xu et 
al. 2003) 
CCL5 Chemokine (C-C 
motif) ligand 5 
↑ Chemokine Recruitment and anti-
apoptotic activity of 
macrophages 
(Keophiphath et al. 2010) 
CD14 CD14 ↑ Immune 
regulatory 
Cell surface protein 
required for the immune 
response to LPS 
(LeVan et al. 2008; Fain et 
al. 2010b) 
CD163 CD163 ↑ Immune 
regulatory 
Plays a role in the anti-
inflammatory response 
(Zeyda et al. 2007; 
Moestrup & Møller 2004) 
CD200 CD200 ↑ Immune 
regulatory 
Suppresses activation of 
macrophages and 
granulocytes via CD200R 
(Zeyda et al. 2007; Hoek et 
al. 2000) 
CD36 CD36 ↑ Immune 
regulatory 
Involved in fatty acids 
transport 
(Bonen et al. 2006; 
Ibrahimi & Abumrad 2002) 
CD40 CD40 ↑ Immune 
regulatory 
Triggers inflammatory 
response in adipocytes 
(Poggi et al. 2009) 
COX-2 Prostaglandin-
endoperoxide 
synthase 2 
↑ Immune 
regulatory 
The key enzyme in 
eicosanoid metabolism 
(Bolduc et al. 2004; Hsieh 
et al. 2009) 
CRP C-reactive protein ↑ APP Marker of inflammation (Esposito et al. 2003; 
Khaodhiar et al. 2004; van 
Dielen et al. 2001; 
Couillard et al. 2005; Festa 
et al. 2001) 
CXCL10 Chemokine C-X-C 
motif ligand 10 
↑ Chemokine Chemoattractant, induced 
by IFN-γ 
(Herder et al. 2006) 
DEFB1 Defensin, β1 N/A Immune 
regulatory 
Anti-microbiel peptide, 
involved in asthma 
(Tesse et al. 2011) 
FIB Fibrinogen ↑ APP Marker of inflammation (Festa et al. 2001; Maresca 
et al. 1999) 
HP Haptoglobin ↑ APP Marker of inflammation (Chiellini et al. 2004) 
IFNG Interferon γ ↑  
(in mice) 
Cytokine Immune-stimulatory and –
modulatory effects 
(Guebre-Xabier et al. 2000; 
Schoenborn & Wilson 
2007) 
IL10 Interleukin 10 ↑  
(↓ in MetS) 
Cytokine Anti- and proinflammatory (Esposito et al. 2003; 
Mocellin et al. 2003) 
IL12A Interleukin 12A ↑ Cytokine Proinflammatory (Silswal et al. 2005; Yang et 
al. 1997) 
IL18 Interleukin 18 ↑ Cytokine Proinflammatory (Simon et al. 2009; 
Esposito et al. 2002) 
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IL1B Interleukin 1, β ↑ Cytokine Several; for example 
stimulate lipolysis, glucose 
transport, and adipocyte 
maturation in adipose 
tissue 
(Maury et al. 2007; Arkan 
et al. 2005; Juge-Aubry et 
al. 2003) 
IL1RN Interleukin 1 receptor 
antagonist 
↑ Cytokine Counteract inflammatory 
effects of IL-1 family 
members 
(Juge-Aubry et al. 2003; 
Sauter et al. 2008) 
IL6 Interleukin 6 ↑ Cytokine Anti- and proinflammatory (Esposito et al. 2003; 
Khaodhiar et al. 2004; 
Hirano et al. 1990) 
IL8 Interleukin 8 ↑ Chemokine Secreted by macrophages, 
is a chemoattractant of 
neutrophils 
(Straczkowski et al. 2002; 
Kim et al. 2006) 
ITIH4  Inter-α-trypsin 
inhibitor heavy chain 
family, member 4 
↑  
(in rats) 
APP Marker of inflammation (Choi et al. 2010) 
LBP Lipopolysaccharide 
binding protein 
↑ APP Recognizes LPS and 
amplifies host response to 
LPS 
(Sun et al. 2010; Weiss 
2003; van Dielen et al. 
2001) 
MUC1 Mucin N/A Immune 
regulatory 
Binds pathogens so they 
cannot reach the cell 
surface 
(Moncada et al. 2003) 
NFKB1 Nuclear factor of 
kappa light 
polypeptide enhancer 
in B-cells 1 
↑ Immune 
regulatory 
Transcription factor in the 
inflammatory cascade 
(O'Hara et al. 2009; Fain et 
al. 2010a; Creely et al. 
2007; Ghanim et al. 2004) 
NFKBIA Nuclear factor of 
kappa light 
polypeptide gene 
enhancer in B-cells 
inhibitor, α 
↓ Immune 
regulatory 
Inhibits transcription factor 
NF-κB 
(O'Hara et al. 2009; 
Ghanim et al. 2004) 
ORM1 Orosomucoid 1 ↑ APP Protection of adipose tissue 
against inflammation and 
metabolic dysfunction 
(Lee et al. 2010; Alfadda et 
al. 2012; van Dielen et al. 
2001) 
PAFAH1B1 Platelet-activating 
factor 
acetylhydrolase 1b 
↑  
(in mice) 
Immune 
regulatory 
Hydrolyses and inactivates 
platelet activating factor 
(PAF) 
(Yamada & Yokota 1998; 
Becerril et al. 2012) 
PDB-2 Defensin, β2 N/A Immune 
regulatory 
Various immune functions (Liu et al. 1998) 
SFTPA1 Surfactant protein A1 N/A APP Various inflammatory 
functions 
(van de Wetering et al. 
2004) 
SAA Serum amyloid A ↑ APP Marker of inflammation (Poitou et al. 2005; van 
Dielen et al. 2001) 
TF Transferrin ↔ APP Binds iron (POMEROY et al. 1997) 
TGFB1 Transforming growth 
factor β 1 
↑ Cytokine Pro- and anti-inflammatory 
functions 
(Scaglione et al. 2003; 
Letterio & Roberts 1998) 
TLR4 Toll-like receptor 4 ↑ Immune 
regulatory 
Proinflammatory, activated 
by LPS and saturated fatty 
acids 
(Shi et al. 2006; Lee et al. 
2003; Tsukumo et al. 2007) 
TNF Tumor necrosis 
factor-α 
↑ Cytokine Proinflammatory, insulin 
inhibitory actions, regulates 
immune cells 
(Cartier et al. 2008; 
Khaodhiar et al. 2004; 
Dandona et al. 1998) 
TNFAIP3 Tumor necrosis factor 
α-induced protein 3 
↓ Cytokine Negative feedback inhibitor 
of transcription factor NF-
κB 
(Amar et al. 2007; 
Boonyasrisawat et al. 
2007) 
Table 1: List of investigated genes, including functions and changes in expression levels in obesity. N/A means no data is 
available. APP means acute phase protein. MetS means the metabolic syndrome. LPS means lipopolysaccharide. 
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1.1.2 The cause of low-grade inflammation 
As previously described, the causes of obesity-induced low-grade inflammation are not known, but a few 
theories will be discussed in this section. 
 1.1.2.1 Hypoxia-induced low-grade inflammation in obesity 
Hypoxia is a known initiator of inflammation (Eltzschig & Carmeliet 2011) and has been proposed as a cause 
of obesity-induced low-grade inflammation. This is due to the facts that the oxygen tension in obese 
patients was reduced in the subcutaneous tissue (Fleischmann et al. 2005; Kabon et al. 2004), that mRNA of 
hypoxia response genes were increased in adipose tissue of the ob/ob mice (Ye et al. 2007), that hypoxia 
stimulates secretion of leptin and vascular epithelial growth factor (VEGF) and hypoxia inhibits 
differentiation of preadipocytes into mature adipocytes in vitro (Hosogai et al. 2007; Ye et al. 2007; Yun et 
al. 2002; Lolméde et al. 2003; Chen et al. 2006; Wang et al. 2007). Furthermore, hypoxia can induce gene 
expression in adipocytes and macrophages, such as TNF-α, IL-6 and IL-1, and thereby induce inflammation 
in the adipose tissues (Ye et al. 2007; Hosogai et al. 2007) and it is known to inhibit macrophage departure 
from hypoxic regions in tissues (Turner et al. 1999).The induction of hypoxia in adipose tissues may be due 
to the alterations in vascularisation caused by obesity; obesity leads to a reduction in vascular density in 
ob/ob mice (Pang et al. 2008) and a reduction of adipose tissue blood flow of 30-40% in obese humans 
(Bolinder et al. 2000). In addition, the increase in adipocytes size in obesity may in itself be a contributor of 
hypoxia and cause problems with oxygen supply in the adipose tissues, as the diameter of a large adipocyte 
can be over 150 µm (Blüher et al. 2002) and oxygen is only able to diffuse about 120 µm (Helmlinger et al. 
1997; Torres Filho et al. 1994). Therefore, as adipocyte diameter increases as obesity progresses, oxygen 
will not be able to reach the cells beyond 120 µm from the capillary. Furthermore, hypoxia could be the 
cause of the decrease of adiponectin in low-grade inflammation described previously, as hypoxia has been 
shown to reduce the expression of adiponectin in adipocytes in obesity (Ye et al. 2007; Hosogai et al. 2007; 
Chen et al. 2006; Wang et al. 2007). This decrease could possibly be through the induction of TNF-α by 
hypoxia which inhibits adiponectin mRNA expression in adipocytes (Fasshauer et al. 2002). As adiponectin 
has anti-inflammatory effects, as previously described, the decrease in adiponectin caused by hypoxia could 
exacerbate the hypoxia-induced inflammation in obesity. 
Hypoxia has been proposed as a cause of adipocyte cell death in adipose tissue (Yin et al. 2009), which 
induces macrophage infiltration (Cinti et al. 2005). In obese individuals, especially those displaying 
metabolic dysfunctions, macrophages are found in aggregates or in multinucleate giant cells. These cells 
are located in relation to, and surrounding, single dead or moribund adipocytes in socalled crown-like 
structures (Weisberg et al. 2003; Cinti et al. 2005) and the macrophages in these crown-like structures have 
higher expressions of TNF-α and IL-6 in obese mice (Strissel et al. 2007). Furthermore, macrophages in the 
adipose tissue of obese mice were found mainly in hypoxic areas (Rausch et al. 2007). As hypothesized by 
Ye (Ye 2008) the infiltration of macrophages in adipose tissue can be to remove the dead adipocytes from 
the tissues, or it can be that the macrophages are simply trapped in the hypoxic area, as previously 
described. 
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1.1.2.2 Gut bacteriel LPS-induced low-grade inflammation in obesity 
Generally, there is consensus about the concept that obesity is influenced by lifestyle factors and host 
susceptibility, and that obesity is caused by a dysbalance between energy intake and expenditure. As an 
organism, humans consist of 10% human cells and 90% microbes (Savage 1977), and several host-microbe 
interactions affecting human health has been described, including obesity (for example reviewed in (Mai & 
Draganov 2009)). Studies performed in mice lacking gut microbiota (germ-free) show that microbiota are 
involved in the extraction of calories and the storage of these in adipose tissues as the germ-free mice 
contained 40% less body fat than mice with normal gut microbiota, even though the food intake of the 
germ-free mice were 30% higher than the mice with normal gut microbiota (Bäckhed et al. 2004). This 
lower percentage of body fat in the germ-free mice was normalized within 2 weeks when the germ-free 
mice were colonized with bacteria from mice with normal gut microbiota (Bäckhed et al. 2004), and the 
body fat mass gain was even more pronounced (20% higher) when colonized with bacteria from ob/ob 
mice  (Turnbaugh et al. 2006). These differences is likely due to the fact that the composition of microbiota 
are different in lean compared to obese mice and humans with a fall in gram-negative bacteria and a rise in 
gram-positive bacteria (Ley et al. 2006; Ley et al. 2005). However, a group of gram-positive bacteria 
(bifidobacteria) was also reduced in high-fat diet-fed mice (Cani et al. 2007), and these have been shown to 
reduce lipopolysaccharide (LPS) intestinal levels in mice and improve mucosal bacterial function in rats 
(Griffiths et al. 2004; Wang et al. 2006). LPS is a large molecule that consists of lipid and polysaccharide 
fractions, and it is a strong trigger of inflammation as it initiates secretion of proinflammatory cytokines of 
innate immune cells, when it binds to CD14 and TLR4 on the surface of these cells (Sweet & Hume 1996; 
Wright et al. 1990). LPS has been proposed to initiate and maintain a low-grade inflammation state when 
feeding on a high-fat diet. A high-fat diet induced higher levels of LPS in the plasma of mice and humans, 
and when LPS was diluted in oil the ingestion of LPS was acute and led to elevated plasma levels of LPS 
(Cani et al. 2007). Endogenous LPS is continually produced within the gut by the death of gram-negative 
bacteria and is translocated into intestinal capillaries through a mechanism involving TLR4 (Neal et al. 
2006). Furthermore, an increased concentration of fatty acids has been shown to impair the integrity of the 
intestinal barrier, and thereby increase the permeability of the gut (Brun et al. 2007; Velasquez et al. 1993). 
Coupled with the fact that the levels of CD14 and TLR4 are elevated during obesity (Table 1) this could be 
two possible explanations of the increase in plasma LPS levels in obesity.  
LPS has been implicated in the development of metabolic diseases related to obesity. To evaluate the effect 
of mildly increased plasma LPS levels on insulin resistance, Cani and coworkers infused mice continually 
with LPS over a period of 4 weeks  and found that mice infused with LPS had increased hepatic insulin 
resistance and heavier liver weight than compared to normal mice (Cani et al. 2007). This has been 
confirmed in human studies as LPS has been found to be involved in the development of type 2 diabetes in 
humans as well (Creely et al. 2007). Furthermore, a relationship between the plasma levels of LPS and the 
development of atherosclerosis and cardiovascular disease in humans have been found (Wiedermann et al. 
1999).     
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1.2 Animal models of obesity 
There are several good cellular model systems to study the regulation of adipocytes, including the 3T3-L1, 
an adipocyte differentiated from a fibroblast. It is however, not possible for studies of more complex 
biological systems to be performed in cell cultures. Therefore, we turn to animal models. There are many 
good rodent animal models for obesity, including the ob/ob mice and the Zucker rat, both of which have 
leptin receptor mutations. Furthermore, most rodents can become obese on high-fat diets, called diet-
induced obesity (DIO) rodent models. However, the metabolic parameters in these rodent models are 
largely dependent on the strain, gender and source of dietary fat (Gajda et al. 2007). In the early days of 
research into the complexities of and correlation between obesity and MetS, rodents were widely used, 
and several adipokines were discovered in rodent models. However, as the same adipokines were 
investigated in humans the results often differed markedly. As discussed in the commentary by Arner 
(Arner 2005) the rodent models differ substantially in the roles of adipokines IL-6, TNF-α, resistin and 
adipsin, and adiponectin levels in Zucker rats are elevated in obesity (Oana et al. 2005) in contrast to the 
decreased levels in obese humans, as described previously. Furthermore, there are other metabolic and 
physiological differences between rodents and humans, as discussed in (Varga et al. 2010). Therefore, new 
and more compatible animal models are needed to enable the translation of biomedical research findings 
in animal models into relevant therapies for obesity and its comorbidities in humans. 
          Swine 
One of these animal 
models is the pig. Pigs 
are becoming 
increasingly popular as 
translational models for 
human disease as they 
share many genetic, 
anatomical and 
physiological 
similarities to humans 
((Lunney 2007; Litten-
Brown et al. 2010) and 
Table 2). There are 
several advantages with working with pigs as they easily accept a human diet, and have large adipose tissue 
depots and organs so it is not necessary to pool samples to gain large enough samples for further analysis 
(Spurlock & Gabler 2008), it is possible to use standard medical technologies to image internal organs and 
vessels and it is possible to collect blood samples repeatedly (Lunney 2007). Furthermore, pigs share a high 
sequence and chromosome structures with humans (Lunney 2007) and it is possible to reduce the genetic 
variation in pigs markedly by using pigs from the same litter, or cloned or transgenic pigs (Litten-Brown et 
al. 2010). One of the drawbacks of using pigs instead of rodents is pricing. Pigs are more costly to feed, 
house and medicate and minipigs especially, can be in short supply and expensive to purchase. Another 
drawback is ethical considerations as the pig is a large experimental animal.  
 
 Humans Domestic Minipig Rats 
Adult BW (kg) 70 60-280 20-50 0.25-0.4 
Heart size-to-BW 
ratio 
- Similar1 Not similiar1 
Pooling of tissues 
(e.g. adipose) 
Not required Not required Required 
Omnivore Yes Yes Yes 
Tooth structure - Similar1 Not similiar1 
Middle ear - Similar1 Not similiar1 
Skin - Similar1 Similar1 
Atherosclerosis - Similar1 Not similiar1 
Kidney structure 
and function 
- Similar1 Not similiar1 
Table 2: Comparison of general anatomical/physiological factors between humans, swine and 
rats. 1Similarity compared to humans. BW means bodyweight. Reproduced from (Litten-Brown et 
al. 2010).  
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The pig has been investigated thoroughly as a model for nutrition (Miller & Ullrey 1987), and it has been 
used for research on metabolic disorders (Lunney 2007), including atherosclerosis (Turk & Laughlin 2004; 
Turk et al. 2005). In regards to MetS, the pig expresses two different genotypes; a lean and an obese. 
Generally, domestic pigs have a long history of selective breeding for lean meat, and fall under the lean 
genotype category. However, the domestic pig display patterns of atherosclerotic alterations when fed 
excessively that are similar to those observed in obese humans (Brambilla & Contafora 2004). This makes 
the domestic pig an comparable model for atherosclerosis, however, it has been difficult to induce type 2 
diabetes in these pigs, except when administering streptozotocin (a β-cell eradicating drug) (Spurlock & 
Gabler 2008) (described further in Section 3.1.2). Different breeds of minipigs are of the obese genotype. 
For more extensive studies of obesity and cardiovascular diseases, the minipig breeds have proven useful, 
and some breeds, namely the Ossabaw and Göttingen minipigs, show symptoms of insulin resistance when 
fed excessively (Dyson et al. 2006; Johansen et al. 2001). This is further described in Section 4.1.1. 
 
Investigations into IL-6, TNF-α and leptin has shown that their expression in plasma and adipose tissue is 
elevated by obesity in pigs (Gondret et al. 2012; Jacobi et al. 2004), and that the expression of adiponectin 
is decreased with adiposity in pigs (Jacobi et al. 2004). These changes correlates to what has been found in 
obese humans, as described previously. All these factors taken together prove that the pig, with Ossabaw 
and Göttingen minipigs in particular, may play an important role in defining the molecular basis of obesity 
and its comorbidities. 
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2 General methods 
This section contains a brief description into the background of the methods used in this thesis as the 
methods and materials are described in detail in the included papers and appendices. 
 
2.1 Gene expression 
DNA (deoxyribonucleic acid) is the genetic material of the cells, and it codes for proteins indirectly via RNA 
(ribonucleic acid) through the processes of transcription and translation. RNA is single-stranded, and is very 
similar to the copied DNA, except for the base uracil instead of thymine in DNA. There are different forms 
of RNA which have different functions in the cells. Messenger RNA (mRNA) is generated as a primary 
complementary transcript of a DNA sequence coding for a specific gene (transcription). The mRNA is 
exported to the ribosome in the cytoplasm, where the information of the mRNA is translated into a protein. 
Many events can impact this process, including enzymes that break down mRNA, thereby regulating the 
expression patterns of the cell. mRNA is rapidly turned over and is degraded and rendered nonfunctional at 
some point in the process of protein translation. This means that protein expression and regulation is very 
sensitive to changes in the rate of mRNA synthesis (transcriptional control). Furthermore, the RNA 
molecule is more unstable than the DNA molecule, because of the single-stranded structure. The stability of 
mRNA may be controlled by adenylation or by binding of the regulatory microRNA, that is associated with 
repression of transcriptional activity (Li 2002; Morgan et al. 2005) (post-transcriptional control). In addition 
there are several mechanisms to control protein production and location at the post-translational level, for 
example through regulating the stability of the protein by glycosylation by proteases and through signal 
peptides destining the protein for export, membrane or cytosol location. 
These things taken together make purification of RNA from different tissues a challenging process, and the 
quality of the RNA purified can have great impact on the results of the investigation.  
 
2.1.1 Purification of RNA 
To achieve the highest quality possible of RNA and the highest yields from samples, it is important that the 
preservation and storage of these samples minimize degradation. The highest and most pure RNA yields are 
acquired by dicing the freshly sampled tissue into smaller pieces followed by rapid submersion in liquid 
nitrogen (Bustin & Nolan 2004). After preservation the samples can be safely stored at -80°C until use, as 
such low temperatures prevent activity of RNA degrading enzymes called RNases. The degradation of RNA 
by these enzymes is one of the main factors contributing to biases and inconsistencies when estimating 
gene expression. Furthermore, just as the time between tissue sampling and preservation should be kept at 
a minimum, it is important that the samples do not thaw prior to sample homogenization with an RNase 
inhibiting agent (see below). 
There are several methods to purify RNA from a tissue sample. When choosing a method, many 
considerations have to be made as the choice of method can interfere with the recovery, abundance and 
the composition of various transcripts of RNA in the sample. Furthermore, different tissues contain 
different concentrations of RNA and the composition of the sample in itself, as well as the origin of the 
sample, may interfere with the extraction of RNA (as described below in section 2.1.1.1). Ideally, when RNA 
has been extracted from the sample, it should be free of contaminants such as genomic DNA, proteins, 
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Mg2+ and phenol, it should be undegraded, and it should be free of enzyme inhibitors (Fleige & Pfaffl 2006). 
All these contaminants can have great impact on the downstream procedures. 
In order to assure that these factors are addressed, it is important to access the quantity and quality of the 
extracted RNA. To assess the quantity of a sample, a NanoDrop spectrophotometer (ND-1000, NanoDrop 
Technologies Inc, USA) was used to estimate the concentration of nucleic acids. Aside from measuring the 
quantity of RNA in the sample, the NanoDrop can be used to measure contamination of a sample. The 
spectrophotometer utilizes the fact that different compounds absorb ultraviolet light in specific patterns: 
Proteins absorb light at 260 nm, nucleic acids at 260 nm, phenol at 270 nm and organic compounds at 230 
nm. To estimate the contamination of proteins and phenol in a nucleic acid sample the ratio of absorbance 
at 260 and 280 nm (A260/280) is used. Especially contamination of phenol has an impact on this ratio. To 
estimate the contamination of organic compounds in a nucleic acid sample the ratio of absorbance at 260 
and 230 nm (A260/230) is used. Both ratios should ideally be about 2.0 for RNA, which indicates no 
contamination, but ratios between 1.8 and 2 are generally accepted. However, as demonstrated by the 
results of the work done in this thesis, it appears that even low numbers of the 260/230 ratio does not 
impact downstream performance in the quantitative real-time PCR (qPCR) methods used.  
To assess the quality of the extracted RNA the Agilent 2100 Bioanalyzer (Agilent Technologies, CA, USA) was 
used. The Bioanalyzer estimates the integrity of the RNA by capillary electrophoresis, and gives a RNA 
integrity number (RIN) between 1 and 10, where 1 is the most degraded and 10 is the most intact profile. 
The algorithm used to calculate the RIN not only utilizes the ratio of 28S and 18S fragments, which has 
previously been used as a measurement of RNA degradation, but also takes into account several other 
factors that is indicative of RNA quality (Mueller et al. 2011), as shown in Figure 3. 
 
    Figure 3: Factors indicative of RNA quality on the Agilent 2100 Bioanalyzer. Source: (Mueller et al. 2011). 
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The RIN vary greatly between tissues, which is possibly due to variations in connective tissues and lipid 
content. Samples with RINs above 5.0 are considered good quality RNA and RINs above 8 are perfect 
quality RNA (Fleige & Pfaffl 2006). However, it is generally agreed upon that if it is not possible to obtain 
high RINs, samples to be compared should at least exhibit uniform integrity values.  
 2.1.1.1 Purification of RNA from adipose tissue 
In this thesis RNA was extracted from a variety of different pig tissues; liver, adipose tissues, small intestine, 
spleen, and mesenteric lymph nodes, using the phenol-chloroform method in the domestic pigs. RNA 
extraction from samples of all tissues, except for adipose tissues, were done with the column-based RNeasy 
Lipid Tissue Midi kit (Qiagen, Ballerup, Denmark) according to manufacturer’s instructions (appendix 9.3), 
and extractions performed with this assay had high RINs and good NanoDrop results (see Table 4 and Table 
5). However, when the same kit was applied to samples of abdominal SAT, the yields were very low. This 
could be due to the fact that the RNeasy Lipid Tissue Midi kit has an upper limit of 500 mg tissue, and the 
adipose tissue has a high lipid content and a low cell number. Therefore, the next step was to extract RNA 
from the abdominal SAT with the RNeasy Maxi kit (Qiagen) which has an upper limit of 1 g of tissue, 
according to manufacturer’s instructions (appendix 9.4). This method proved successful for the samples of 
abdominal SAT in the pilot study for the pigs in group 1 (see Table 3, Table 5, and Paper I p. 27) with yields 
of 50-100 ng/µl and 260/230 and 260/280 ratios of about 2. However, when applied to the abdominal SAT 
samples of group 2 and 3 (Table 3), and to other adipose tissues, the method produced low yields of RNA. 
Therefore, variations of the method were tested, including higher concentrations of phenol/chloroform, 
changes in centrifugation (higher rpm and more time) and elution of RNA with more/less RNase-free water. 
However, none of this increased the RNA yields. Because of the low cell and high lipid content of adipose 
tissue, concerns were that most of the extracted RNA was retained in the membrane of the columns, so the 
next step was to circumvent the columns. Therefore it was necessary to find a way to precipitate the RNA 
without columns, and different proportions of ethanol and isopropanol was tried. This eventually gave 
good results with yields above 100 ng/µl, 260/230 ratios of around 2.3, 260/280 ratios of above 1.8 (see 
Table 5) and the method is described in detail in appendix 9.5, Paper I p. 27, and Paper II p. 39.  
When applying this method to the adipose tissue samples from the Ossabaw and Göttingen minipigs, the 
method produced no yields of RNA. Another round of optimization was initiated; the amount of tissue was 
changed, new proportions of reagents were tested, whether ethanol was better than isopropanol to 
precipitate the RNA was tested, the temperature of the water used to elute was changed, and the 
centrifugation speed and time were changed. Although good yields were obtained during optimization on 
some samples, they had low 260nm/280nm ratios (about 1.6) and had poor performance when tested with 
qPCR. After good advice from Associate Professor Susanna Cirera (KU-SUND) another approach was tried as 
there was a possibility that the lipids interfered with the RNA extraction negatively; after the initial 
centrifugation of the homogenized sample with phenol in a cold centrifuge (4°C), the lipids in the sample 
had gathered in a layer on top. This lipid layer was discarded, and instead of air drying the RNA precipitate 
it was dried on a thermo block for 10 minutes at 55°C. This gave excellent results with yields of generally 
above 200 ng/µl and 260nm/280nm ratios of around 1.9 (Table 6 and Table 7). Therefore this method, as 
described in appendix p. 9.6, Paper III p. 70 and Paper IV p. 95, was used for extracting RNA from the 
adipose tissues of the minipigs. As the method was not tested on the domestic pigs it is not possible to 
account for its applicability in other species or tissues.             
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2.1.2  Real-time quantitative PCR (qPCR) 
qPCR is a technique used to amplify and quantify a targeted DNA molecule. As qPCR is performed on 
double-stranded DNA molecules, it is necessary to convert mRNA into DNA before analysis can be 
performed. To do this the enzyme reverse transcriptase is used. Reverse transcriptase is a multifunctional 
enzyme with 3 distinct enzymatic activities: A RNA-dependent DNA polymerase that reverse transcribes 
complementary DNA (cDNA) from an RNA template, a hybrid-dependent exoribonuclease that degrades 
RNA hybridized to cDNA, and finally a DNA-dependent DNA polymerase that synthesizes the second cDNA 
strand. For all samples, the QuantiTect Reverse Transcription Kit (Qiagen) was used according to 
manufacturer’s instructions. This kit includes a step that eliminates genomic DNA, which is important as 
this is one of the pitfalls of quantifying RNA by qPCR. 
The next step is dependent on what PCR platform is to be used. For this thesis two platforms were used; 
the Rotor-Gene Q instrument (Qiagen) for analysis of a few genes or a few samples (method is described in 
appendix 9.8), and the high-throughput Bio-Mark (Fluidigm, CA, USA) for analysis of multiple genes (48/96) 
and samples (48/96) simultaneously (method is described in appendix 9.10). Before high-throughput qPCR, 
the samples were preamplified to stretch the samples (method is described in appendix 9.9).  
Preamplification can be done by different methods; DNA-dependent DNA polymerase or DNA-dependent 
RNA polymerase, where antisense RNA is produced, which 
then is reverse transcribed into cDNA. In this thesis the first 
enzyme was used, via the TaqMan PreAmp Master Mix 
(Applied Biosystems, Nærum, Denmark) with 16 
amplification cycles. The preamplification is done with the 
primers used for the high-throughput qPCR, to enrich the 
cDNA for gene specific targets.  
PCR is a three-step process with denaturation, annealing 
and elongation steps, where the amount of cDNA is 
doubled by each reaction cycle (Freeman et al. 1999). The 
sequences of cDNA amplified are determined by the 
selection of primers. For detection and quantification of the 
amplified PCR product the dyes SYBR Green (SYBR green 
Jumpstart Taq Readymix, Sigma-Aldrich, MO, USA) and 
EvaGreen (EvaGreen 20X (Biotium, Inc., CA, USA) were 
used. These dyes bind to double-stranded DNA and 
produce a fluorescent signal. Furthermore, the Readymix 
and Master Mix (TaqMan Gene Expression Master mix, 
Applied Biosystems, CA, USA) contains an antibody that inactivates the DNA polymerase at room 
temperature. When the temperature is raised above 70°C in the first denaturation step the complex 
dissociates and the DNA polymerase becomes fully active. 
The efficiency of the PCR is dependent on a variety of factors, including the annealing temperature and the 
length of the amplified product. The annealing temperature can vary greatly from primer to primer, which 
is not a problem in single-gene qPCR. However, when performing high-throughput qPCR, the annealing 
temperature will have to be the same for all primers, and this must be considered when designing primers. 
Figure 4: Schematic overview of the polymerase chain 
reaction. Primers are in green. Image obtained from: 
http://www.web-books.com/MoBio/Free/Ch9E.htm 
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Furthermore, the amplification of large products (>400 bp) is very dependent on good quality RNA, 
whereas short amplicons (70-250 bp) are less dependent of the quality of RNA (Fleige & Pfaffl 2006). In 
order to correct for sample to sample variations introduced in the up-stream procedures of qPCR, such as 
extraction yield, reverse-transcription yield and amplification efficiency, it is necessary to normalize the 
data to enable the comparison of mRNA concentrations across different samples. To do this, the expression 
of reference genes is measured. Reference genes are stable genes with abundance which show strong 
correlations with the amount of mRNA present in the sample. As the mRNA levels of reference genes can 
vary between tissues and individuals, it is important to validate each for the experimental setup, and to 
choose more than one reference gene (Bustin & Nolan 2004). GeNorm was used to determine the most 
stable reference genes. The program calculates a gene-stability measure (M) for all reference genes in a 
given set of samples, and thereby identifies the number and identity of the most stable reference genes in 
that set of samples. These reference genes are then used to calculate the geometric mean used to 
normalize the samples.    
To accommodate the concerns raised as to what could negatively affect the reproducibility and biological 
relevance of the samples, several steps were taken. For the high-throughput qPCR, replicates were 
produced in the cDNA-synthesis, making it possible to check for introduced variation. For the single-gene 
qPCR, all samples were run in triplicates in the assay to check for pipetting variation. For both types of 
qPCR, no-template controls (NTCs) containing no sample and no reverse transcription (-RT) controls where 
the sample was not reverse transcribed were included in the assays to assess the degree of DNA 
contamination and specificity (e.g. primer dimers) of the results. Furthermore, 5 reference genes were 
included to be able to determine the optimal reference genes for normalization. To compensate for low 
quality RNA experienced in some samples, only primers with short amplicon targets (<250 bp) were used.      
 
2.2 Protein expression in blood 
To quantitatively determine the levels of specific proteins in blood serum, the method enzyme-linked 
immunosorbent assay (ELISA) was used. To be able to quantify the concentration of the protein, a standard 
curve based on known concentrations of antigen was prepared. ELISAs were performed to quantify the 
proteins ORM, haptoglobin, CRP, TNF-α, IL-6 and SAA. Two types of ELISAs were used in this work; the 
competitive ELISA (ORM) and the sandwich ELISA (the rest).  
In the employed competitive ELISA format the plate is coated with antigen, and the sample and the 
competitive buffer with antibody is added. The more antibody that is present in the sample, the less 
antibody from the competitive buffer will be able to bind to the antigen-coated well. After addition of HRP-
conjugated secondary antibody specific to the antibody from the competitive buffer, the amount of 
primary antibody bound to the well can be determined. The higher the concentration of antibody in the 
original sample, the lower the absorbance of the assay. 
In the sandwich ELISA the plate is coated with antibody, and the sample is added. After addition of a HRP-
conjugated antibody the amount of antigen bound can be measured. In the sandwich ELISA, the higher the 
concentration of antigen in the original sample, the higher the absorbance. 
To accommodate introduced variation in the assays several steps were taken. In all the assays the standard 
curve was included, as well as wells without sample (blanks). The correlation of the standard curve was 
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estimated in each assay as a quality control, and the background contamination was calculated from the 
blanks. Furthermore, to accommodate variation introduced through pipetting, all samples were analyzed in 
duplicates. 
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3 Study I – Cloned/non-cloned lean/obese domestic pig 
This study was done in collaboration with Aarhus University at Foulum, Tjele and was part of a large 
collaboration between different groups, universities and business funded by a FØSU-grant (Nutriomics – 
functional foods for cloned lean/obese pigs). All pigs were cloned and reared at Foulum. The object of the 
study was to generate a nutriomic pig model that would allow determination of the most important effects 
of food-derived interactions with pig gene expression, proteins and metabolites. This would make it 
possible to determine if cloned pigs were better nutritional models than non-cloned pigs (controls) in terms 
of less variation and equal responses as the controls, and to determine the effect of functional foods (pre- 
and probiotica, as well as hydrolyzed whey) on the response to obesity. So far, four papers have been 
published from this project (Rødgaard et al. 2012; Clausen et al. 2011; Christensen et al. 2012; Varga et al. 
2010).  
Unfortunately, several parts of the project did not go as according to plan. First, according to the project 
description it was estimated that the project would produce 120 clones of the domestic pig, as the lean 
phenotype (Figure 5A), and a further 120 clones of the obese phenotype pig. At time of completion for the 
cloning part of the project, 17 cloned domestic pigs and 10 cloned pigs of the obese phenotype were 
produced. Second, the supplier of the pre- and probiotics suddenly pulled out of the project, before their 
products had been investigated. Therefore, a new supplier was found, however, this time it was with 
hydrolyzed whey. Third, the choice of obese phenotype pig was problematic. At the start of the project, the 
Hungarian Mangalica (Mangalitsa) pig (see Figure 5C) was chosen as the obese phenotype pig because of 
availability. However, due to problems with cloning this breed it was abandoned for the Yucatan minipig 
(Figure 5B). The Hungarian Mangalica pig has not been investigated as an obese phenotype pig, and even 
though it has been used as a lard pig, and they are generally able to become very fat, there is no evidence 
that these pigs are negatively affected by their adiposity. Therefore, it is quite possible that this breed of 
pig, as other breeds of pigs, have developed ways to cope with the adiposity, making this pig not a very 
good model for obesity. In contrast, the Yucatan minipig has been used and investigated as a model for 
obesity and obesity-related diseases. However, most of these studies have been made in pigs bred 
selectively over several generations to have impaired glucose tolerance (discussed in (Bellinger et al. 
2006)). In fact, when “normal” not-selectively bred Yucatan minipigs were investigated, they were found 
not to develop many of the comorbidities of obesity, including insulin resistance and atherosclerotic lesions 
(de Smet et al. 1998). The Yucatan minipigs bred for this study were not selectively bred. Because of this, 
the preliminary results that clones did not show less variation than controls, and the small groups of 
Yucatans produced (10 clones; 5 lean and 5 obese, and 7 controls; 4 lean and 3 obese), we chose not to use 
the Yucatan minipigs as an obese phenotype pig either in this project.       
Figure 5: The breeds of pigs used for the Nutriomics study. (A) Lean phenotype pig: Yorkshire/landrace mix 
(domestic pig). (B) Obese phenotype pig: Yucatan minipig. (C) Obese phenotype pig: Hungarian Mangalica pig (not 
used). 
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3.1 Background 
The domestic pigs were bred over a 3 year period, starting January 2008 and ending January 2011. The 36 
pigs used in this study were from three groups born almost a year apart. For specifications of the pigs, see 
Table 3, Paper I p. 27 and Paper II p. 39. For biochemical characteristics of the pigs, see appendix 9.12.    
Group                      Diets Genetic composition 
  Ad libitum Restricted  
Group 1 (2008) Clones 4  65% L 35% Y 
 Controls 3  36% L 64% Y 
  1  75% L 25% Y 
     
Group 2 (2009) Clones 5  65% L 35% Y 
 Controls      6  75% L 25% Y 
     
Group 3 (2010/2011) Clones  8 65% L 35% Y 
 Controls  9 75% L 25% Y 
Total  19 17  
Table 3: Overview of the specifications of the domestic pigs used in Study I. The year in parenthesis indicates year of             
slaughter. 
  
3.1.1 Cloning 
Cloning has enormous potential applications; it can be used to generate multiple copies of transgenic 
animals for pharmaceutical production or xeno-transplantation, and to preserve endangered species. 
Furthermore, cloning is already an important tool for studying gene function, genomic re-programming, 
genetic diseases and gene therapy (discussed in (Tian et al. 2003)). 
 
Figure 6: Cloning by somatic cell nuclear transfer (SCNT) 
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When cloning by somatic cell nuclear transfer (SCNT), the nucleus of a somatic cell is transferred into an 
enucleated oocyte from a donor (Figure 5). The genes inactivated through tissue differentiation are re-
activated by the process of nuclear reprogramming, enabling the reversion of a differentiated nucleus into 
a totipotent cell. SCNT is widely used, and has been applied for this thesis.   
Unfortunately, cloning by SCNT is a procedure very low in efficiency, with a success rate of only 0-4% 
(Wilmut et al. 2002), and a high percentage of embryo loss and perinatal mortality (Park et al. 2005; 
Whitworth et al. 2009). Even when born the cloned offspring has a higher mortality, and many die within 
the first 24 hours of birth (Wilmut et al. 2002). However, surviving cloned offspring generally have normal 
production and reproductive properties, even though cloned pigs have been showed to have deviant 
phenotypes. This is further described in Paper I p. 27 and Paper II p. 39.  
One of the advantages of using cloned animals in biological investigation is to reduce the number of 
animals needed to obtain statistically sound data, as cloned animals are expected to show less inter-
individual genetic and phenotypic variation due to identical genotypes. However, studies have repeatedly 
shown that cloned pigs do not have reduced variability, neither genetic nor phenotypic, when compared to 
normal outbred pigs. This is further described in Paper I p. 27 and Paper II p. 39. 
 
3.1.2 Domestic pigs as model animals for nutritional studies 
The domestic pig of Landrace/Yorkshire mix used for the Nutriomics study is a breed widely used as a 
production pig in Denmark. It has been bred selectively for leanness for more than 40 years. However, 
when fed a high cholesterol and high fat diet the domestic pigs develop humanoid atherosclerosis (Gerrity 
et al. 1979), and can with injections of streptozotocin, that induces DNA strands to break within β-cells, 
become hyperglycemic (Gerrity et al. 2001). Therefore, this breed of pig has been widely used as a model 
for diet-induced and diabetes-induced atherosclerosis (Gerrity et al. 1979; Gerrity et al. 2001; Askari et al. 
2002; Natarajan et al. 2002). Furthermore, when fed a paleolithic diet, a diet consistent with the hunter-
gatherer life-style of human ancestors, domestic pigs become leaner, have lower blood pressure and are 
more sensitive to insulin than pigs fed a cereal based diet, suggesting that pigs, as humans, are not adapted 
to a diet with large amounts of cereal (Jonsson et al. 2006). 
 
3.2 Hypothesis for Study I 
• Cloned animals show less inter-individual phenotypic variation, making it possible to reduce group 
numbers to retain statistical power in future studies  
• Obesity alters the expression of innate immune response genes and the response of the innate 
immune genes is similar between cloned and control pigs, as pigs have similar genetic backgrounds 
• The serum concentrations of innate immune response proteins are differentially expressed in 
obese pigs compared to lean and is similar between cloned and control pigs 
• Adipose tissues from the abdomen; the abdominal SAT and VAT, have a higher number of affected 
innate immune response genes than the neck SAT 
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3.3 Results for Study I 
3.3.1 Preliminary study of the expression of selected innate immune factors in 5 tissues 
To help select tissues of interest, a small preliminary study of the pigs of Group 1 (4 clones and 4 controls, 
see Table 3) into the expression profiles of cytokines IL1, IL6, and TNF and APPs HP, SAA and APOA1 was 
conducted with qPCR (Rotor-Gene) (described in appendix 9.8). The pre-PCR data is shown in Table 4. 
 
Tissue ng/µl 260/230 260/280 RIN 
Liver 79-2419 
(1257) 
2.12-2.28 
(2.22) 
2.09-2.18 
(2.14) 
8.7-9.1 
(8.9) 
Abdominal SAT 74-191 
(136) 
1.93-2.19 
(2.11) 
2.08-2.17 
(2.13) 
7.1-8.7 
(7.7) 
Mesenteric lymphnodes 524-3152 
(1680) 
2.2-2.31 
(2.26) 
2.03-2.13 
(2.08) 
7.4-9.2 
(8.7) 
Spleen 1075-2054 
(1370) 
2.26-2.31 
(2.29) 
2.11-2.15 
(2.12) 
7.7-8.7 
(8.3) 
Small intestine 878-1805 
(1361) 
2.27-2.29 
(2.29) 
2.1-2.2 
(2.15) 
8.2-9.3 
(8.9) 
Table 4: Pre-qPCR data from the preliminary study. Yields, ratios and RINs of the pigs from             
Group 1 in the five measured tissues. The lowest and highest values are shown, with the mean            
in parenthesis. Small intestine n=7, the rest of the tissues n=8. 
From a panel of five putative reference genes (beta-2-microglobulin (B2M), ribosomal protein L13A 
(RPL13A), ACTB (β-actin), glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and hypozanthine 
phosphoribosyl transferase 1 (HPRT1)), the most stable (RPL13A, GAPDH and HPRT1) were selected using 
GeNorm. Figure 7 shows the melting curves, quantification curves and standard curve of a qPCR run with 
RPL13A, as a representative qPCR run on a Rotor-Gene Q instrument. The tissues investigated are possible 
immune regulatory sites, and were: liver (Figure 8A), spleen (Figure 8B), small intestine (Figure 8C), 
mesenteric lymph nodes (Figure 8D), and abdominal SAT (Figure 8E).  
 
Figure 7: (A) Melting curves, (B) quantification curves and (C) standard curves from a representative run with RPL13A. Black 
line=NTC. 
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Figure 8: Expression of six innate immune regulatory genes in (A) liver, (B) spleen, (C) small intestine, (D) mesenteric lymph 
nodes and (E) abdominal SAT. 
 
The geometric mean of the selected reference genes were used to normalize all samples. Relative 
expression for all samples were calculated relative to the least expressed sample for each primer assay, and 
data were log2 transformed to obtain a normal distribution prior to unpaired, two-tailed t-test. Data are 
expressed as the mean ± standard error of the mean (SEM). 
Three of the tissues showed differential significant expression, namely the liver, mesenteric lymph nodes, 
and abdominal SAT (Figure 8). Therefore, the spleen and small intestine were not selected as tissue to 
investigate. Even though the liver only showed differential regulation of one of the 6 genes, this tissue was 
selected for further investigations as it is a way to gage the systemic reaction to obesity. Interestingly, the 
abdominal SAT showed differential significant regulation in two genes, and as the mesenteric lymph nodes, 
which drains the mesenteric VAT, among others, showed differential significant regulation in three genes, 
we decided to include the two adipose tissues (abdominal SAT and VAT) in the study. Furthermore, we 
decided to include the neck SAT as an adipose control tissue, as the expression is expected to be lower here 
than in the other two adipose tissues (as discussed previously). 
This preliminary study was the first indication that the clones appeared to exhibit a different innate 
immune response pattern than the controls. 
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3.3.2 Data from Study I not included in Paper I 
The yields and quality measurements of the 36 pigs and four tissues as measured with the NanoDrop and 
Bioanalyzer (discussed in section 2.1.1) are shown in Table 5. On average the yields, ratios and RINs of all 
the tissues were within accepted ranges. 
 
Tissue ng/µl 260/230 260/280 RIN 
Liver 79-2419 
(1078) 
2.03-2.28 
(2.22) 
2.03-2.18 
(2.12) 
7.9-9.3 
(8.8) 
Abdominal SAT 60-734 
(261) 
1.92-2.55 
(2.18) 
1.69-2.17 
(2.00) 
6.8-9.3 
(7.8) 
VAT 42-600 
(355) 
1.66-2.62 
(2.20) 
1.58-2.19 
(1.92) 
5.1-9.4 
(7.1) 
Neck SAT 43-429 
(109) 
1.58-2.49 
(2.22) 
1.62-2.12 
(1.85) 
5.9-9.0 
(7.4) 
Table 5: Yields, ratios and RINs of the pigs from Study I in the four measured tissues. The lowest        
and highest values are shown, with the mean in parenthesis.  
 
   
Figure 9: Heatmap from high-throughput qPCR (Fluidigm). On top the 48 primers are named and on the left side the 48           
samples are shown. Samples from 01-03 is used to interrun calibrate the runs, samples from 04-32 (except 22, which is the NTC) 
is liver tissue samples, and samples from 33-48 is abdominal SAT samples. 
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The preliminary data of a qPCR run with a high-throughput Bio-Mark real-time PCR instrument (Fluidigm) 
depicted as a heatmap, is shown in Figure 9. The heatmap shown is from number four out of nine qPCR 
runs in total for Study I.  
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3.3.3 Paper I  
Expression of innate immune response genes in liver and three types of adipose tissue in cloned pigs 
Rødgaard T, Skovgaard K, Stagsted J, Heegaard PMH. Cell Reprogram.
The gene expression of 40 innate immune response genes were investigated with high-throughput chip-
based qPCR (FluiDigm) in liver, abdominal SAT, VAT and neck SAT, as well as the serum protein expression 
of six immune response factors with ELISA (haptoglobin, SAA, ORM1, CRP, IL-6 and TNF-α) in lean control 
and cloned domestic pigs. These pigs were not treated in any way, and the only difference between them 
was the cloning, making this a study into the effects of cloning. The results indicate subtle but distinct 
tissue specific changes in these four tissues upon cloning, with several genes being significantly 
differentially regulated in cloned domestic pigs. In the liver and the neck SAT (the two control tissues), the 
affected genes were generally upregulated in the clones, whereas, the affected genes were generally 
downregulated in the abdominal SAT and VAT. However, this did not translate into changed serum protein 
expression levels in the clones.  
 2012, 14(5), Epub ahead of print  
The variation between the clones and the controls were investigated as well, to see whether cloning results 
in less inter-individual variation. As the variance of the two groups was found to be equal, the variance was 
not reduced in the clones. 
In conclusion, the fact that a notable number of genes of the innate immune system are affected by cloning 
could affect the usability of the cloned pigs as a model for nutritional studies negatively, and should be 
considered if choosing cloned pigs as a model for the study of the involvement in the innate immune 
system and inflammation in the development of diet-induced obesity-related diseases.
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3.3.4 Paper II  
Cloning changes the response to obesity of innate immune factors in blood, liver and adipose tissues in 
domestic pigsRødgaard T, Skovgaard K, Stagsted J, Heegaard PMH. Cellular Reprogramming.
The layout of the article is changed compared to the submitted version. 
 2012, 
submitted as original paper 
The object of this study was to evaluate the usability of cloned pigs as nutritional models. Hopefully, cloned 
pigs should improve the current porcine nutritional model, as fewer animals will be needed to retain 
statistical power due to lower inter-individual variation, and the pigs should exhibit a similar immune 
response as controls. The gene expression of 36 genes in the liver and 31 genes for the three adipose 
tissues; abdominal SAT, VAT and neck SAT were investigated with high-throughput chip-based qPCR 
(Fluidigm). Furthermore, the blood serum expression levels of six immune factors were investigated with 
ELISA (haptoglobin, SAA, ORM1, CRP, IL-6 and TNF- α). This was measured in obese clones and controls, and 
lean clones and controls. The obese pigs were fed a high fat/high sucrose-diet ad libitum, and the lean pigs 
were fed the same diet, though restricted to 60% of ad libitum-diet.  
For genes being differentially expressed between the adipose tissues, obesity and cloning decreased the 
number of differentially expressed genes. These effects were additive so obese, cloned pigs showed little or 
no genes being differentially expressed between liver and adipose tissues 
In the serum no changes in concentrations in any of the six immune factors were detected between the 
lean and obese controls. However, ORM levels were significantly elevated in the obese clones when 
compared to the lean clones. Furthermore, two proteins were significantly elevated in the obese clones 
when compared to the controls, namely ORM and haptoglobin. This suggests that the obese clones are 
exhibiting a response to the diet that neither the lean clones nor the obese controls are exhibiting. 
The variance between the obese clones and controls were tested, and contrary to the study of the lean 
pigs, a different variance was found between the obese clones and controls in serum proteins ORM and 
CRP. The inter-individual variation in ORM expression was smaller in the clones, but for CRP it was smaller 
in the controls. 
In conclusion, clear differences between clones and controls, both lean and obese, were found in 
expression levels of mRNA in tissues and serum expression levels in the blood. As even small changes in the 
expression of innate immune factors can have detrimental effects in obesity long term, this adds another 
blow to the benefits of cloned animals as nutritional models. 
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Abstract 25 
The objective of the study was to evaluate the usefulness of cloned pigs as porcine obesity models 26 
reflecting obesity associated changes in innate immune factor gene expression profiles. 27 
Liver and adipose tissue expression of 43 innate immune genes as well as serum concentrations of 28 
six immune factors were analyzed in lean and diet-induced obese cloned domestic pigs compared to 29 
normal domestic pigs (obese and lean). The number of genes affected by obesity was lower in 30 
cloned animals than in control animals. All genes affected by obesity in adipose tissues of clones 31 
were down-regulated; in the controls both up- and down-regulation was observed. Cloning resulted 32 
in a less differentiated adipose tissue expression pattern. Finally, the serum concentrations of two 33 
acute phase proteins (APPs) HP and ORM were increased in obese clones as compared to obese 34 
controls as well as lean clones and controls. Generally, phenotypic variation was not reduced in 35 
cloned pigs.  36 
Therefore, we conclude that cloning limits both the number of genes responding to obesity as well 37 
as the degree of tissue differentiated gene expression, concomitantly with an increase in APP serum 38 
concentrations only seen in cloned, obese pigs. This may suggest that the APP response seen in 39 
obese, cloned pigs is an abnormal consequence of the clone specific, skewed gene response to 40 
obesity described in this work. This should be taken into consideration when using cloned animals 41 
as models for innate responses to obesity. 42 
 43 
Introduction 44 
Obesity is associated with a chronic activation of the innate immune system resulting in a low-grade 45 
inflammation of the white adipose tissue, which has been implicated in the development of obesity 46 
related diseases such as type 2 diabetes, cardiovascular diseases and hepatic steatosis constituting 47 
important parts of the metabolic syndrome (Bastard et al., 2006;Federico et al., 2010;Gil et al., 48 
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2007). Soluble mediators of the innate immune system include proteins such as cytokines, 49 
chemokines and acute phase proteins (APPs). These proteins are mainly produced by cells of the 50 
immune system and by the liver, however, several of these proteins have been shown to be 51 
produced by the adipose tissues as well, such as C-reactive protein (CRP), IL-6 and TNF-α 52 
(reviewed in (Fain, 2010;Fantuzzi, 2005)). Low-grade inflammation in the adipose tissues is not 53 
only a local phenomenon as elevated serum levels of pro-inflammatory cytokines and APPs have 54 
been found in obese individuals (Chiellini et al., 2004;Mendall et al., 1997) and Mohamed-Ali and 55 
coworkers (Mohamed-Ali et al., 1997) found that 30% of the circulating interleukin-6 (IL-6) is 56 
derived from adipocytes in obese individuals. Furthermore, serum concentrations of APPs can be 57 
used as a predictor of weight gain (Engström et al., 2003). 58 
Pigs are promising models for the obesity-induced inflammation-related responses thought to be the 59 
underlying cause of the metabolic syndrome (Litten-Brown et al., 2010). Cloned pigs should in 60 
theory show less inter-individual variation as they have identical genotypes and therefore are 61 
expected to have more uniform phenotypes than normal outbred pigs and thus have potential to 62 
improve the model. However, it has been shown by us and others that inter-individual phenotypic 63 
variation was not reduced for a number of traits by cloning, including expression levels of specific 64 
genes (Rødgaard et al., 2012;Tian et al., 2008). Even though several reports have shown that 65 
animals cloned by somatic cell nuclear transfer (SCNT) are healthy and normal, other investigations 66 
report deviant phenotypes (Clausen et al., 2011;Hwang et al., 2009;Park et al., 2011;Whyte et al., 67 
2011), including lower body weights (Park et al., 2005;Tian et al., 2008). Furthermore, cloning by 68 
SCNT leads to higher perinatal and early postnatal mortality (Park et al., 2005;Whitworth et al., 69 
2009). This has been attributed to a large number of causes, including metabolic and 70 
cardiopulmonary abnormalities (Hill et al., 1999;Wells et al., 1999), lymphoid hypoplasia (Renard 71 
et al., 1999) and neonatal respiratory distress (Hill et al., 1999), but also, interestingly, to bacterial 72 
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infections (Carter et al., 2002;Keefer et al., 2001;Peura et al., 2003). Studies in cloned piglets 73 
(Carter et al., 2002) and cloned cattle (Chavatte-Palmer et al., 2009) have revealed that the adaptive 74 
immune system is apparently not affected by the cloning process. However, we have previously 75 
described that basal innate immune response gene expression is altered in cloned pigs compared to 76 
normal outbred pigs (Rødgaard et al., 2012) supported by earlier findings by Carroll and coworkers 77 
(Carroll et al., 2005) on altered innate immune responses to lipopolysaccharide in cloned pigs. 78 
All of this has raised concerns regarding the use of cloned animals in metabolic and knock-out 79 
analysis (St John et al., 2005) and there is a need for further investigations into the use of cloned 80 
animals in nutrition studies to supplement the few studies which have already been conducted 81 
(Christensen et al., 2012;Jensen et al., 2010).  82 
Therefore the objective of this study was to evaluate the usability of cloned pigs in nutritional 83 
studies by looking at the expression of innate immune genes and serum levels of APPs and 84 
cytokines in obese cloned pigs and to investigate whether cloning reduced inter-individual variation 85 
in these parameters and whether cloning had any other effects on these parameters. Cloned pigs 86 
(n=9) and normal outbred pigs (controls, n=10) fed a high fat/high sucrose diet ad libitum (obese 87 
group), and cloned pigs (n=8) and normal outbred pigs (controls, n=9) fed a high fat/high sucrose 88 
diet restricted to 60% of ad libitum intake (lean group) were compared. 89 
 90 
Materials and procedures 91 
All methods and descriptions of the lean clones and controls have been previously described in 92 
(Rødgaard et al., 2012). The following is a brief summary. 93 
 94 
Animals, diets and sampling 95 
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All experimental procedures involving animals were approved by the Danish Animal Experimental 96 
Committee. 97 
Somatic cell nuclear transfer was used to perform the cloning, as described in (Kragh et al., 2004). 98 
Donor cells were from cultured ear fibroblasts obtained from a Danish Landrace x Yorkshire 99 
(65%:35%) sow and the cloned embryos were transferred to surrogate sows five to six days after 100 
cloning, as described in (Schmidt et al., 2010). Controls were normal litters (either 36%:64% or 101 
75%:25%) obtained by standard insemination. The lean pigs are described in (Rødgaard et al., 102 
2012). 103 
The obese pigs were from two groups born a year apart. Group 1 consisted of four clones and four 104 
controls, and group 2 consisted of five clones and six controls. Piglets from groups 1 were delivered 105 
normally and piglets from group 2 were delivered by Ceasarian section on gestation day 116 106 
(Schmidt et al., 2010), with treatment with a prostaglandin analogue (175 µg Estrumate i.m., 107 
Pitman-Morre, UK) 24 h before Ceasarian section. All pigs were reared in the experimental stables 108 
of Aarhus University (Tjele, Denmark). Pigs were weaned after 28 days and at three months of age 109 
the pigs were fed a high-energy diet (containing 10% sugar and 10% soy oil) ad libitum (the diet is 110 
described in (Christensen et al., 2012)). At an age of 7-8 months the pigs were killed with a bolt 111 
pistol after overnight fasting. The animals were desangiunated and the carcass split into two halves; 112 
the right side was used for tissue sampling and the left side was used for CT scanning. Tissue 113 
samples were snap frozen in liquid nitrogen. Blood was allowed to clot at room temperature for 1 114 
hour, centrifuged at 3000 rpm for 10 minutes at 4°C and aliquots of serum were then frozen. Tissue 115 
and serum samples were kept at -80°C until analysis. CT scanning was performed with a High-116 
speed single-slice CTi instrument from General Electric, obtaining slices of 5 mm resolution. CT 117 
data were analyzed using VG MAX 2.1 software (Volume Graphics GmBH, Germany) for 118 
quantification of fat and muscle volume. 119 
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  120 
For RNA extracted from abdominal fat samples from group 1 and liver tissue from group 1 and 2 122 
the following method was used: Total RNA from ~100 mg of liver tissue was isolated by a RNeasy 123 
Lipid tissue Midi kit (Qiagen, Ballerup, Denmark) and ~1 g of abdominal fat tissue was isolated by 124 
a RNeasy Maxi kit (Qiagen) and QIAzol Lysis Reagent (Qiagen) according to manufacturer's 125 
protocol. Both were treated with on-column RNase-free DNase digestion (Qiagen). The tissues 126 
from group 1 were homogenized with a hand blender, where the liver tissue from group 2 was 127 
homogenized on the gentleMACS Dissociator (Miltenyi Biotec, Germany) in gentleMACS M tubes 128 
(Miltenyi Biotec). 129 
Extraction of RNA 121 
For the abdominal SAT from group 2 as well as the VAT and neck SAT from group 1 and 2 the 130 
method of RNA extraction with phenol and chloroform was used. ~1 g of fatty tissue was 131 
homogenized with QIAzol Lysis Reagent on the gentleMACS Dissociator after which chloroform 132 
was added. After centrifugation isopropanol (2-propanol) was added to the upper, aqueous phase. 133 
The tube was centrifuged and the pellet was washed 3 times in cold 75% EtOH. The supernatant 134 
was removed completely and pellet was left to air dry. The RNA was dissolved in RNase-free 135 
water. The RNA yield was then measured on the NanoDrop (ND-1000 Spectrophotometer, 136 
NanoDrop Technologies Inc, USA). 137 
 138 
For the assessment of RNA integrity the Agilent 2100 Bioanalyzer (Agilent Technologies, CA, 140 
USA) was used. The RNA integrity number (RIN) was identified with the use of Agilent RNA 6000 141 
Nano Kit (Agilent Technologies) according to manufacturer's protocol. In the liver all samples had 142 
a RIN of above 8, whereas all samples in the fatty tissues had a RIN of above 6.2. 143 
RNA integrity 139 
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 144 
Each sample of extracted RNA was run in duplicates and 500 ng total RNA was reverse transcribed 146 
using the QuantiTECT Reverse Transcription kit (Qiagen), according to the manufacturer's instruc-147 
tions. Prior to pre amplification, which was performed using TaqMan PreAmp Master Mix (Applied 148 
Biosystems, CA, USA), the cDNA was diluted in low EDTA TE-buffer (VWR – Bie & Berntsen, 149 
Herlev, Denmark). Pre amplified cDNA was diluted in low EDTA TE-buffer before qPCR. 150 
cDNA synthesis and pre amplification 145 
  151 
Primers were designed using Primer3 (http://frodo.wi.mit.edu/) as described previously in 153 
(Skovgaard et al., 2009) and synthesized at TAG Copenhagen (Copenhagen, Denmark). Primer 154 
specificities, primer amplification efficiencies, dynamic ranges, specificity and sequences was 155 
tested and described in (Rødgaard et al., 2012).  156 
Primer design and validation 152 
 157 
qPCR was performed in 48.48 Dynamic Array Integrated Fluidic Circuits (Fluidigm, CA, USA), 159 
combining 48 samples with 48 primer sets for 2304 simultaneous qPCR reactions in the BioMark 160 
real-time RCR instrument (FluiDigm). Reaction mix was prepared with  ABI TaqMan Gene 161 
Expression Master Mix (Applied Biosystems), 20X DNA Binding Dye Sample Loading Reagent 162 
(Fluidigm), 20X EvaGreen (Biotium, VWR – Bie & Berntsen), and low EDTA TE Buffer. Reaction 163 
mix was mixed with pre amplified cDNA, diluted in low EDTA TE-buffer. Specific primer mix 164 
were prepared using 20 µM primer (forward and reverse), 2X Assay Loading Reagent (Fluidigm) 165 
and low EDTA TE-buffer.  166 
Quantitative real time PCR (qPCR)  158 
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Expression data were acquired using the Fluidigm Real-Time PCR Analysis software 3.0.2 167 
(Fluidigm) and exported to GenEx5 ((MultiD, Göteborg, Sweden).  168 
 169 
GenEx5 was used for data pre-processing, normalisation, relative quantification and statistics. Data 171 
were corrected for PCR efficiency for each primer assay individually. The most stable expressed 172 
reference genes were found for each tissue type individually as well as for all samples combined out 173 
of a panel of five putative reference genes using GeNorm (Vandesompele et al., 2002) and the 174 
geometric mean of these were used for normalization in GenEx5. Expressions were calculated 175 
relative to the least expressed samples for each primer assay and data were log2 transformed to 176 
approach normal distribution prior to two-tailed, unpaired t-test, one-way ANOVA with Tukey-177 
Kramer post test, and/or F-test. Gene expression changes were considered to be significant if p≤0.05 178 
with a fold change of at least ±1.5. Data are expressed as the mean ± standard error of the mean 179 
(SEM).  180 
Data analysis and statistics 170 
 181 
The protein concentrations in serum of CRP, HP, ORM, IL-6, TNF-α and SAA were analyzed by 183 
sandwich ELISAs. CRP, HP and ORM was analyzed with in-house assays, where commercially 184 
available ELISA assays were used to determine IL-6 (Porcine IL-6 Duoset kit, R&D Systems, MN, 185 
USA), TNF-α (Swine TNF-α CytoSetTM, Invitrogen,CA, USA, with Antibody Pair Buffer Kit 186 
(Invitrogen, CA, USA)) and SAA (Phase SAA assay, Tridelta Development Ltd., Kildare, Ireland). 187 
All ELISAs were developed using TMB-plus (KEM-EN-TEC, Taastrup, Denmark) according to the 188 
manufacturer’s instructions and read using an automatic plate reader (Thermo Multiskan Ex 189 
spectrophotometer, Thermo Scientific, Waltham, MA, USA). Within a single assay all samples 190 
Quantitative serum ELISA 182 
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were run in duplicates and an intra-assay coefficient of variation of <15% was accepted. Ascent 191 
software v. 2.6, Thermo Scientific was used to calculate sample values and significance was tested 192 
using a two-tailed unpaired t-test where variance was tested with an F-test. p≤0.05 was considered 193 
significant. Outliers were removed from dataset after evaluation with Grubbs outlier test (Grubbs, 194 
1969) where applicable. Data are expressed as the mean ± standard error of the mean (SEM). 195 
 196 
Results 197 
When comparing the four groups (lean controls, lean clones, obese controls and obese clones) at the 199 
time of slaughter there was no significant difference in the weight of the lean controls and lean 200 
clones (Rødgaard et al., 2012). The weights of the obese clones and controls were significantly 201 
higher than the lean clones (p<0.0001) and lean controls (p=0.03), respectively.  However, the 202 
obese control animals weighed significantly more than the obese clones (170.1±4.9 kg and 203 
147.5±5.9 kg, respectively, p=0.009). CT scans were performed on all lean pigs and on 6 obese 204 
controls and 5 obese clones, selected to be representative of the groups. A representative CT scan 205 
from each group is shown in Figure 1 and the percentage of total body fat calculated from these 206 
scans is shown in Figure 2. The CT scans showed a significantly higher percentage of total body fat 207 
(p=0.002) in the obese controls when compared to the obese clones. Furthermore, the obese controls 208 
had more back fat (p<0.0001) and abdominal SAT (p<0.0001) than the obese clones (data not 209 
shown). In addition, a significantly higher proportion of total body fat was seen in the obese 210 
controls (40.1%±1.5%) and obese clones (28.4%±2.3%) compared to the lean controls 211 
(21.8%±1.3%, p<0.0001) and lean clones (18.4%±2.5%, p=0.02), respectively.  212 
Pigs 198 
 213 
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Figure 1: Images from CT scan 214 
 215 
Representative CT scans of obese controls (A) and clones (B) and lean controls (C) and clones (D) 216 
done at endpoint. The thickness of fat was measured at the 3 lines drawn in the back fat and 217 
abdominal SAT, and a mean of the three measurements were found. Arrows indicate ribs, kidney, 218 
fat, skin and muscle. All measurements were done in scans from the last rib.  219 
 220 
A total of 43 immune related genes and 5 reference genes were analyzed. After quality control as 222 
described in (Rødgaard et al., 2012), a number of genes were found to yield sub-quality data and 223 
were excluded from further evaluation. This included MUC1, DEFB1 and IL12 for all tissues, 224 
SFTPA1, FIB, IFNG, LBP, IL1RN, ORM1 and IL10(b) for all adipose tissues and IL8(a) and IL6 225 
for the liver. Furthermore, when duplicate primer sets were used with similar results, only the result 226 
from one of the primer sets is shown (IL8(a) in the adipose tissues, IL10(a) for the liver and 227 
ITIH4(b) for all tissues). Significantly differentially expressed genes were defined as genes showing 228 
Gene expression 221 
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a statistically significant difference in expression (p≤0.05) and a fold change of at least ±1.5, 229 
comparing either two pig groups or two types of tissues (tissue expression patterns). 230 
Figure 2: Percent total body fat  231 
 232 
Percentage of total body fat in lean and obese clones and controls, as measured from CT scans 233 
done at endpoint. n=9 for lean controls, n=8 for lean clones, n=6 for obese controls, and n=5 for 234 
obese clones. Error bars depict SEM.   235 
 236 
The expression data for obese clones and obese controls (set to 1), for all tissues, are shown in Sup-237 
plementary Table 1, while Table 1 shows expression levels in adipose tissues (abdominal SAT and 238 
VAT) relative to neck SAT (set to 1) for all four pig groups, illustrating the tissue expression 239 
patterns for the 31 genes. 240 
Figure 3 shows the expression for all four tissues investigated of all genes that were significantly 241 
differentially expressed in obese as compared to lean pigs (set to 1) for both controls and for clones. 242 
 243 
Effect of cloning 244 
As a general observation, the inter-individual variability in gene expression between pigs in the 245 
group of obese clones was not different from that observed between individual pigs of the obese 246 
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control group as analyzed by the F-test (p=0.54 for liver, p=0.36 for abdominal SAT, p=0.87 for 247 
VAT and p=0.72 for neck SAT).    248 
Only few genes showed a significantly changed expression in obese clones compared to obese 249 
controls (Supplementary Table 1). Two genes were slightly (LBP) or moderately (SAA) 250 
significantly up-regulated in the liver, whereas one gene in each of the adipose tissues was affected 251 
by cloning (IL1B in abdominal SAT, C3 in VAT and IL18 in neck SAT). 252 
Tissue specific expression patterns, i.e. the relative expression in the three adipose tissues using the 253 
level of expression in neck SAT as a reference (i.e. set to 1 for each group) were compared for 31 254 
genes in obese clones versus obese controls (Table 1).  In the obese control group, differential 255 
expression was seen for a substantial number of genes with five genes being higher expressed in 256 
abdominal SAT than in neck SAT and five genes being higher expressed and one lower expressed 257 
in VAT than in neck SAT. In contrast, in the obese clones, only two genes in abdominal SAT and 258 
one gene in VAT were differentially expressed compared to neck SAT, all being higher expressed. 259 
In comparison, in the lean control group nine genes in abdominal SAT and 13 in VAT were 260 
significantly differentially expressed compared to neck SAT (all except two genes were higher 261 
expressed), while the corresponding numbers for lean clones were two and three, respectively. 262 
Differential expression in abdominal SAT compared to VAT (Table 1) were seen for eight genes in 263 
obese controls and for no genes in obese clones. In the lean group six genes were differentially 264 
expressed in abdominal SAT compared to VAT in the controls and two in the clones. 265 
Thus, both cloned groups showed a much reduced differentiated adipose tissue specific gene 266 
expression. 267 
 268 
 269 
 270 
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Supplementary Table 1: Overview of gene expression in the liver and three adipose tissues 271 
 272 
Relative innate immune gene expression in liver, abdominal SAT, VAT and neck SAT in obese 273 
cloned pigs as compared to obese controls (set to 1), as analyzed by qPCR ± SEM. a significant 274 
difference with a fold change of at least ±1.5; NQ = not quantifiable. 275 
AOAH 1.00 ± 0.11 1.35 ± 0.14 1.00 ± 0.21 0.91 ± 0.10 1.00 ± 0.15 1.26 ± 0.16 1.00 ± 0.33 0.84 ± 0.21
APOA1 1.00 ± 0.08 1.10 ± 0.11 1.00 ± 0.15 0.86 ± 0.08 1.00 ± 0.25 1.01 ± 0.17 1.00 ± 0.08 0.92 ± 0.09
C3 1.00 ± 0.06 1.00 ± 0.13 1.00 ± 0.32 0.49 ± 0.12 1.00 ± 0.15 0.51 ± 0.13a 1.00 ± 0.12 1.33 ± 0.32
CCL2 1.00 ± 0.28 0.85 ± 0.22 1.00 ± 0.12 1.02 ± 0.11 1.00 ± 0.25 0.86 ± 0.16 1.00 ± 0.09 0.86 ± 0.07
CCL3L1 1.00 ± 0.17 1.13 ± 0.21 1.00 ± 0.11 0.72 ± 0.06 1.00 ± 0.32 1.32 ± 0.44 1.00 ± 0.29 0.65 ± 0.09
CCL5 1.00 ± 0.11 1.15 ± 0.09 1.00 ± 0.08 1.27 ± 0.16 1.00 ± 0.22 0.98 ± 0.12 1.00 ± 0.07 1.03 ± 0.17
CD14 1.00 ± 0.07 1.09 ± 0.09 1.00 ± 0.10 0.99 ± 0.12 1.00 ± 0.23 1.31 ± 0.19 1.00 ± 0.05 0.89 ± 0.07
CD163 1.00 ± 0.11 1.34 ± 0.10 1.00 ± 0.13 1.12 ± 0.18 1.00 ± 0.23 1.11 ± 0.18 1.00 ± 0.09 0.91 ± 0.12
CD200 1.00 ± 0.09 0.99 ± 0.10 1.00 ± 0.13 1.18 ± 0.12 1.00 ± 0.13 1.11 ± 0.10 1.00 ± 0.05 0.81 ± 0.08
CD36 1.00 ± 0.09 1.11 ± 0.12 1.00 ± 0.10 0.93 ± 0.12 1.00 ± 0.12 1.27 ± 0.16 1.00 ± 0.05 1.01 ± 0.05
CD40 1.00 ± 0.07 0.97 ± 0.08 1.00 ± 0.12 1.01 ± 0.11 1.00 ± 0.28 1.03 ± 0.33 1.00 ± 0.04 0.87 ± 0.08
COX-2 1.00 ± 0.37 1.22 ± 0.38 1.00 ± 0.16 1.01 ± 0.22 1.00 ± 0.30 0.62 ± 0.24 1.00 ± 0.32 0.68 ± 0.15
CRP 1.00 ± 0.21 2.11 ± 0.54 1.00 ± 0.59 0.12 ± 0.06 1.00 ± 0.13 1.21 ± 0.21 1.00 ± 0.09 1.61 ± 0.60
CXCL10 1.00 ± 0.18 0.71 ± 0.06 1.00 ± 0.11 0.88 ± 0.11 1.00 ± 0.22 1.20 ± 0.24 1.00 ± 0.19 0.70 ± 0.06
FIB 1.00 ± 0.11 1.12 ± 0.14
HP 1.00 ± 0.07 1.24 ± 0.15 1.00 ± 0.60 0.09 ± 0.06 1.00 ± 0.26 0.58 ± 0.13 1.00 ± 0.15 3.15 ± 1.53
IFNG 1.00 ± 0.22 1.46 ± 0.36
IL10 1.00 ± 0.14 1.65 ± 0.36 1.00 ± 0.14 0.95 ± 0.10 1.00 ± 0.17 1.05 ± 0.15 1.00 ± 0.06 0.84 ± 0.11
IL18 1.00 ± 0.08 1.34 ± 0.07 1.00 ± 0.24 1.66 ± 0.36 1.00 ± 0.23 1.35 ± 0.41 1.00 ± 0.04 1.59 ± 0.27a
IL1B 1.00 ± 0.13 1.25 ± 0.24 1.00 ± 0.18 1.97 ± 0.35a 1.00 ± 0.54 1.97 ± 1.04 1.00 ± 0.20 1.77 ± 0.42
IL6 1.00 ± 0.14 0.98 ± 0.15 1.00 ± 0.44 1.48 ± 0.60 1.00 ± 0.18 0.81 ± 0.10
IL1RN 1.00 ± 0.14 0.77 ± 0.11
IL8(a) 1.00 ± 0.29 0.57 ± 0.09 1.00 ± 0.43 1.02 ± 0.28 1.00 ± 0.48 0.29 ± 0.09 1.00 ± 0.19 1.54 ± 0.34
ITIH4(a) 1.00 ± 0.10 1.67 ± 0.34 1.00 ± 0.58 0.24 ± 0.09 1.00 ± 0.15 0.72 ± 0.12 1.00 ± 0.12 1.11 ± 0.16
LBP 1.00 ± 0.23 1.80 ± 0,31a
NFkB1 1.00 ± 0.06 0.93 ± 0.06 1.00 ± 0.05 1.05 ± 0.05 1.00 ± 0.09 1.05 ± 0.07 1.00 ± 0.03 0.92 ± 0.04
NFKBIA 1.00 ± 0.07 0.91 ± 0.09 1.00 ± 0.05 1.11 ± 0.09 1.00 ± 0.11 0.91 ± 0.11 1.00 ± 0.06 1.03 ± 0.11
ORM1 1.00 ± 0.09 1.25 ± 0.17
PAFAH1B1 1.00 ± 0.06 0.92 ± 0.05 1.00 ± 0.03 1.02 ± 0.04 1.00 ± 0.08 1.03 ± 0.08 1.00 ± 0.02 0.92 ± 0.05
PDB2 1.00 ± 0.19 1.26 ± 0.32 1.00 ± 0.14 0.66 ± 0.11 1.00 ± 0.24 1.15 ± 0.25 1.00 ± 0.07 0.96 ± 0.10
SFTPA1 1.00 ± 0.36 0.59 ± 0.15
SAA 1.00 ± 0.24 3.06 ± 1,17a 1.00 ± 0.66 0.13 ± 0.10 1.00 ± 0.23 0.52 ± 0.04 1.00 ± 0.29 1.33 ± 0.73
TF 1.00 ± 0.08 1.22 ± 0.08 1.00 ± 0.59 0.05 ± 0.01 1.00 ± 0.46 0.83 ± 0.20 1.00 ± 0.28 1.99 ± 0.84
TGFB1 1.00 ± 0.07 1.03 ± 0.07 1.00 ± 0.07 1.06 ± 0.08 1.00 ± 0.15 0.93 ± 0.14 1.00 ± 0.04 1.00 ± 0.10
TLR4 1.00 ± 0.09 1.20 ± 0.10 1.00 ± 0.13 0.98 ± 0.15 1.00 ± 0.14 1.15 ± 0.17 1.00 ± 0.07 0.78 ± 0.05
TNF 1.00 ± 0.13 1.20 ± 0.20 1.00 ± 0.15 1.12 ± 0.11 1.00 ± 0.20 1.33 ± 0.20 1.00 ± 0.14 0.97 ± 0.07
TNFAIP3 1.00 ± 0.09 0.80 ± 0.09 1.00 ± 0.11 0.93 ± 0.09 1.00 ± 0.13 1.31 ± 0.28 1.00 ± 0.08 0.85 ± 0.13
Liver
Controls Clones Controls Clones
Abdominal SAT
NQ
ClonesControls
VAT Neck SAT
ClonesControls
NQ NQ NQ NQ NQ
NQNQNQ NQ NQ NQ
NQ NQ
NQ NQ NQ NQ NQ
NQ NQ NQ NQ NQ NQ
NQ
NQ
NQNQ NQ NQ NQ NQ
NQ NQ NQ NQ NQ
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Table 1: Comparative gene expression of the three adipose tissues in lean and obese pigs 276 
 277 
Relative innate immune gene expression in abdominal SAT, VAT as compared to neck SAT (set to 1) in lean and obese controls and clones, as analyzed by 278 
qPCR ± SEM. a= significant difference and fold change of at least ± 1.5 between abdominal SAT/VAT and neck SAT, b = significant difference and fold 279 
change of at least ±1.5 between abdominal SAT and VAT.   280 
APOA1 0.71 ± 0.08 0.70 ± 0.13 1.00 ± 0.05 0.64 ± 0.09 0.72 ± 0.07 1.00 ± 0.14 1.00 ± 0.14 0.68 ± 0.17 1.00 ± 0.08 0.94 ± 0.09 0.76 ± 0.12 1.00 ± 0.05
CD14 1.75 ± 0.19 0.95 ± 0.13 1.00 ± 0.06 1.66 ± 0.21 1.07 ± 0.13 1.00 ± 0.10 1.52 ± 0,15b 0.84 ± 0,19b 1.00 ± 0.05 1.43 ± 0.18 1.04 ± 0.15 1.00 ± 0.06
CD40 2.42 ± 0,30a 3.02 ± 0,98a 1.00 ± 0.10 1.47 ± 0.16 1.49 ± 0.10 1.00 ± 0.09 1.28 ± 0.16 2.05 ± 0.58 1.00 ± 0.04 1.71 ± 0.19 2.78 ± 0.89 1.00 ± 0.10
C3 3.28 ± 0,88a 4.73 ± 0,60a 1.00 ± 0.29 1.42 ± 0.32 2.45 ± 0.53 1.00 ± 0.14 5.75 ± 1,83a 5.68 ± 0,84a 1.00 ± 0.12 1.41 ± 0.33 1.43 ± 0.38 1.00 ± 0.29
CRP 0.79 ± 0.09 0.77 ± 0.34 1.00 ± 0.27 1.16 ± 0.11 0.63 ± 0.05 1.00 ± 0.15 15.68 ± 9,21ab 0.61 ± 0,08b 1.00 ± 0.09 1.08 ± 0.55 0.41 ± 0.07 1.00 ± 0.27
PDB2 1.58 ± 0.33 1.10 ± 0.26 1.00 ± 0.13 0.39 ± 0.06 0.38 ± 0.11 1.00 ± 0.48 1.25 ± 0.17 1.01 ± 0.24 1.00 ± 0.07 0.78 ± 0.12 1.08 ± 0.24 1.00 ± 0.13
HP 1.77 ± 0.83 2.14 ± 1.30 1.00 ± 0.45 0.44 ± 0.17 0.46 ± 0.08 1.00 ± 0.69 32.13 ± 19,24ab 1.98 ± 0,52b 1.00 ± 0.15 0.74 ± 0.47 0.28 ± 0.06 1.00 ± 0.45
IL8(a) 6.78 ± 2,59a 17.01 ± 8,47a 1.00 ± 0.28 0.98 ± 0.22 1.88 ± 0,44a 1.00 ± 0.82 3.09 ± 1.20 10.49 ± 4,72a 1.00 ± 0.14 3.07 ± 0.79 3.49 ± 1.10 1.00 ± 0.28
IL1b 2.83 ± 0.77 11.72 ± 4,43a 1.00 ± 0.20 2.26 ± 0.66 4.54 ± 1.71 1.00 ± 0.38 1.58 ± 0.28 5.63 ± 3,03a 1.00 ± 0.20 2.73 ± 0.48 9.73 ± 5.11 1.00 ± 0.20
IL6 0.47 ± 0,17b 2.83 ± 0,73b 1.00 ± 0.20 0.81 ± 0.29 1.74 ± 0.50 1.00 ± 0.56 1.22 ± 0.17 2.68 ± 1.17 1.00 ± 0.18 0.63 ± 0.10 2.09 ± 0.84 1.00 ± 0.20
IL10(a) 2.43 ± 0,26a 1.95 ± 0,22a 1.00 ± 0.09 1.35 ± 0.18 1.12 ± 0.18 1.00 ± 0.31 1.38 ± 0.19 1.48 ± 0.25 1.00 ± 0.06 1.97 ± 0.21 2.33 ± 0,34a 1.00 ± 0.09
IL18 8.51 ± 1,70a 4.68 ± 1,66a 1.00 ± 0.10 2.66 ± 0,52a 1.52 ± 0.40 1.00 ± 0.48 3.00 ± 0,73a 3.46 ± 0,81a 1.00 ± 0.04 6.05 ± 1,33a 5.68 ± 1.74 1.00 ± 0.10
ITIH4(b) 0.99 ± 0.10 1.69 ± 0.41 1.00 ± 0.07 0.96 ± 0.18 0.99 ± 0.18 1.00 ± 0.05 7.25 ± 4.20 1.21 ± 0.18 1.00 ± 0.12 1.59 ± 0.60 0.81 ± 0.14 1.00 ± 0.07
SAA 32.54 ± 21,62a 1.94 ± 0.29 1.00 ± 0.17 1.88 ± 0.50 0.57 ± 0.06 1.00 ± 0.15 45.37 ± 30,16ab 1.15 ± 0,26b 1.00 ± 0.29 7.45 ± 5,42a 0.74 ± 0.06 1.00 ± 0.17
TGFB 1.75 ± 0,10a 2.09 ± 0,26a 1.00 ± 0.05 1.39 ± 0.09 1.54 ± 0.14 1.00 ± 0.09 1.22 ± 0.09 1.54 ± 0.22 1.00 ± 0.04 1.51 ± 0.12 1.67 ± 0.25 1.00 ± 0.05
TNF 1.25 ± 0.16 1.54 ± 0.36 1.00 ± 0.14 1.23 ± 0.15 0.97 ± 0.16 1.00 ± 0.22 0.98 ± 0.15 1.28 ± 0.25 1.00 ± 0.14 1.50 ± 0.15 2.33 ± 0.35 1.00 ± 0.14
TLR4 1.68 ± 0,27a 0.78 ± 0.08 1.00 ± 0.03 1.85 ± 0,27b 0.87 ± 0,13b 1.00 ± 0.11 1.21 ± 0,15b 0.67 ± 0,10b 1.00 ± 0.07 1.29 ± 0.20 0.84 ± 0.12 1.00 ± 0.03
AOAH 1.22 ± 0.13 1.16 ± 0.20 1.00 ± 0.06 0.95 ± 0.10 0.94 ± 0.09 1.00 ± 0.10 0.92 ± 0.19 0.76 ± 0.11 1.00 ± 0.33 1.52 ± 0.16 1.76 ± 0.22 1.00 ± 0.06
CXCL10 1.79 ± 0.49 2.16 ± 0.46 1.00 ± 0.14 0.60 ± 0.36 1.12 ± 0.87 1.00 ± 0.88 1.30 ± 0.14 1.18 ± 0.26 1.00 ± 0.19 1.28 ± 0.15 1.57 ± 0.31 1.00 ± 0.14
CCL3LI 1.43 ± 0,23b 6.19 ± 2,47ab 1.00 ± 0.20 1.81 ± 0.19 4.85 ± 0,93a 1.00 ± 0.17 1.14 ± 0.13 1.80 ± 0.58 1.00 ± 0.29 1.38 ± 0.12 3.99 ± 1.33 1.00 ± 0.20
CCL2 1.89 ± 0.25 3.66 ± 0,72a 1.00 ± 0.14 1.45 ± 0.15 2.01 ± 0.46 1.00 ± 0.31 1.05 ± 0.13 1.85 ± 0.47 1.00 ± 0.09 1.25 ± 0.14 1.87 ± 0.36 1.00 ± 0.14
CCL5 1.17 ± 0,24b 2.59 ± 0,28ab 1.00 ± 0.12 0.84 ± 0,05b 2.76 ± 0,49ab 1.00 ± 0.10 0.92 ± 0,07b 1.87 ± 0,42b 1.00 ± 0.07 1.26 ± 0.16 2.00 ± 0.24 1.00 ± 0.12
PAFAH1B1 0.99 ± 0,03b 0.71 ± 0,05ab 1.00 ± 0.02 1.14 ± 0.07 0.90 ± 0.06 1.00 ± 0.04 0.90 ± 0.03 0.76 ± 0.06 1.00 ± 0.02 0.90 ± 0.04 0.77 ± 0.06 1.00 ± 0.02
TNFAIP3 0.98 ± 0.08 1.29 ± 0.21 1.00 ± 0.06 1.03 ± 0.12 1.29 ± 0.23 1.00 ± 0.14 1.03 ± 0.11 1.14 ± 0.15 1.00 ± 0.08 0.94 ± 0.09 1.47 ± 0.31 1.00 ± 0.06
CD163 1.93 ± 0.16 1.27 ± 0.15 1.00 ± 0.12 1.54 ± 0.21 0.96 ± 0.12 1.00 ± 0.13 1.37 ± 0.17 1.01 ± 0.23 1.00 ± 0.09 2.34 ± 0.37 1.72 ± 0.29 1.00 ± 0.12
NFKB1 1.27 ± 0.09 1.08 ± 0.07 1.00 ± 0.02 1.11 ± 0.09 0.96 ± 0.06 1.00 ± 0.14 1.09 ± 0.06 0.95 ± 0.08 1.00 ± 0.03 1.14 ± 0.06 0.99 ± 0.07 1.00 ± 0.02
NFKBIA 1.02 ± 0,12b 1.94 ± 0,30ab 1.00 ± 0.08 0.63 ± 0.08 0.90 ± 0.10 1.00 ± 0.30 0.98 ± 0,05b 1.52 ± 0,17ab 1.00 ± 0.06 1.07 ± 0.09 1.36 ± 0.16 1.00 ± 0.08
TF 1.67 ± 1.11 1.86 ± 1.47 1.00 ± 0.34 0.53 ± 0.28 0.13 ± 0.03 1.00 ± 0.69 11.62 ± 6,80b 0.38 ± 0,18b 1.00 ± 0.28 0.26 ± 0.06 0.14 ± 0.03 1.00 ± 0.34
CD36 0.42 ± 0.09 0.49 ± 0,07a 1.00 ± 0.06 0.78 ± 0.13 0.93 ± 0.05 1.00 ± 0.15 0.79 ± 0.08 0.53 ± 0,06a 1.00 ± 0.05 0.62 ± 0.08 0.57 ± 0.07 1.00 ± 0.06
COX2 1.21 ± 0.23 3.03 ± 0.54 1.00 ± 0.19 0.74 ± 0.18 1.51 ± 0.37 1.00 ± 0.65 1.29 ± 0.20 2.38 ± 0.71 1.00 ± 0.32 1.23 ± 0.27 1.39 ± 0.55 1.00 ± 0.19
CD200 2.41 ± 0,33ab 1.23 ± 0,19b 1.00 ± 0.13 2.05 ± 0,30a 1.41 ± 0.12 1.00 ± 0.20 1.22 ± 0.16 1.10 ± 0.15 1.00 ± 0.05 1.41 ± 0.15 1.20 ± 0.11 1.00 ± 0.13
Neck SATAbd. SAT VAT Neck SAT Abd. SAT VAT Neck SAT Abd. SAT VAT Neck SAT Abd. SAT VAT
Controls (n=9) Controls (n=10)Clones (n=8) Clones (n=9)
Lean Obese
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Effect of obesity 281 
Considering the effect of obesity on liver gene expression in controls and clones, respectively, a 282 
mixed effect was seen in the control group (Figure 3A) with 3 out of 8 significantly differentially 283 
expressed genes being up-regulated, namely two chemokine genes (IL8 and CXCL10) as well as 284 
SFTPA1. The effect of obesity on gene expression in the liver of the cloned pigs (Figure 3B) was 285 
limited to only two genes being up-regulated (IL8 and IL18) and HP being down-regulated with all 286 
changes being very small. A more limited effect of obesity in cloned as compared to control pigs 287 
was also seen on abdominal SAT gene expression as only one gene was down-regulated to a minor 288 
degree in obese cloned pigs (TLR4, Figure 3D) while in the obese control group (Figure 3C) five 289 
genes were changed compared to lean controls, two of which were up-regulated to a minor degree 290 
(APOA1 and CD36). In the neck SAT (Figure 3G) five genes were affected by obesity in control 291 
pigs, while only two genes changed expression in cloned pigs (Figure 3H) (down-regulation of 292 
ITIH4 and NFKBIA). In VAT, in contrast to the other tissues, a higher number of genes was 293 
affected by obesity in the cloned group compared to the control group (Figure 3E and F); in the 294 
latter C3 was the only gene affected (minor down-regulation) while four down-regulated genes 295 
were observed in the cloned group (IL8, ITIH4, CCL5 and COX-2). As a general trend, all adipose 296 
tissue genes changing expression as an effect of obesity in the cloned group were down-regulated 297 
while obesity had a mixed effect on adipose tissue gene expression in the control group (Figure 3).  298 
The effect of obesity on tissue specific expression patterns, using neck SAT expression as the 299 
reference (set to 1) can also be seen in Table 1. The five genes being higher expressed in abdominal 300 
SAT of obese controls included one cytokine (IL18) and a group of APPs (C3, CRP, HP and SAA) 301 
and the six differentially expressed genes in VAT represented all groups of immune factors.  302 
 303 
 304 
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Figure 3: Control vs. clones – significant genes 305 
 306 
Significantly differentially expressed genes in lean (set to 1) compared to obese in clones and 307 
controls with a fold change of ±1.5 in liver (A+B), abdominal SAT (C+D), VAT (E+F) and neck 308 
SAT (G+H) as measured with qPCR. For all tissues; controls n=9 and clones n=8 (n=7 in neck 309 
SAT). Error bars depict SEM. *=p<0.05, **=p<0.01 and ***=p<0.001. 310 
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In both  abdominal SAT and VAT of lean controls, a wide range of innate immune factors, the 311 
cytokines IL10, IL18 and TGFB, the APPs C3 and SAA, the chemokine IL8 and the immune 312 
related factors CD40, CD200 and TLR4 were differentially expressed with additional differential 313 
expression by IL18, CCL2, CCL3L1 and CCL5 in VAT. In obese clones, abdominal SAT showed 314 
differential expression of only SAA and IL18 while only IL10 was differentially expressed in VAT. 315 
In comparison, lean clones showed differential expression of IL18 and CD200 in both abdominal 316 
SAT and VAT with the addition of a group of chemokines (IL8, CCL3L1 and CCL5) in VAT. 317 
Finally, genes being differentially expressed between abdominal SAT and VAT were six and eight 318 
for lean and obese controls, respectively and two and 0 for lean and obese clones, respectively. 319 
Thus, generally, differential tissue expression was reduced by cloning and further reduced by 320 
obesity. 321 
 322 
Serum protein concentrations of ORM, HP and CRP in the lean and obese controls and clones are 324 
shown in Figure 4. IL-6, SAA and TNF-α were below the lower limit of detection for most samples. 325 
Possible outlier data points were pin-pointed by the Grubbs test and removed (1 for ORM, 1 for HP 326 
and 2 for CRP).  327 
Protein concentrations in serum 323 
The inter-individual variation in specific serum protein concentrations between animals of the 328 
cloned groups was compared to the variation between the animals in the control groups, using the 329 
F-test. The variance was found to be not equal for ORM (p=0.05) and CRP (p=0.02), and bordering 330 
on significance for HP (p=0.053). However, only for ORM the inter-individual variance was 331 
reduced in the clones; for the two other proteins the clones showed higher inter-individual variation 332 
than the controls. 333 
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The APPs ORM (p=0.03) and HP (p=0.02) had a significantly higher serum concentration in the 334 
obese clones compared to the obese controls, being increased approximately 50% and 120%, 335 
respectively. CRP also was slightly (although not significantly) elevated in the obese clones. 336 
Furthermore, there was a clear and significant higher serum concentration of ORM in obese clones 337 
compared to lean clones (p=0.0002), and a tendency for the same to be true for HP and CRP. This 338 
was not seen for lean controls compared to obese controls. 339 
Figure 4: Protein quantification in the serum 340 
 341 
Mean serum concentrations of ORM 
(A-C), HP (D-F) and CRP (G-I) 
measured with ELISA in obese clones 
vs. controls (A, D, G), in lean vs. obese 
controls (B, E, H) and lean vs. obese 
clones (C, F, I). Error bars depict 
SEM. For lean controls n=9 for ORM 
and n=8 for HP and CRP, for lean 
clones n=7 for ORM and CRP and n=8 
for HP, for obese controls n=10 and 
for obese clones n=9. *=p<0.05 and 
***=p<0.001. 
 
 58 
 
Discussion 342 
Both obese pig groups (controls and clones) in this study had a significantly increased body weight 343 
and percentage of body fat compared to both lean groups, however, while the weights of lean 344 
controls and lean clones were not significantly different (Rødgaard et al., 2012), cloned obese pigs 345 
weighed significantly less than the obese controls and had significantly lower percentage of body 346 
fat. Biochemical values reported elsewhere (Christensen et al., 2012) indicate that the feed intake of 347 
the obese clones was significantly lower and the daily weight gain correspondingly smaller than 348 
seen with the obese controls. As discussed below this potentially could hamper the comparison of 349 
adipose gene expression in obese clones with that of obese controls. 350 
It was not possible in this study to demonstrate a lower intra-individual variation in the cloned pigs 351 
compared to that of the control pigs for either gene expression or serum protein concentrations, 352 
except for the serum concentrations of ORM. This supports other recent findings in pigs cloned by 353 
SCNT (Christensen et al., 2012;Clausen et al., 2011;Hwang et al., 2009;Park et al., 2011;Rødgaard 354 
et al., 2012;Whyte et al., 2011). For the serum proteins CRP and HP, the trend was that the inter-355 
individual variation was even higher in the cloned group than in the control group. 356 
First, the effect of cloning on innate immune gene expression was studied in the two obese pig 357 
groups (clones vs. controls). In the liver (Supplementary Table 1) gene expression was unchanged 358 
by cloning except for two significantly differentially up-regulated genes (LBP and SAA), however, 359 
the approximately 3 fold up-regulation in liver SAA expression in obese clones was not reflected in 360 
serum SAA concentration (data not shown). The same pattern was observed in lean clones 361 
compared to lean controls, as SAA expression in the liver was up regulated by 2.5 fold with no 362 
concomitant rise in serum SAA concentrations (Rødgaard et al., 2012). In each of the adipose 363 
tissues one gene showed a changed expression in obese cloned pigs compared to obese controls 364 
(Supplementary Table 1). Overall, the number of genes which was differentially expressed in obese 365 
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clones compared to obese controls were smaller than observed in lean clones compared to lean 366 
controls, where 2-5 genes were differentially expressed in the adipose tissues (Rødgaard et al., 367 
2012). For tissue expression patterns only very few genes were expressed at significantly different 368 
levels in VAT and abdominal SAT compared to neck SAT in the cloned pigs. As discussed below, 369 
cloning also reduced differentiated expression in lean pigs (Rødgaard et al., 2012), however not to 370 
the same degree as seen in obese pigs. 371 
Second, the response to obesity was compared between clones and controls. In all other tissues than 372 
VAT, obesity resulted in fewer gene expression changes in cloned pigs than in control pigs. In 373 
cloned pigs all adipose tissue genes affected by obesity were down-regulated, while in the adipose 374 
tissue of the control pigs a mixed gene expression response to obesity was seen. The general down-375 
regulation of the adipose tissue response to obesity in the clones observed here is surprising as it 376 
does not confirm the elevated levels of immune factors reported to be secreted by adipose tissue in 377 
obese subjects (reviewed by for example (Fain, 2010;Weisberg et al., 2003)). Several of the innate 378 
immune factors investigated here are known to be secreted by active immune cells in adipose tissue 379 
(Fain et al., 2004;Weisberg et al., 2003). Increased infiltration and activity of immune cells are 380 
expected in obesity as part of the low-grade adipose-located inflammation implicated in the obesity-381 
related disease syndrome (Bastard et al., 2006;Hotamisligil, 2006), however, one possible reason 382 
why the adipose tissue of the obese clones express less chemokines and/or the immune cells might 383 
not be activated to the same degree as seen in the controls, could be that obese clones were 384 
significantly less obese than the obese controls in this study. 385 
Finally, looking at relative gene expression levels (differential expression) between the three 386 
adipose tissue types, neck SAT generally showed the lowest gene expression levels of the immune 387 
factors studied here in all four groups of pigs. More genes were more highly expressed in either 388 
VAT or abdominal SAT or both in the controls compared to the clones. In the obese clones this 389 
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could be explained by the difference in percentage of body fat between the obese clones and 390 
controls (Figure 1 and 2), however, this does not explain the lowered gene expression changes in 391 
lean clones compared to lean controls. The weights of lean clones and controls were similar, even 392 
though a significantly different daily weight gain was observed, and the two groups shows a very 393 
similar response to the diet, as reported by (Christensen et al., 2012). Therefore, it would seem that 394 
the cloning procedure in itself is a factor in limiting the differentiation of innate immune response 395 
genes.  396 
Differences between controls and cloned animals were also observed for the serum concentrations 397 
of APPs, including ORM and HP (with CRP showing the same tendency), as obese, cloned pigs 398 
showed significantly increased serum concentrations of those APPs. It is of interest to note that the 399 
liver expression of HP was in fact down-regulated in obese clones compared to lean clones and not 400 
found to be changed in any other tissue; thus the observed increase in serum HP concentration must 401 
be ascribed to other, unknown sources. Blood plasma concentration of CRP, SAA and IL-6 were 402 
found to be elevated in overweight women with cardiovascular disease (Ridker et al., 2000) and 403 
serum concentrations of ORM and HP were increased in obese humans (Chiellini et al., 2004;Lee et 404 
al., 2010) so taken alone the cloned pigs seem to reflect this obesity response better than the control 405 
pigs, even if pro-inflammatory cytokines like TNF-α and IL-6, classically involved in the low-grade 406 
inflammation of obesity (reviewed in (Tataranni and Ortega, 2005)) were not detected in either 407 
obese controls or obese clones (data not shown).  408 
Overall, cloning decreased the number of genes responding to obesity in all tissues (except VAT) 409 
investigated and also decreased the number of genes being differentially expressed in the three 410 
different adipose tissues investigated, both in lean and obese pigs. There was a small difference in 411 
the genetic background of the clones (65% Landrace; 35% Yorkshire) and the two control 412 
crossbreeds (36%:64% and 75%:25%) however it may be assumed that this small genetic difference 413 
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will not by itself lead to the observed gene expression differences between clones and controls. This 414 
is supported by the fact that the two genetically slightly different control cross breeds did not show 415 
any difference in reference gene expression.  416 
One possible explanation for the more limited gene expression changes seen in obese cloned 417 
animals as opposed to obese control animals is the lower feed intake of the cloned pigs (Christensen 418 
et al., 2012) and the consequently lower final weight than the obese controls, simply leading to a 419 
reduced “obesity effect” on the animal. Interestingly, however, we did find changes (increases) in 420 
the serum concentrations of APPs in the obese, cloned pig group compared to the other three groups 421 
while control pigs showed obesity induced changes in the expression in a number of innate immune 422 
system related genes in all of the four tissues investigated. These controls, however, did not show 423 
any change in circulating APP or cytokine serum concentrations as a response to obesity. Taken 424 
together this may indicate that the less differentiated and more constant expression of innate 425 
immune genes in the cloned pigs might result in a decreased ability to cope with obesity as 426 
indicated by the observable changes in APP concentrations. This is probably related to 427 
inflammation and is originating from an extra-hepatic source. 428 
In summary, as in the lean pigs (Rødgaard et al., 2012) cloning did not reduce inter-individual 429 
variability in innate immune gene expression between obese pigs. Furthermore, cloning influenced 430 
the expression of 1-2 innate immune genes in each of the tissues of obese clones compared to obese 431 
controls. In light of these results and other published data (Christensen et al., 2012;Clausen et al., 432 
2011;Jensen et al., 2010) it can be concluded that cloning does not increase the usability of pigs as 433 
model animals for innate responses to diet-induced obesity, even though cloned pigs showed an 434 
increase in serum APP concentrations in agreement with human studies. 435 
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4 Study II – Göttingen and Ossabaw minipigs 
As explained in Chapter 3 the obese phenotypes pigs from the Nutriomics project were not utilized in the 
work for this thesis and we therefore had to locate other pigs that could serve as such. As a result, we have 
established collaborations with groups and universities that have made two obese phenotype pigs available 
to us; namely the Göttingen minipig and the Ossabaw minipig.  
 
4.1 Background 
Samples from the Göttingen minipigs were made available through a collaboration with Novo Nordisk A/S 
and the University of Copenhagen. Seven female obese Göttingen minipigs had been used in therapeutic 
studies investigating the effect of different therapeutic peptides on obesity by Novo Nordisk. As the pigs 
were nearing termination, Novo Nordisk A/S offered them to be investigated by different groups and 
universities. Seven female lean age matched controls were purchased from Ellegaard Göttingen Minipigs 
A/S (Dalmose, Denmark) where the obese pigs had been purchased originally as well. All pigs were 
ovariectomized. Obesity was induced by ad libitum feeding and the lean pigs received 2 x 150 g gram a day. 
Both groups were fed standard minipig chow, so the obese pigs were not fed high fat, high sugar or high 
cholesterol diets. Nonetheless, the obese minipigs weighed significantly more and had a significantly higher 
body fat percent than the lean pigs, as evident by the pictures in Figure 10. For phenotypic characterization 
of these pigs, see Table 10, Paper III p. 70 and Paper IV p. 95. The pigs were housed at the stables at the 
University of Copenhagen (Taastrup, Denmark). Several investigations have been performed in these pigs 
so far, however, none have been published yet. 
 
Figure 10: Pictures of a lean and an obese Göttingen minipig. Courtesy of the University of Copenhagen and Novo Nordisk A/S. 
Samples from the Ossabaw minipigs were made available through a collaboration with Professor Michael 
Sturek and his group at the University of Indiana. Samples from several studies were made available to us, 
however, as we were interested in the effects of obesity, only samples from one study into obesity and 
polycystic ovary syndrome (PCO) was used (the Ossabaw14 study). The study comprised of 12 female pigs; 
seven lean and five obese, however, we were not supplied with samples from all pigs: We received a full set 
of samples from abdominal SAT and VAT, no samples from the neck SAT, liver samples from only six lean 
pigs, and serum samples from six lean and four obese pigs. The lean pigs were fed a standard chow (5L80) 
Lean Obese 
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and the obese pigs were fed an atherogenic diet. Both diets are further described in (Lee et al. 2009). All 
pigs were obtained from the Indiana University-Purdue University Indianapolis Medical Center and they 
were reared and housed at Purdue University breeding colony (West Lafayette, IN, USA). Obese Ossabaw 
minipigs weighed significantly more than the lean pigs, as depicted in Figure 11. For phenotypic 
characterization of these pigs, see Paper IV p. 95, Table 10 and (Lee et al. 2009). 
 
Figure 11: Pictures of a lean and an obese Ossabaw minipig. Source: (Kreutz et al. 2011) 
 
4.1.1 Göttingen and Ossabaw minipigs as model animals for nutritional studies 
The Ossabaw and Göttingen breeds of minipigs have been thoroughly investigated as models for obesity-
induced metabolic pathologies.   4.1.1.1 The Göttingen minipig 
The Göttingen minipig is developed by crossbreeding the Vietnamese swine, the Hormel, and German 
improved Landrace swine in the 1960s at the Institute of Animal Breeding and Genetics at the University of 
Göttingen in Germany. It has been developed and used extensively as a model for diabetes by researchers 
at Novo Nordisk A/S, among others, and the use of Göttingen as a model for diabetes is reviewed in (Larsen 
& Rolin 2004). Both female and male Göttingen minipigs become obese when fed a high-fat high-energy 
diet, with increased body weights and body fat (Bollen et al. 2005). When compared to males, female 
Göttingen minipigs had significantly higher body weights, were more obese and had a more atherogenic 
plasma profile than male minipigs, therefore, female Göttingen minipigs have been suggested to be better 
models for MetS than male minipigs (Bollen et al. 2005; Christoffersen et al. 2007). Furthermore, age have 
an impact on plasma concentrations of several metabolic factors, including increased levels of triglycerides 
and glucose, in both female and male pigs (Christoffersen et al. 2007; Larsen et al. 2001). 
 4.1.1.2 The Ossabaw minipig 
The Ossabaw minipig is a feral breed found on the Ossabaw Island, GA, USA. It is believed that the 
population on the island is derived from pigs being left on the island in the 1500s by Spanish explorers, and 
since then have been subjected to a selection pressure of seasonal feast and famine ecology of the 
Ossabaw Island, which has led to the adaptation of a “thrifty genotype” in the pigs (Sturek et al. 2007). The 
thrifty genotype hypothesis is that humans have had to develop an ability to store excess fat in the hunter-
gatherer stages of human development in order to survive periods of famine (Neel 1962). Due to this, and 
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other unique adaptations to their natural habitat, the Ossabaw minipigs were studied extensively in the 
1970s and 1980s, as described in (Sturek et al. 2007). In the beginning of the 2000s, the Ossabaw minipig 
sparked renewed interest because of the obesity and diabetes epidemic, and a breeding colony was 
established at the University of Indiana, USA, after an expedition to the island in 2002.  
When compared to Yorkshire pigs which is a lean phenotype pig, it was found that Ossabaws have more 
back fat; 2.64 cm in Yorkshire, and 5.97 cm in age-matched Ossabaws (Hausman & Martin 1981), and when 
dietary restricted to 65% of ad libitum intake, the Yorkshire had a 7-fold decrease in adipose tissue, where 
Ossabaw pigs only had a 2.6-fold decrease in adipose tissue (Etherton et al. 1982; Etherton & Kris-Etherton 
1980). When fed excess calories, the Ossabaw minipigs develops several symptoms of the MetS, including 
intra-abdominal obesity, insulin resistance and impaired glucose tolerance (Wangsness et al. 1977; 
Wangsness et al. 1980), as well as increased triglyceride and cholesterol levels in the blood (Etherton & 
Kris-Etherton 1980), when compared to lean Ossabaw pigs. As these studies were done before the MetS 
was recognized as a serious health problem, several studies were done to confirm the metabolic 
characteristics of male and female Ossabaw minipigs in the 2000s (Dyson et al. 2006; Neeb et al. 2010; Lee 
et al. 2009) and it was found that female obese Ossabaw minipigs had 5 characteristics of the MetS (Dyson 
et al. 2006). Therefore the Ossabaw minipigs has been proposed as one of the best porcine models for 
obesity, MetS and diabetes not induced by chemicals (Bellinger et al. 2006). 
 
4.2 Hypothesis for Study II 
• Lean and obese Ossabaw and Göttingen minipigs show differential tissue and blood serum 
expression of innate immune factors 
• In the Göttingen minipigs the adipose tissue from the abdomen; retroperitoneal adipose tissue 
(RPAT) and VAT, have a higher number of innate immune response genes that are affected by 
obesity than the neck SAT  
• The Ossabaw and Göttingen minipigs have similar responses to obesity in terms of the innate 
immune response as humans 
 
4.3 Results for Study II – Göttingen minipigs 
4.3.1 Pre-PCR data for Göttingen minipigs 
 
Tissue ng/µl 260/230 260/280 RIN 
Liver 129-1418 
(413) 
1.87-2.20 
(2.06) 
2.02-2.13 
(2.08) 
8.3-9.5 
(9.0) 
RPAT 58-811 
(264) 
0.28-2.16 
(1.45) 
1.85-1.97 
(1.78) 
2.5-8.2 
(7.1) 
VAT 48-739 
(510) 
0.94-2.15 
(1.53) 
1.63-2.06 
(1.93) 
2.4-6.8 
(5.5) 
Neck SAT 41-606 
(252) 
0.50-2.03 
(1.53) 
1.58-1.97 
(1.79) 
5.4-7.5 
(6.8) 
Table 6: Yields, ratios and RINs of the Göttingen minipigs in the four measured tissues. The                                
lowest and highest values are shown, with the mean in parenthesis. n=14 for all tissues. 
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The yields and quality measurements of the 14 pigs and 4 tissues as measured with the NanoDrop and 
Bioanalyzer (discussed in section 2.1.1) are shown in Table 6. The yields were high in all tissues and the 
260/230 and 260/280 ratios and RINS showed high quality RNA for liver. All adipose tissues showed low 
260/230 ratios, and RPAT and neck SAT showed 260/280 ratios averaged just below the accepted 1.8 (as 
described in section 2.1.1). The RINs for especially VAT were low (5.5), but over 5, which was described in 
section 2.1.1 as good quality RNA.  
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4.3.2 Paper III  
Characterization of gene expression in obese Göttingen minipigs: Extensive gene expression changes in 
liver and adipose tissue in otherwise well-adapted, obese Göttingen minipigs 
Rødgaard T, Skovgaard K, Moesgaard, SG, Christoffersen BØ, Heegaard PMH. J Anim Sci.
The layout of the article is changed compared to the submitted version. 
 2012, submitted as 
original paper 
Even though the Göttingen minipig has been investigated extensively as a model for obesity and diabetes 
(section 4.1.1.1), it has not yet been investigated how the immune system is affected by obesity in these 
pigs, and how similar the response is to the human response. Therefore, we tested a panel of 35 genes in 
the liver and 33 genes in the adipose tissue related to the innate immune system with high-throughput 
chip-based qPCR (Fluidigm), as well as five innate immune serum proteins in the blood with ELISA.  
The study revealed extensive gene expression changes in the tissues between lean and obese pigs, as nine 
genes had significantly differential expression in the liver, 11 in the abdominal SAT, 12 in the VAT and eight 
in the neck SAT. Of these, three genes were significantly differentially expressed in all three adipose tissues 
in obese pigs; proinflammatory CCL3L1 was upregulated, anti-inflammatory CD200 was downregulated and 
the proinflammatory antagonist IL1RN was upregulated, which corresponds to obese humans. However, 
the Göttingen minipigs did not show a differentiated serum protein response which does not correspond to 
human serum protein response to obesity. 
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ABSTRACT 18 
The usability of Göttingen minipigs as models for obesity and obesity-related pathologies is well-19 
established. The low-grade inflammation associated with obesity involves a range of innate immune 20 
factors, however, to our knowledge, the impact of obesity on innate immune factor expression has 21 
not been studied in Göttingen minipigs. Therefore, we studied the expression of innate immune 22 
genes in liver and adipose tissues, and serum concentrations of cytokines and acute phase proteins 23 
in obese vs. lean Göttingen minipigs. In the liver, out of 35 investigated genes, the expression of 9 24 
was significantly different in obese pigs. Of 33 genes in adipose tissues obesity changed the 25 
expression of 12 genes in the visceral adipose tissue (VAT), 11 in the abdominal retroperitoneal 26 
adipose tissue (RPAT), and 8 in the subcutaneous adipose tissue (SAT) from the neck. Three genes 27 
were differentially expressed in all adipose tissues, namely the CC chemokine ligand 3-like 1 28 
(CCL3L1), CD200 and interleukin 1 receptor antagonist (IL1RN) with IL1RN being the most 29 
highly regulated gene in both VAT and abdominal SAT. In contrast to obese humans, no changes in 30 
serum concentrations of HP, CRP, SAA, TNF-α and IL-6 were found in obese Göttingen minipigs. 31 
 32 
KEYWORDS 33 
Göttingen minipigs, obesity, gene expression, innate immune response, mRNA. 34 
 35 
INTRODUCTION 36 
Obesity has become an important health problem worldwide and is associated with elevated risks of 37 
several life-threatening conditions, including cardiovascular diseases and type II diabetes. Obesity 38 
is associated with chronic low-grade activation of the innate immune system, resulting in a chronic 39 
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inflammation of the adipose tissue which is thought to lead to the development of these disease 40 
states (Bastard et al., 2006; Federico et al., 2010; Gil et al., 2007). A wide range of factors of the 41 
innate immune response have been investigated with regards to obesity (reviewed for example in 42 
(Gil et al., 2007) and (Federico et al., 2010)). In the search for good animal models of obesity, the 43 
pig has been proposed as an excellent biomedical model as it is very similar to man with regards to 44 
anatomy, physiology, biochemistry and metabolism (Litten-Brown et al., 2010). The Göttingen 45 
minipig has been proposed as a useful model of human obesity (Johansen et al., 2001) and diabetes 46 
(Larsen et al., 2007; Larsen et al., 2002). To further investigate the usability of the Göttingen 47 
minipig as a human obesity model, it is important to investigate other molecular parameters 48 
associated with obesity. The objective of this study was therefore to elucidate the effects of diet-49 
induced obesity on the gene expression of innate immune factors in the liver and 3 types of adipose 50 
tissues in the Göttingen minipig and relate this to human obesity.  51 
 52 
MATERIALS AND METHODS 53 
The study was approved by the Danish Animal Experiments Inspectorate. Fourteen female, 54 
ovariectomized Göttingen minipigs (7 lean and 7 obese) originating from Ellegaard Göttingen 55 
Minipigs A/S (Dalmose, Denmark) were included in the study. The pigs were housed at University 56 
of Copenhagen (Taastrup, Denmark) from 1-2 yr of age and forward. The obese pigs had previously 57 
been used in pharmacological studies with therapeutic peptides, but had been subjected to a suitable 58 
wash-out period prior to this study. Lean pigs were fed minipig standard chow; Altromin 9023 59 
2x150 g a day and obese pigs were fed minipig standard chow; Altromin 9033 ad libitum. The 60 
minipigs were euthanized at 41-47 mo of age with pentobarbital and desangiunated. Tissues were 61 
collected from the liver, subcutaneous adipose tissue (SAT) from the neck, mesenteric adipose 62 
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tissue (VAT), and abdominal cranioventral retroperitoneal adipose tissue (RPAT) and snap frozen 63 
in liquid nitrogen, and blood was collected for serum preparation. Tissue and serum samples were 64 
kept at -80°C until analysis. 65 
Extraction of RNA 66 
All samples were homogenized on a gentleMACS Dissociator (Miltenyi Biotec, Bergisch Gladbach, 67 
Germany) in gentleMACS M tubes (Miltenyi Biotec). For liver samples RNA was extracted using 68 
the RNeasy Lipid tissue Midi kit (Qiagen, Copenhagen, Denmark) according to manufacturer's 69 
protocol. All samples were subjected to on-column RNase-free DNase digestion (Qiagen).  70 
For the adipose tissues an optimized procedure was developed as follows: RNA was extracted with 71 
phenol and chloroform: Approximately ½ g of adipose tissue was homogenized with 4 mL of 72 
QIAzol Lysis Reagent (Qiagen) on the gentleMACS Dissociator and then placed at room 73 
temperature for 5 min. The homogenate was centrifuged at 12.000xg for 10 min at 4°C after which 74 
the fatty upper layer was removed. Chloroform (Merck, NJ, USA) was mixed with the remaining 75 
supernatant and placed at room temperature for 3 minutes after vigorous shaking for 15 s. 1 mL of 76 
isopropanol (2-propanol, Merck) was added to the upper, aqueous phase and was centrifuged at 77 
12000xg for 10 min at 4°C after 5 min at room temperature. The pellet was washed 2 times in cold 78 
75% ethanol, with a centrifugation step of 8 min at 8000xg at 4°C between each wash and then 79 
dried at 55°C for 2 min. The RNA was dissolved in RNase-free water at 55°C for 10 min.  80 
For all samples the RNA yield was measured on the NanoDrop (ND-1000 Spectrophotometer, 81 
NanoDrop Technologies Inc, USA) and RNA integrity was measured with the Agilent RNA 6000 82 
Nano Kit (Agilent Technologies, CA, USA) on the Agilent 2100 Bioanalyzer (Agilent 83 
Technologies) according to the manufacturer's protocol. Liver samples yielded RNA with an RNA 84 
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integrity numbers (RINs) of 9.0±0.1, RPAT samples had RINs of 7.1±0.4, VAT sample RINs was 85 
5.5±0.4, and neck SAT samples had RINs of 6.8±0.2. 86 
Gene Expression 87 
The gene expression was performed as described in Rødgaard et al. Briefly, cDNA syntheses of the 88 
samples was performed in duplicate (technical replicates) using 500 ng of total RNA. This was 89 
reverse transcribed using the QuantiTECT Reverse Transcription kit (Qiagen), according to the 90 
manufacturer's instructions. Pre amplification was performed using TaqMan PreAmp Master Mix 91 
(Applied Biosystems, CA, USA). 92 
Primers were designed as described previously in (Skovgaard et al., 2009). Gene symbols, primer 93 
sequences and amplicon lengths are shown in Table 1. Primer amplification efficiencies, dynamic 94 
ranges, specificity and sequences were analyzed as described in (Rødgaard et al., 2012). 95 
Quantitative real-time PCR was performed in 48.48 Dynamic Array Integrated Fluidic Circuits 96 
(Fluidigm, CA, USA), combining 48 samples with 48 primer sets in the BioMark real-time PCR 97 
instrument (Fluidigm). Expression data were acquired using the Fluidigm Real-Time PCR Analysis 98 
software 3.0.2 (Fluidigm) and exported to GenEx5 ((MultiD, Göteborg, Sweden).  99 
Table 1: Primers used for high-throughput qPCR  100 
Gene symbol Gene name Sequence                                              Amplicon length   101 
   102 
AOAH Acyloxyacyl hydrolase F: GTAATGGCATTTGGGGTGTC  97      103 
  R: TCTCCCAGCAAAATGATTCC 104 
ADIPOQ Adiponectin F: AACATGCCCATTCGCTTTAC  121 105 
  R:AGACCGTGATGTGGAAGGAG 106 
ORM1(a) Orosomucoid 1 F: AGTCCTGAGCCTCCTTCCTC  123 107 
  R: GCCGAGCCGATATAATACCA 108 
ORM1(b) Orosomucoid 1 F: ACCCCCAGTACAATGAGTCG  210 109 
  R: TTAACAGCAGGTCAGCAACG 110 
APOA1 Apolipoprotein A-I F: GTTCTGGGACAACCTGGAAA  86 111 
  R: GCTGCACCTTCTTCTTCACC 112 
B2M Beta-2-microglobulin F: TGAAGCACGTGACTCTCGAT  70 113 
  R: CTCTGTGATGCCGGTTAGTG 114 
ACTB Beta-actin F: CTACGTCGCCCTGGACTTC  76 115 
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  R: GCAGCTCGTAGCTCTTCTCC 116 
CRP  C-reactive protein F: GGTGGGAGACATTGGAGATG  85  117 
  R: GAAGGTCCCACCAGCATAGA 118 
CD14 CD14 F: GGGTTCCTGCTCAGATTCTG  164 119 
  R: CCCACGACACATTACGGAGT  120 
CD36 CD36 F: GCCTATCCTCTGGCTTAATGAG  135 121 
  R: AACATCCCCACACCAACACT 122 
CD40 CD40 F: TGAGAGCCCTGGTGGTTATC  90 123 
  R: GCTCCTTGGTCACCTTTCTG 124 
CD163 CD163 F: CACATGTGCCAACAAAATAAGAC 130 125 
  R: CACCACCTGAGCATCTTCAA 126 
CD200 CD200 F: TCCCCAGGAAGTTTTGATTG  84 127 
  R: CCATGGTTCTTGCTGAAGGT 128 
CCL2 Chemokine (C-C motif) ligand 2 F: GCAAGTGTCCTAAAGAAGCAGTG 103 129 
  R: TCCAGGTGGCTTATGGAGTC 130 
CCL3L1  Chemokine (C-C motif) ligand  F: CCAGGTCTTCTCTGCACCAC  90 131 
 3-like 1 R: GCTACGAATTTGCGAGGAAG 132 
CCL5 Chemokine (C-C motif) ligand 5 F: CTCCATGGCAGCAGTCGT  121 133 
  R: AAGGCTTCCTCCATCCTAGC 134 
CXCL10 Chemokine C-X-C motif ligand F: CCCACATGTTGAGATCATTGC  141 135 
 10 R: GCTTCTCTCTGTGTTCGAGGA 136 
C3 Complement component 3 F: ATCAAATCAGGCTCCGATGA  76 137 
  R: GGGCTTCTCTGCATTTGATG 138 
PBD2 Defensin, beta 2 F: CAGGATTGAAGGGACCTGTT  99  139 
  R: CTTCACTTGGCCTGTGTGTC 140 
FIB  Fibrinogen F: GAATTTTGGCTGGGAAATGA  86 141 
  R: CAGTCCTCCAGCTGCACTCT 142 
GAPDH Glyceraldehyde-3- F: ACCCAGAAGACTGTGGATGG  79 143 
 phosphate dehydrogenase R: AAGCAGGGATGATGTTCTGG 144 
HP Haptoglobin F: ACAGATGCCACAGATGACAGC  105 145 
  R: CGTGCGCAGTTTGTAGTAGG 146 
HPRT1 Hypoxanthine phosphoribisyl F: ACACTGGCAAAACAATGCAA  71   147 
 transferase I R: TGCAACCTTGACCATCTTTG 148 
IL1B Interleukin 1, beta F: CCAAAGAGGGACATGGAGAA  123  149 
  R: GGGCTTTTGTTCTGCTTGAG 150 
IL6(a) Interleukin 6 F: TGGGTTCAATCAGGAGACCT  116 151 
  R: CAGCCTCGACATTTCCCTTA 152 
IL6(b) Interleukin 6 F:CCTCTCCGGACAAAACTGAA   118 153 
  R:TCTGCCAGTACCTCCTTGCT    154 
IL8(a) Interleukin 8 F: GAAGAGAACTGAGAAGCAACAACA 99 155 
  R: TTGTGTTGGCATCTTTACTGAGA 156 
IL8(b)  Interleukin 8 F: TTGCCAGAGAAATCACAGGA  78 157 
  R: TGCATGGGACACTGGAAATA 158 
IL10(a) Interleukin 10 F: CTGCCTCCCACTTTCTCTTG  95 159 
  R: TCAAAGGGGCTCCCTAGTTT 160 
IL10(b) Interleukin 10 F: TACAACAGGGGCTTGCTCTT  110  161 
  R: GCCAGGAAGATCAGGCAATA 162 
IL12A Interleukin 12A F: CCACCTGGACCATCTCAGTT  94 163 
  R: CAGCAGATTTTGGGAGTGGT 164 
IL18 Interleukin 18 F: CTGCTGAACCGGAAGACAAT  100 165 
  R: TCCGATTCCAGGTCTTCATC  166 
IL1RN Interleukin 1 receptor antagonist F: TGCCTGTCCTGTGTCAAGTC  90 167 
  R: GTCCTGCTCGCTGTTCTTTC  168 
ITIH4(b) Inter-alpha-trypsin inhibitor heavy F: AGGCCCTCACCATATCACAG  110  169 
 chain family, member 4 R: GTTGCCATCCAGGACTGTTT 170 
ITIH4(a)  Inter-alpha-trypsin inhibitor heavy F: ATGACAGCAAGCGAACAGTG   85 171 
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 chain family, member 4 R: GGGGATCCCTCTTGGTAATC 172 
IFNG Interferon gamma F: CCATTCAAAGGAGCATGGAT  76 173 
  R: TTCAGTTTCCCAGAGCTACCA 174 
LBP Lipopolysaccharide binding F: CCCAAGGTCAATGATAAGTTGG  83 175 
 protein R: ATCTGGAGAACAGGGTCGTG 176 
NFKB1 Nuclear factor of kappa light F: CTCGCACAAGGAGACATGAA  97 177 
 polypeptide enhancer in B-cells 1 R: GGGTAGCCCAGTTTTTGTCA 178 
NFKBIA Nuclear factor of kappa light polypeptide F: GAGGATGAGCTGCCCTATGAC   85 179 
 gene enhancer in B-cells inhibitor, alpha R: CCATGGTCTTTTAGACACTTTCC 180 
PAFAH1B1 Platelet-activating factor F: GCAAACTGGCTACTGTGTGAAG  113 181 
 acetylhydrolase 1b R: GCACAGTCTGGTCATTGGAA 182 
COX2 Prostaglandin-endoperoxide F: AGGCTGATACTGATAGGAGAAACG 100 183 
 synthase 2 R: GCAGCTCTGGGTCAAACTTC  184 
RPL13A Ribosomal protein L13a F: ATTGTGGCCAAGCAGGTACT  76 185 
  R: AATTGCCAGAAATGTTGATGC 186 
SAA Serum amyloid A F: TGGAGAGCCTACTCGGACAT  90 187 
  R: CCTTTGGGCAGCATCATAGT  188 
SFTPA1 Surfactant protein A1 F: CATGGGTGTCCTCAGTTTCC  86 189 
  R: CATCAAAAGCGACTGACTGC 190 
TLR4 Toll-like receptor 4 F: TTTCCACAAAAGTCGGAAGG  145  191 
  R: CAACTTCTGCAGGACGATGA  192 
TF Transferrin F: CTCAACCTCAAAACTCCTGGAA  82  193 
  R: CCGTCTCCATCAGGTGGTA 194 
TGFB1 Transforming growth factor beta 1 F: GCAAGGTCCTGGCTCTGTA  97 195 
  R: TAGTACACGATGGGCAGTGG 196 
TNF Tumor necrosis factor  F: CCCCCAGAAGGAAGAGTTTC  92 197 
  R: CGGGCTTATCTGAGGTTTGA 198 
TNFAIP3 Tumor necrosis factor  F: CCCAGCTTTCTCTCATGGAC  113 199 
alpha-induced protein 3 R: TTGGTTCTTCTGCCGTCTCT 200 
a and b denotes different primer pair annealing to the same mRNA transcript 201 
Serum Protein Quantification 202 
Serum protein concentrations were determined using sandwich ELISA. Commercially available 203 
ELISA assays were used for IL-6 (Porcine IL-6 Duoset kit, R&D Systems, inc., MN,USA), TNF-α 204 
(Swine TNF-α CytoSetTM, Invitrogen, CA, USA, with Antibody Pair Buffer Kit (Invitrogen)) and 205 
SAA (Phase SAA assay, Tridelta Development Ltd., Kildare, Ireland) according to manufacturer’s 206 
protocol. CRP and HP were analyzed with in-house assays as described in (Rødgaard et al., 2012). 207 
TMB-plus (KEM-EN-TEC, Taastrup, Denmark) was used for developing the ELISA-plates, 208 
according to the manufacturer’s instructions, which were then read using an automatic plate reader 209 
(Thermo Multiskan Ex spectrophotometer, Thermo Scientific, MA, USA). Ascent software v. 2.6, 210 
Thermo Scientific was used to calculate sample values calibrating each plate with several dilutions 211 
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of a standard solution of known concentration of the protein in question. Outliers were identified 212 
with Grubbs outlier test (Grubbs, 1969) and removed from the dataset where applicable. 213 
Data Analysis and Statistics 214 
For qPCR data pre-processing, normalisation and relative quantification GenEx5 was used. Out of a 215 
panel of 5 putative reference genes the most stably expressed were selected for normalisation (for 216 
liver: GAPDH, B2M, RPL13A, and ACTB, and for the adipose tissues all 5 were chosen: RPL13A, 217 
HPRT1, GAPDH, B2M, and ACTB) using GeNorm (Vandesompele et al., 2002). The geometric 218 
mean of these was used for normalization of each tissue individually in GenEx5. To calculate 219 
relative expression levels, the Cq values were calculated relative to the least expressed sample for 220 
each primer set and log2 transformed to approach normal distribution prior to two-tailed, unpaired 221 
t-test, one-way ANOVA with Tukey-Kramer post test, and/or F-test. Statistics were performed in 222 
GenEx5 or Prism5 (GraphPad Software, Inc., CA, USA). For ELISAs significance was tested using 223 
a two-tailed unpaired t-test and variance was tested with an F-test. p≤0.05 was considered 224 
significant. Data are expressed as the mean ± SEM.   225 
 226 
RESULTS 227 
Gene Expression 228 
The expression profiles of 39 genes related to innate immunity were analyzed as well as 5 putative 229 
reference genes. In the pre processing of data, several genes were removed from further analysis 230 
due to low efficiencies or due to high variation between the technical replicates (as described in 231 
(Rødgaard et al., 2012)): FIB, IL1B, IL8(a), IL8(b), AOAH, IL10(b), ORM1(a), ORM1(b), 232 
 79 
 
SFTPA1 and IFNG were removed from the fatty tissue data and IL1B, AOAH, SFTPA1, ORM1(a), 233 
ORM1(b), ADIPOQ, LBP and IL8(a) from the liver tissue data.   234 
Figure 1:  Significant differentially expressed genes in lean compared to obese Göttingen 235 
minipigs 236 
 237 
Significantly expressed genes in lean (set to 1) compared to obese Göttingen minipigs with a fold 238 
change equal to or greater than ±1.5 in liver (A), RPAT (B), VAT (C) and neck SAT (D) as 239 
determined with qPCR. In the VAT, both primers for IL6 showed similar patterns and significance 240 
(**), therefore IL6(b) was removed from the graph. For all tissues; lean n=7 and obese n=7. Error 241 
bars depict SEM. *=p<0.05, **=p<0.01 and ***=p<0.001. 242 
 243 
Genes differentially expressed between lean and obese pigs at significance level p=0.05 and with a 244 
change of at least ± 1.5 fold are depicted for all four tissues in Fig. 1.  Overall, obesity resulted in a 245 
significantly changed expression of 12 genes in VAT (9 of which were down-regulated in obese 246 
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animals), 11 genes in RPAT (of which 7 were up-regulated in the obese group), and 8 genes in neck 247 
SAT (3 of these genes being down-regulated). The genes significantly affected by obesity in the 248 
liver were mostly down-regulated (6 out of 9). 249 
Three genes were significantly differentially regulated between the lean and obese minipigs in all 3 250 
adipose tissues, namely CCL3L1, IL1RN and CD200, with CCL3L1 and IL1RN being up-regulated 251 
and CD200 being down-regulated in all three adipose tissue types of obese pigs. In the liver, none 252 
of these three genes were affected by obesity.   253 
The pattern of tissue specific adipose tissue gene expression may also be compared between lean 254 
and obese pig, see Table 2. 255 
For both obese and lean pigs approximately half of the investigated genes showed different 256 
expression levels in the three types of adipose tissues. In the lean group, all of these genes were 257 
expressed at higher levels in RPAT and VAT than in neck SAT (19 genes), while in the obese pigs 258 
the proportion of genes being up-regulated in RPAT and VAT compared to neck SAT was lower 259 
(10 genes). Specifically, in the obese group, more APPs were significantly differentially regulated 260 
between adipose tissues, with 6 genes (C3, CRP, HP, ITIH4(a), ITIH4(b), LBP and SAA) compared 261 
to two genes (C3 and CRP) in the lean minipigs; in contrast only 2 cytokines (TGFB1 and IL1RN) 262 
and no chemokines were significantly differentially regulated between adipose tissues in the obese 263 
animals, compared to 4 cytokines (IL10, IL18, TGFB1 and TNFAIP3) and 2 chemokines (CCL3L1 264 
and CXCL10) in the adipose tissues of lean minipigs. 265 
 266 
 267 
 268 
 269 
 270 
 271 
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Table 2: Innate immune gene expression in adipose tissues 272 
 273 
a means significantly difference between RPAT and VAT. b means significantly difference between 274 
RPAT and neck SAT. c means significantly difference between VAT and neck SAT. 1 is cytokines. 2 275 
is acute phase proteins. 3 is chemokines. 4 is immune regulatory genes. 5 is adipokines. 276 
 277 
Serum Concentrations of Proteins 278 
The serum concentrations of HP, CRP and SAA are depicted in Fig. 2. No significant differences in 279 
HP, CRP or SAA serum concentrations were found between the lean and obese Göttingen minipigs. 280 
The serum levels of TNF-α and IL-6 were below the detection limit (except in 1 lean minipig in the 281 
IL-6 ELISA) and are therefore not depicted.  None of the transcripts coding for these proteins were 282 
significantly differentially regulated in the liver of obese compared to lean pigs, however, in the 283 
Genes a b c a b c
ADIPOQ1 36.75 ± 4.36 19.39 ± 3.97 16.32 ± 2.15 0.11 0.05 1.00 22.35 ± 2.61 4.65 ± 1.31 12.97 ± 1.19 <0.001 0.39 <0.001
APOA12 2.08 ± 0.32 4.41 ± 0.84 3.91 ± 0.63 0.97 1.00 1.00 7.17 ± 2.43 5.26 ± 0.50 5.93 ± 0.93 0.97 0.91 1.00
C32 10.54 ± 5.14 249.09 ± 20.89 3.71 ± 1.09 <0.001 0.15 <0.001 46.95 ± 15.21 93.50 ± 12.69 9.02 ± 1.55 0.27 0.12 <0.001
CCL23 4.19 ± 0.85 5.71 ± 0.93 3.06 ± 0.60 0.87 0.89 0.27 4.35 ± 0.67 7.27 ± 1.89 5.61 ± 1.30 0.98 1.00 0.97
CCL3L13 5.52 ± 1.28 11.36 ± 1.15 6.62 ± 1.23 0.05 0.95 0.28 18.13 ± 3.20 27.66 ± 6.40 20.37 ± 3.73 0.82 1.00 0.97
CCL53 3.67 ± 0.67 5.86 ± 0.42 3.61 ± 0.69 0.19 1.00 0.22 6.81 ± 2.07 4.50 ± 0.34 5.12 ± 0.60 1.00 1.00 1.00
CD144 2.22 ± 0.31 4.52 ± 0.71 1.85 ± 0.29 0.005 0.87 <0.001 4.31 ± 0.39 3.99 ± 0.36 3.06 ± 0.09 1.00 0.74 0.93
CD1634 4.37 ± 0.39 10.02 ± 2.04 1.90 ± 0.34 0.28 0.008 <0.001 11.01 ± 2.30 13.52 ± 1.85 3.53 ± 0.91 0.90 0.001 <0.001
CD2004 6.33 ± 0.54 6.91 ± 0.85 2.52 ± 0.25 1.00 0.03 0.02 4.02 ± 0.70 3.53 ± 0.73 1.55 ± 0.19 0.96 0.006 0.051
CD364 5.73 ± 0.56 2.16 ± 0.38 2.64 ± 0.23 <0.001 <0.001 0.74 3.45 ± 0.40 1.78 ± 0.16 2.47 ± 0.21 0.03 0.26 0.88
CD404 2.35 ± 0.27 4.68 ± 0.21 1.44 ± 0.15 0.002 0.03 <0.001 2.97 ± 0.32 5.44 ± 0.49 2.71 ± 0.31 0.00 0.99 <0.001
COX-24 4.54 ± 0.57 6.65 ± 0.52 2.97 ± 0.47 0.63 0.50 0.02 3.87 ± 0.66 5.72 ± 0.99 4.88 ± 0.89 0.97 0.96 1.00
CRP2 11.38 ± 2.64 7.11 ± 1.26 3.44 ± 0.59 0.86 0.03 0.34 25.45 ± 6.84 4.24 ± 0.64 3.33 ± 0.52 0.02 <0.001 0.83
CXCL103 18.41 ± 4.55 17.90 ± 4.26 2.91 ± 0.55 1.00 0.01 0.01 6.44 ± 1.29 8.07 ± 0.99 5.17 ± 1.40 0.99 0.62 0.29
HP2 241.31 ± 215.68 59.36 ± 19.47 10.18 ± 2.56 1.00 0.47 0.48 2777.86 ± 1219.88 7.08 ± 1.62 14.73 ± 4.87 0.03 0.11 1.00
IL10(a)1 9.10 ± 1.33 18.15 ± 3.56 3.40 ± 0.54 0.92 0.05 0.003 6.56 ± 0.87 11.37 ± 2.18 4.01 ± 1.00 0.99 0.17 0.053
IL181 5.35 ± 1.18 9.78 ± 2.30 3.00 ± 0.59 0.98 0.19 0.04 17.65 ± 2.41 14.21 ± 2.55 6.68 ± 0.79 0.96 0.07 0.35
IL1RN1 23.60 ± 5.07 68.60 ± 11.30 30.92 ± 7.18 0.15 1.00 0.16 178.33 ± 36.97 511.44 ± 149.53 68.19 ± 14.99 0.34 0.25 0.002
IL6(a)1 3.37 ± 0.64 2.36 ± 0.35 2.49 ± 0.23 0.84 0.95 1.00 6.40 ± 1.34 5.13 ± 0.58 3.06 ± 0.56 1.00 0.47 0.078
IL6(b)1 3.66 ± 0.56 2.38 ± 0.37 2.50 ± 0.35 0.70 0.81 1.00 8.36 ± 1.62 5.57 ± 0.74 3.26 ± 0.72 0.84 0.17 0.81
ITIH4(a)2 3.98 ± 0.89 2.45 ± 0.27 2.63 ± 0.37 0.70 0.51 1.00 12.50 ± 4.26 1.46 ± 0.21 3.79 ± 0.66 0.01 0.95 0.10
ITIH4(b)2 3.85 ± 1.03 3.31 ± 0.25 4.35 ± 0.55 0.96 1.00 0.99 13.74 ± 4.81 2.54 ± 0.58 5.67 ± 0.88 0.005 0.31 0.45
LBP2 197.03 ± 85.54 65.79 ± 16.09 85.56 ± 9.09 0.55 0.74 1.00 1389.84 ± 612.95 10.65 ± 4.65 42.33 ± 15.15 <0.001 0.051 0.04
NFKB14 2.19 ± 0.13 2.98 ± 0.22 1.54 ± 0.11 0.46 0.004 <0.001 2.40 ± 0.18 2.78 ± 0.18 1.74 ± 0.12 0.77 0.07 0.002
NFKBIA4 2.31 ± 0.21 2.69 ± 0.24 1.45 ± 0.16 1.00 0.03 0.008 2.63 ± 0.33 3.56 ± 0.55 1.27 ± 0.11 0.73 0.01 <0.001
PAFAH1B14 1.71 ± 0.08 1.64 ± 0.06 1.32 ± 0.08 0.85 0.004 0.08 1.79 ± 0.08 1.43 ± 0.06 1.40 ± 0.04 0.20 0.13 1.00
PDB-24 311.91 ± 107.09 351.50 ± 58.67 906.21 ± 381.26 1.00 0.83 0.86 143.78 ± 13.98 179.47 ± 40.83 105.94 ± 20.08 0.95 0.96 1.00
SAA2 14.01 ± 5.49 9.21 ± 1.89 4.60 ± 1.37 1.00 0.49 0.30 38.64 ± 14.11 4.42 ± 0.38 4.13 ± 0.78 0.04 0.06 1.00
TF2 62.37 ± 56.27 63.68 ± 9.22 12.55 ± 3.48 0.85 0.99 0.46 409.07 ± 237.01 29.65 ± 11.58 8.17 ± 1.09 0.75 0.13 0.82
TGFB11 2.87 ± 0.20 5.86 ± 0.54 1.77 ± 0.20 <0.001 0.001 <0.001 4.27 ± 0.29 6.81 ± 0.72 2.49 ± 0.19 0.03 0.004 <0.001
TLR44 1.63 ± 0.11 3.74 ± 0.22 2.14 ± 0.10 0.02 1.00 0.02 3.02 ± 0.52 5.08 ± 0.72 2.63 ± 0.24 0.07 1.00 0.03
TNF1 61.12 ± 13.59 118.16 ± 24.56 35.74 ± 5.73 0.18 1.00 0.10 75.63 ± 14.26 109.03 ± 22.78 53.10 ± 9.55 0.97 0.97 0.64
TNFAIP31 2.02 ± 0.31 2.67 ± 0.15 1.53 ± 0.14 0.49 0.81 0.05 2.92 ± 0.46 3.40 ± 0.77 1.75 ± 0.04 1.00 0.34 0.15
Lean P-values: Obese P-values:
RPAT VAT Neck SAT RPAT VAT Neck SAT
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VAT the APPs HP and SAA were significantly differentially down-regulated in the obese minipigs 284 
compared to the lean minipigs and IL6 was up-regulated in both the RPAT and the VAT in the 285 
obese minipigs compared to the lean (Fig. 1).  286 
Figure 2: Serum protein concentrations 287 
 288 
Serum concentrations of HP (A), CRP (B) and SAA (C) measured with ELISA, lean n=7 and obese 289 
n=7. Error bars depict SEM.  290 
 291 
DISCUSSION 292 
Obesity-related changes in the expression of innate immune system related genes and possible 293 
similarities to human obesity of obese Göttingen minipigs has to our knowledge not been 294 
thoroughly described before. The obese Göttingen minipigs had significantly higher bodyweights 295 
than the lean pigs (S. G. Moesgaard et al, unpublished data) and  we find clear differences in the 296 
gene regulation in the obese minipigs compared to lean, including APP and cytokine genes in 297 
adipose tissues. The expression of a number of other relevant obesity-related genes in these pigs 298 
will be published elsewhere (S. Cirera et al, University of Copenhagen, Frederiksberg C, Denmark, 299 
personal communication).  300 
Interestingly, three genes were significantly differentially regulated in all three tissues of the obese 301 
pigs as compared to the lean pigs in all three adipose tissues, namely CCL3L1, IL1RN and CD200. 302 
CCL3L1, a chemokine also known as macrophage inflammatory protein 1-α (MIP-1α), is up-303 
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regulated in the obese minipigs and is involved in acute inflammation by recruiting and activating 304 
polymorphonuclear leukocytes (Wolpe et al., 1989). Previous work in mice has established that this 305 
gene is up-regulated in the epididymal white adipose tissue  from obese mice and may play a role in 306 
the development of type II diabetes (Xu et al., 2003). To our knowledge the gene expression of 307 
CCL3L1 has not yet been investigated in human adipose tissues, however, the serum protein 308 
concentration is similar in lean and obese humans (Kim et al., 2006).  The up-regulation of this pro-309 
inflammatory gene (CCL3L1) is accompanied by the down-regulation of the anti-inflammatory 310 
gene CD200. CD-200 is a receptor on the surface of e. g. macrophages  and helps down-regulate 311 
myeloid cell activity (Hoek et al., 2000; Wright et al., 2000). The combined effect of these changes 312 
in the adipose tissues of the obese minipigs compared to the lean would be pro-inflammatory. 313 
However, the most up-regulated gene in VAT and RPAT of obese pigs is IL1RN. The product of 314 
IL1RN is the interleukin 1 receptor antagonist (IL1ra), a naturally occurring inhibitor of the pro-315 
inflammatory proteins IL-1α and –β (Seckinger et al., 1987). White adipose tissue has been found to 316 
be a major source of I IL1ra in both mice and men (Juge-Aubry et al., 2003) and IL1ra may play a 317 
role in acquired resistance to leptin in obesity in rats and humans (Luheshi et al., 1999; Meier et al., 318 
2002). IL1RN is significantly up-regulated in the VAT compared to neck SAT in the obese pigs, 319 
which could counteract the pro-inflammatory effects of the down-regulated CD200 and the up-320 
regulated CCL3L1, and thereby offer an explanation as to why the cytokine and APP serum protein 321 
concentrations is not elevated by obesity. Interestingly, IL6 is up-regulated in the RPAT and VAT 322 
in the obese minipigs, and previous reports suggest that IL-6 suppresses inflammation via induction 323 
of IL1ra synthesis in humans (Tilg et al., 1994). This is supported by the findings that the up-324 
regulation of IL1RN expression in the RPAT and VAT, where IL6 is up-regulated, is much higher 325 
than in the neck SAT (7.5 times higher in the RPAT and VAT of the obese pigs, and only 2 times 326 
higher in the neck SAT of the obese minipigs compared to lean).   327 
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A correlation between increased adipose tissue expression and elevated serum levels of various 328 
innate immune factors in obesity has been established in humans for a number of proteins, including 329 
IL-6 (Fontana et al., 2007), haptoglobin (Chiellini et al., 2004) and SAA (Poitou et al., 2006). 330 
However, such correlations were not found in the Göttingen minipigs investigated in the present 331 
study. Of the three genes mentioned, adipose tissue expression of only IL6 was elevated, in both the 332 
RPAT and the VAT, however, no increases in serum concentration of IL-6 were measured in the 333 
Göttingen minipigs. The expression of both SAA and HP was down-regulated in the VAT and no 334 
elevated serum levels of these proteins were detected either. This contrasts with the serum protein 335 
changes observed in the human response to obesity, in which CRP, SAA and haptoglobin serum 336 
concentrations are elevated (Chiellini et al., 2004; Esposito et al., 2003; van Dielen et al., 2001). A 337 
reason for this could be that the fold changes of the genes significantly affected by obesity in the 338 
liver are very small, and perhaps too small for the changes to be translated into elevated serum 339 
protein concentration. Another reason why the Göttingen minipigs in this study do not show a 340 
human-like serum obesity response could be that their diet contained no excess fat or sugar, and it is 341 
possible that a standard diet does not induce a systemic or local low-grade inflammation. However, 342 
the pigs have been obese for a prolonged period of time, as they are euthanized at 41-47 mo, which 343 
mimics human obesity. 344 
Preliminary results in young Göttingen minipigs indicate that 3-4 mo of high calorie, high 345 
cholesterol feeding leads to significant changes in acute phase protein serum concentrations (T. P. 346 
Ludvigsen et al., Novo Nordisk A/S, Maaløv, Denmark, personal communication), however, further 347 
investigation is needed to establish whether this is due to age- or diet differences. Therefore it could 348 
be interesting to repeat the investigations in pigs fed a high calorie diet for the same extended 349 
period of time (41-47 mo) to see if both the gene expression and serum concentrations of several 350 
innate immune factors are affected by obesity when fed a high calorie diet. Furthermore, it could be 351 
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interesting to investigate whether the changes in gene expression in obesity is translated into 352 
measurable changes in the local expression of corresponding proteins in the tissues in question.   353 
In summary, the gene expression of Göttingen minipig is affected by obesity, as a wide range of 354 
innate immunology related genes are significantly differentially regulated in the obese pigs 355 
compared to the lean pigs. However, in contrast to human obesity, this does not translate into 356 
changes in serum concentrations of cytokines and APPs in the obese pigs compared to the lean.  357 
 358 
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4.4 Results for Study II – Ossabaw minipigs (unpublished)      
The Ossabaw minipigs are widely accepted as good model for human obesity, however, no studies into the 
response of the innate immune response to obesity have been made on these pigs. Therefore, this study 
into the expression of innate immune factors in liver, two adipose tissues and blood was conducted. Tissues 
from 12 pigs, and serum from 10 pigs, were used (n=7 for the two adipose tissues) and all pigs were female. 
The obese pigs weighed significantly more than the lean (p=0.008) and further descriptions regarding the 
pigs is shown in Table 10. The pre-PCR data for the 12 pigs and three tissues as measured with the 
NanoDrop and Bioanalyzer (discussed in section 2.1.1) is shown in Table 7. Even though the yields (ng/µl) 
were high in all tissues, and the 260/230 and 260/280 ratios and RINs of the liver showed RNA of high 
quality, the 260/230 ratios were generally low for the adipose tissues. The 260/280 ratios were within the 
accepted range of 1.8-2 for all tissues, however, the average RINS for the adipose tissues were low (below 
5), and all the samples in the VAT had consistently low RINs. 
Tissue ng/µl 260/230 260/280 RIN 
Liver 393-3166 
(1931) 
1.95-2.27 
(2.18) 
2.01-2.16 
(2.11) 
7.1-8.5 
(7.7) 
Abdominal SAT 126-922 
(463) 
0.61-1.99 
(1.64) 
1.88-2.03 
(1.94) 
2.4-6.8 
(4.6) 
VAT 56-871 
(269) 
0.30-2.10 
(1.36) 
1.78-1.93 
(1.86) 
2.3-3.4 
(2.7) 
Table 7: Yields, ratios and RINs of the Ossabaw minipigs in the three measured tissues. The                                  
lowest and highest values are shown, with the mean in parenthesis. n=12 for liver, n=7 for                    
abdominal SAT and VAT. 
cDNA synthesis of the samples was performed in duplicates using 500 ng of total RNA. Primers were 
designed as described in (Skovgaard et al. 2009), and a table of the primers used for this study is shown in 
Paper III p. 70. The expression of 48 innate immune response genes, including five putative reference 
genes, was tested in a high-throughput chip-based qPCR (Fluidigm). Expression data was acquired using the 
Fluidigm Real-Time PCR Analysis Software 3.0.2 (Fluidigm). For preprocessing of data, normalization and 
relative quantification GenEx5 (MultiD, Göteborg, Sweden) was used. GeNorm was used to select the most 
stable reference genes for normalization; for the adipose tissues GAPDH was chosen, and for liver GAPDH, 
B2M and RPL13A were chosen. Cq-values were calculated relative to the least expressed sample for each 
primer set and data was log2 transformed to approach normal distribution prior to statistical analysis with 
either a two-tailed, unpaired t-test or a one-way ANOVA with Tukey-Kramer post test. Statistics were 
performed in GenEx5 or Prism5 (GraphPad Software Inc.). Changes in gene expression were considered 
significant if p≤0.05 and biologically relevant if the fold change was at least ±1.5. Data was evaluated for 
outliers with Grubbs outlier test (Grubbs 1969) where applicable. Data is expressed as the mean ± SEM.  
Contamination and primer specificity were tested with –RT samples and a NTC (data not shown). NTC 
showed no contamination, neither did the –RT sample for liver, but for the adipose tissues the –RT sample 
revealed genomic DNA contamination/low primer specificity in 24 of the 48 primers tested. As the Ossabaw 
data was not purposed for publication, due to small groups and low quality of the RNA, the genes showing 
contamination were not removed before preprocessing of data. 
In the preprocessing of data, several genes were removed due to low efficiency or in the quality validation 
of the technical replicates (cDNA) if the standard deviation was above 15% (as described in appendix 9.2): 
For both tissues CRP, IL1B, COX2, IL6(b), ITIH4(b), IL18, ORM1(a), IL10(b), IFNG, TNF, and AOAH were 
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removed, in the liver additionally ADIPOQ, IL6(a), SFTPA1, IL8(a), CD36 and ORM1(b) were removed and in 
the adipose tissues additionally CD40, PBD2, FIB, TLR4, CXCL10 and CCL3 were removed. Furthermore, due 
to large differences between the two technical replicates of cDNA (>30%) two VAT samples and one 
abdominal SAT sample were removed (all samples from the lean group). Because of this, the lean group in 
the VAT only consisted of two pigs, and it was not possible to perform statistical analysis on the data. The 
expression of the remaining samples, and remaining 26 genes in the liver and 25 genes in the adipose 
tissues are shown in Table 8.  
Interestingly, as seen in Table 8, all the genes showing significant differential expression in the liver are 
downregulated in the obese pigs. No clear patterns are evident as the genes being downregulated are 
different types of innate immune genes (chemokines, immune regulatory and APPs), and are involved in 
both the proinflammatory response (CCL2, CD14, FIB and HP) and in the anti-inflammatory response (IL1RN 
and TF). In the abdominal SAT only onw gene is significantly differentially regulated, namely LBP, an APP 
part of the proinflammatory response, which is upregulated 9-fold in the obese pigs.   
 
Table 8: Relative gene expression (mRNA levels) of innate immune genes in lean (set to 1) and obese Ossabaw minipigs in liver 
and thre types of adipose tissue as analyzed by qPCR. For liver; lean n=7, obese n=5, for abdominal SAT; lean n=3, obese n=3, for 
VAT; lean n=2, obese n=3. (*)p≤0.05, (**)p<0.01, (***)p<0.001. NQ, not quantifiable. 
ADIPOQ 1 ± 0.94 0.82 ±0.25 1 ± 0.07 1.50 ± 0.27
APOA1 1 ± 0.11 1.52 ± 0.39 1 ± 0.56 16.30 ±15.53 1 ± 0.18 5.33 ± 1.41
C3 1 ± 0.11 0.80 ± 0.17 1 ± 0.11 9.65 ±3.54 1 ± 0.55 57.87 ± 32.28
CCL2 1 ± 0.31 0.23 ± 0.08* 1 ± 0.20 14.61 ±8.64 1 ± 0.93 2.47 ± 1.34
CCL3L1 1 ± 0.36 0.63 ± 0.30
CCL5 1 ± 0.10 0.78 ± 0.18 1 ± 0.53 3.61 ±1.67 1 ± 0.38 4.00 ± 1.33
CD14 1 ± 0.12 0.50 ± 0.10** 1 ± 0.59 2.50 ±0.75 1 ± 0.59 9.80 ± 8.07
CD163 1 ± 0.06 2.25 ± 0.71 1 ± 0.31 0.77 ±0.24 1 ± 0.16 4.92 ± 3.28
CD200 1 ± 0.12 1.00 ± 0.49 1 ± 0.40 1.75 ±0.80 1 ± 0.67 6.90 ± 6.53
CD36 1 ± 0.73 0.72 ±0.22 1 ± 0.20 1.50 ± 0.40
CD40 1 ± 0.18 0.64 ± 0.14
CXCL10 1 ± 0.33 0.38 ± 0.12
FIB 1 ± 0.06 0.55 ± 0.11**
HP 1 ± 0.05 0.57 ± 0.07*** 1 ± 0.44 4.05 ±3.39 1 ± 0.06 18.99 ± 13.14
IL10(a) 1 ± 0.20 0.84 ± 0.42 1 ± 0.33 1.15 ±0.32 1 ± 0.91 10.71 ± 10.03
IL1RN 1 ± 0.21 0.18 ± 0.12** 1 ± 0.05 1.30 ±0.42 1 ± 0.88 0.42 ± 0.24
IL6(a) 1 ± 0.13 9.79 ±7.75 1 ± 0.82 1.33 ± 0.66
IL8(a) 1 ± 0.38 3.16 ±1.83 1 ± 0.88 4.50 ± 3.52
IL8(b) 1 ± 0.39 0.65 ± 0.36 1 ± 0.32 5.99 ±3.99 1 ± 0.93 2.71 ± 2.03
ITIH4(a) 1 ± 0.13 0.57 ± 0.21 1 ± 0.68 1.14 ±0.51 1 ± 0.23 22.69 ± 18.16
LBP 1 ± 0.13 1.05 ± 0.46 1 ± 0.35 9.60 ±2.92* 1 ± 0.78 40.08 ± 37.22
NFKB1 1 ± 0.07 0.75 ± 0.16 1 ± 0.40 1.65 ±0.69 1 ± 0.18 2.09 ± 0.74
NFKBIA 1 ± 0.30 0.53 ± 0.06 1 ± 0.31 2.51 ±1.37 1 ± 0.11 5.06 ± 2.76
ORM1(b) 1 ± 1.00 97.89 ±97.85 1 ± 0.73 110.78 ± 102.74
PAFAH1B1 1 ± 0.05 0.87 ± 0.05 1 ± 0.32 0.99 ±0.33 1 ± 0.15 1.92 ± 0.35
PDB2 1 ± 0.23 1.06 ± 0.45
SAA 1 ± 0.27 0.59 ± 0.51 1 ± 0.38 3.76 ±1.77 1 ± 0.90 8.02 ± 7.62
TF 1 ± 0.11 0.62 ± 0.11* 1 ± 0.99 15.59 ±15.51 1 ± 0.85 37.07 ± 31.72
TGFB1 1 ± 0.13 0.88 ± 0.18 1 ± 0.32 1.43 ±0.54 1 ± 0.23 4.96 ± 3.58
TLR4 1 ± 0.09 1.64 ± 0.59
TNFAIP3 1 ± 0.61 0.72 ± 0.45 1 ± 0.12 2.44 ±1.23 1 ± 0.42 5.61 ± 3.93
NQ
NQ
NQ
NQ
NQ
NQNQ
NQ
NQ NQ
NQNQNQ
NQ
NQ
NQ
NQ
NQNQ
NQ
NQ
NQ
NQ
NQ
NQ
NQ
NQ NQ
NQ
NQ
NQ
NQNQNQ
Liver Abdominal SAT VAT
Lean ObeseLeanObeseLeanObese
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The concentrations of serum proteins HP, CRP, IL-6, TNF-α and SAA were determined using sandwich 
ELISAs. To determine IL-6, TNF-α and SAA commercially available ELISAs were used according to 
manufacturer’s protocols, and to determine CRP and HP in-house assays were used (for details on all 
ELISAs, see Paper I p. 27). Samples were run in triplicates to eliminate pipetting variation, and dilutions of a 
standard of known concentration were present in all ELISAs. Significance was tested with a two-tailed, 
unpaired t-test and p≤0.05 was considered significant. Data was evaluated for outliers with Grubbs outlier 
test where applicable. Serum protein expression for lean and obese Ossabaw minipigs is shown in Figure 
12. Protein concentrations of TNF-α and for most samples of IL-6 were below detection level. No significant 
difference was found in any of the 5 measured serum proteins.  
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Figure 12: Scatter plot of serum concentrations of CRP, HP, IL-6, TNF-α and SAA measured with ELISA in lean (n=6) and obese 
(n=4 for IL-6 and TNF-α, n=3 for CRP, HP and SAA). 
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5 Study III: Comparison of the three breeds of porcine obesity models 
All three breeds of pigs investigated in this thesis have been used as in studies as models for human 
metabolic perturbations. Therefore, it would be interesting to compare the three breeds, despite age and 
feed differences. 
 
5.1 Background 
The domestic pigs were 8-9 months of age, the Göttingen minipigs 41-47 months of age and the Ossabaw 
minipigs were 14-16 months of age at euthanasia, making the pigs very different in age. Furthermore, the 
diets of the three breeds of pigs also differed in the contents of protein, fat and carbohydrates, as seen in                            
Table 9. The compositions of the feeds of the Göttingen minipigs were low fat/high carbohydrates as both 
were standard diets for minipigs (Altromin 9023 and 9033). The diet of the obese Ossabaw minipigs 
contained most fat (46%) of all the diets. The diets are described in detail in appendix 9.11. 
  Domestic pigs   Göttingen minipigs   Ossabaw minipigs 
% Lean/obese   Lean Obese   Lean Obese 
Protein 18   19 25   18.5 8 
Fat 25   8 11   10.5 46 
Carbohydrates 57   73 64   71 43 
                           Table 9: Composition as total content (%) of the experimental diets of the three breeds of pigs 
The literature comparing the three breeds is very limited. No papers have been published, to our 
knowledge, comparing the Ossabaw and Göttingen minipigs directly. In the 1970s and 80s a number of 
papers were published comparing the Ossabaw minipig with Yorkshire pigs to describe the Ossabaw 
minipigs as an obese phenotype pig. Some of these are referred to in Section 4.1.1.2. Göttingen minipigs 
have also been compared to domestic pigs; to establish that the usability of Göttingen minipigs as a model 
for chronic heart failure and myocardial infarction was higher than Yorkshire pigs (Schuleri et al. 2008), and 
to establish that Göttingen minipigs were better models for atherosclerosis than Swedish Landrace pigs 
(Jacobsson 1986). 
 
5.1.1 The acute phase protein orosomucoid (ORM) 
Orosomucoid (ORM), also known as α-1-acid glycoprotein, is a member of the APP family. During acute 
infection the serum concentration of ORM increases 2-5 times in all mammals, except in the pig where 
ORM is a negative APP (Skovgaard et al. 2009). It is one of the most abundant plasma proteins, as it 
accounts for approximately 1% of all plasma proteins (Hochepied et al. 2003; Fournier et al. 2000). In 
humans two variants of ORM exists, ORM1 and ORM2, which are coded by two different genes, and the 
major component of serum ORM is ORM1 (Fournier et al. 2000). In pigs an ORM gene has been found, 
which shares 70% homology with the coding sequence of human ORM1 (Stone & Maurer 1987; Fournier et 
al. 2000). ORM has been found to have anti-inflammatory and immunemodulatory effects (Hochepied et al. 
2003; Williams et al. 1997) and ORM has been implicated in maintenance of metabolic homeostasis in 
obesity by suppressing local and systemic inflammation in mice (Lee et al. 2010). The mRNA expression of 
ORM in adipose tissues of obese mice were elevated with increasing ORM plasma levels (Lee et al. 2010), 
however, this relationship was not found in humans (Alfadda et al. 2012). In humans, correlations were 
found between circulating ORM levels, BMI and body fat percent (Alfadda et al. 2012) indicating that 
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secretion of ORM from adipose tissues may be a contributing source for the rise of circulating ORM levels in 
the blood in obesity. To our knowledge, no information of the differential expression of ORM in adipose 
tissues between lean and obese humans or pigs has been published.  Furthermore, even though ORM is a 
negative APP in acute infections in pigs, a proteomics study in Ossabaw minipigs found that serum ORM 
levels were elevated in Ossabaws fed an atherogenic diet compared to control pigs (Bell et al. 2010), 
indicating that the response of ORM in pigs to obesity is similar to the human response.  
Due to this, and to interesting data from the primer set of ORM1 on the high-throughput qPCR of the three 
breeds where the expression of ORM1 was too high to be analyzed in the domestic pigs and too low to be 
analyzed in the minipigs, we decided to investigate the expression of this interesting APP in lean and obese 
domestic pigs, Göttingen minipigs and Ossabaw minipigs. 
 
5.2 Hypothesis for Study III 
• The response of innate immune genes and serum proteins to obesity is differentiated between the 
domestic pigs and the two breeds of minipigs, with the response of the minipigs being more 
human-like 
• ORM serum concentrations are higher in obese pigs than lean, especially in the Göttingen and 
Ossabaw minipigs 
• The expression of the ORM1 gene is upregulated in obese pigs compared to lean 
 
5.3 Results of Study III 
5.3.1 Phenotypic parameters in the three breeds of pig 
 
Parameters  Domestic pig Göttingen minipigs Ossabaw minipigs 
 Lean 
(n=9) 
Obese 
(n=10) 
p-
value 
Lean  
(n=7) 
Obese 
(n=7) 
p- 
value 
Lean 
(n=4) 
Obese 
(n=3) 
p-
value 
Body weight (kg)  119.1±3.2 170.1±4.9 0.03 50.3±1.6 92.6±5.2 <0.0001 60.4±7.6 100.00±3.3 0.008 
Fasting blood 
glucose  
(mmol/L)  
4.5±0.1  4.4±0.2  0.59 3.8±0.1  3.7 ±0.4  0.87 4.2±0.1  4.6±0.2  0.16 
Fasting insulin  
(pmol/L)  
12.1±3.4  29.3±5.2 
 
0.87 141.2±32.4  39.2±9.9  0.01 15.0±3.5 
 
34.7±7.5  0.10 
Total cholesterol 
(mmol/L)  
2.1±0.1  3.2±0.1  0.01 1.8±0.1  2.0±0.1 0.17 2.0±0.1  12.8±2.0 0.03 
Triglycerides  
(mmol/L)  
0.3±0.03 0.4±0.05  0.85 0.3±0.04  0.5±0.07 0.07 0.3± 0.03  0.5 ±0.03 0.02 
Table 10: Summary of weights and blood parameters in the three breeds of pigs. Domestic pig data is taken from (Christensen et 
al. 2012), data from Göttingen minipigs is from (Moesgaard et al, article in preparation) and data from Ossabaw minipigs is from 
(Lee et al. 2009). Data is expressed at mean±SEM. 
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The summary of several phenotypic traits relevant for animal models of obesity is shown in Table 10. None 
of the three breeds of pigs showed differential fasting blood glucose levels between lean and obese pigs. 
The domestic pigs and the Göttingen minipigs only showed differential levels of one parameter between 
lean and obese pigs, namely total cholesterol (p=0.01) and fasting insulin (p=0.01), respectively, whereas 
the Ossabaw minipigs showed differential levels in two parameters between lean and obese pigs, namely 
total cholesterol (p=0.03) and triglycerides (p=0.02).    
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5.3.2 Paper IV  
Orosomucoid expression in liver, adipose tissues and serum of lean and obese domestic pigs, Göttingen 
minipigs and Ossabaw minipigs 
Rødgaard T, Stagsted J, Christoffersen BØ, Cirera S, Moesgaard SG, Sturek M, Alloosh M, Heegaard PMH. 
Vet Immunol Immunopathol.
Orosomucoid is an APP with anti-inflammatory and immunomodulatory effects, which has been implicated 
in maintaining metabolic homeostasis in obesity. The mRNA and serum expression of ORM has been 
investigated in obese humans and mice, but not in pigs, even though porcine obesity models are widely 
used for obesity-related metabolic symptoms.  
 2012, short communication, in press 
The objective was to characterize the ORM mRNA expression in liver and three types of adipose tissues; 
RPAT/abdominal SAT, VAT and neck SAT, as well as the serum concentrations of ORM in three breeds of 
porcine obesity models; domestic pigs, Göttingen minipigs and Ossabaw minipigs. 
We found no changes in mRNA expression of ORM in any of the four investigated tissues in lean compared 
to obese pigs, or between the adipose tissues of obese pigs. Ossabaw minipigs were the only breed to show 
a differentiated ORM serum response, with elevated concentrations of ORM in obese Ossabaw minipigs, 
which is similar to the human response. Therefore, in this regard, the obese Ossabaw minipigs behave 
more similar to obese humans. 
  
96 
 
 
 97 
 
 98 
 
 99 
 
 100 
 
 
 101 
 
  
102 
 
6 Discussion 
6.1 General discussion 
In the domestic pigs, the RINs of the adipose tissues are generally slightly lower than that of the liver tissue, 
as are the 260/280 ratio and yields (ng/µl) (Table 5). In the Göttingen minipigs the quality of RNA varies 
somewhat between the tissues with the highest RINs in the liver (mean of 9) (Table 6). The RINs of the 
adipose tissues are all lower than the RINs of the liver, with averages of 5.5-7.1, which could have an impact 
on the results, especially if comparing liver and adipose tissue samples. Generally, the extractions of RNA 
from the adipose tissues proved to be more difficult than extractions from liver. This is due to several 
reasons: Firstly, the liver tissue has a higher density of cells as liver cells are smaller than adipocytes. When 
using the same amount of starting material (e.g. ½ g), the liver sample will contain a much higher amount 
of RNA than the adipose tissue sample. As the limitation for the methods used for RNA extraction is 
approximately 1 g this can have a high impact on the amount of RNA extracted from adipose tissue 
samples. Secondly, the lipid content of the adipose tissue appears to have an impact on the quality of RNA 
extracted from the adipose tissue. One of the steps of optimization described in section 2.1.1.1 was to 
remove the lipid content of the sample after homogenization, and this step improved the yield and quality 
of RNA greatly. 
The variation within the methods of RNA extraction was tested by comparing the expression of the 
reference genes. In this way the 2 different methods for extracting RNA used in the adipose tissues of the 
domestic pigs were compared and no difference was found on the results. As described in section 2.1.1, the 
260/230 ratio is used to estimate the contamination of organic compounds in a sample, and a ratio of 1.8-2 
is accepted as a sample with no or little contamination. In all the studies in this thesis the ratio is very 
different within the tissues (Table 5, Table 6 and Table 7), however, when the expression of the reference 
genes were tested in samples having different 260/230 ratios within a tissue, this contamination did not 
have an impact on the expression of the reference genes, and was therefore not considered to be of 
importance for this assay.  
Generally, extractions of RNA from the adipose tissues of the Ossabaw pigs were problematic, with low 
RINs as indicators of low quality RNA in especially the VAT (Table 7). It is possible that the samples were not 
snap frozen rapidly enough after tissue sampling or that the samples were not stored cold enough, so the 
RNA has become degraded as a consequence.          
As described in the appendix p. 124 and 125, some samples were removed in the preprocessing of the data 
due to high variation between the technical replicates. For the domestic pigs, three samples were removed. 
The RINs of the three samples were within accepted range (6.9-8.9), and all had 260/230 and 260/280 
ratios of about 2. Therefore, it would seem that variation introduced was not due to low quality RNA. No 
samples were removed from the dataset of the Göttingen minipigs, however, an entire cDNA-synthesis was 
removed due to low efficiency. Three samples were removed in the Ossabaw dataset due to high variation 
between technical replicates. These samples had low RINs, so the variation could be due to introduced 
variation or to low quality of RNA.  
The fold change criterion used to point out biological relevant significantly differentially expressed genes 
was set to 1.5. During a normal, acute infection this number might be too low as most APPs and cytokines 
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show big changes in plasma levels during infections. For example, the APP CRP has an increase in plasma 
concentrations of up to 1000 times during infection in humans, and generally APPs are defined as plasma 
proteins whose concentrations increase by more than 2-fold following an inflammatory stimulus (Baumann 
& Gauldie 1990). However, the response to obesity-induced low-grade inflammation of cytokines and APPs 
is not as clear as during normal infections, and generally the plasma concentrations of these proteins are 
not raised to the same extent. For example, increases in CRP levels of <2 fold have been found to be 
associated with increased risk of cardiovascular disease in overweight women (Ridker et al. 1998), and IL-8 
levels have been found to only increase by 1.3-fold in obese humans (Straczkowski et al. 2002). Therefore, 
it is important that the fold change criterion is set low enough to detect changes, but still high enough to 
make sure the changes are biologically relevant. Consequently, the fold change criterion was set to 1.5 for 
this work. 
 
6.2 Study II 
6.2.1 Göttingen minipigs 
As the analysis of gene expression and blood proteins has already been discussed in Paper III p. 70, this 
section will only contain discussions on the data that has not been discussed elsewhere. 
The hypothesis that the expression between the adipose tissues (Table 2 in Paper III p. 70) is differential, 
and that the adipose tissues from the abdomen are more metabolically active than neck SAT is confirmed. 
However, this is not just due to obesity as more genes are differentially regulated in the abdominal adipose 
tissues of the lean pigs than the obese. 17 out of 18 genes that are significantly differentially expressed in 
the neck SAT compared to the RPAT and VAT combined are expressed at lower levels in the neck SAT. In the 
obese pigs the same pattern is present, though with fewer genes being affected, as 10 out of 12 genes are 
downregulated in the neck SAT compared to the RPAT and VAT combined. Comparing RPAT and VAT in the 
lean pigs only seven genes are significantly differentially expressed and in the obese pigs nine genes are 
significantly differentially regulated between the RPAT and VAT. It is interesting that this is so, as it is 
expected that the differences in adipose tissue expression will increase in obesity, as the VAT and RPAT 
become more metabolically active during obesity than the neck SAT in humans (reviewed in (Clement & 
Langin 2007; Wronska & Kmiec 2012)). As the lean and obese pigs are of the same age, and has both been 
fed a standard diet, although in different quantities, it appears that obesity in itself with access to ad 
libitum feed actually lowers the differential response in all the investigated adipose tissues in the pigs. 
However, the obese pigs have been treated with therapeutic peptides in pharmacological studies at Novo 
Nordisk A/S, and it has not been possible to get any information on these peptides. Even though the pigs 
had been subjected to a wash-out period, it is possible that the unknown peptides could have an impact on 
the results of this study.    
 
6.2.2 Ossabaw minipigs 
There is a clear difference in the number of significantly differentially expressed genes between the lean 
and obese Ossabaw pigs in liver and the adipose tissues, as six genes are significantly differentially 
regulated in the liver, and only one is significantly differentially regulated in both investigated adipose 
tissues combined (Table 8). This could be due to the very low number of pigs in the groups of the adipose 
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tissues, making it difficult to achieve statistical power; in the liver the lean group consisted of seven pigs 
and the obese group consisted of five pigs. In the abdominal SAT, the lean and obese groups consisted of 
three pigs each, and in both the adipose tissues the data has high variation (SEM). One of the reasons for 
this could be the low quality of RNA extracted from the samples (Table 7) where the VAT samples showed 
consistently low RINs (mean of 2.7), and the samples from the abdominal SAT varied a great deal in RINs 
(RINs between 2.4 and 6.8), even though the 260/280 ratios were within accepted range (mean of 1.94). 
Another reason for the high SEMs could be that half the genes in the study showed DNA contamination/low 
specificity. This is surely to have an effect on the data. Unfortunately, it was not possible to extract RNA of 
higher quality, or without contamination, in these samples, even though numerous attempts to do so were 
carried out. The difference in RINs between the tissues could have an impact when comparing the gene 
expression between tissues, however, that analysis has not been performed in this study.      
Of the genes investigated (Table 8) the genes showing significantly differential regulation all differ in 
regulation from expected, except LBP which is upregulated in the abdominal SAT. As shown in Table 1, the 
mRNA levels of CCL2, FIB, HP, IL1RN and CD14 in the liver of humans are expected to rise in obesity, and the 
level of TF is expected to not be affected by obesity. Yet all the genes mentioned are downregulated in the 
liver of obese Ossabaw minipigs compared to lean. In the liver most genes show tendencies of down-
regulation (20/26), however, in the adipose tissues most genes show tendencies of upregulation (19/25 in 
the abdominal SAT and 24/25 in the VAT). Even though this is only tendencies, and not statistically 
significant, it is interesting that obesity shifts the response of the innate immune genes from the liver to the 
adipose tissues. An acute inflammatory response will lead to hepatic secretion of several immune factors. 
However, as discussed, the low-grade inflammation caused by obesity is chronic, and not acute, and that 
could be the reason for this shift. 
The serum concentrations of several proteins were not affected by obesity in the Ossabaw minipigs (Figure 
12). There was no induction of TNF-α in either the lean or the obese minipigs, even though the expression 
of this inflammatory cytokine has been shown to be elevated in the serum of obese humans (Dandona et 
al. 1998). Over half the pigs of both groups had IL-6 serum concentrations below the detection limit of the 
ELISA, which is different than what has been found in obese humans (Khaodhiar et al. 2004). The 
expression of the remaining three serum proteins measured (CRP, HP and SAA) was not affected by obesity, 
which is also in contrast to what has been found in humans (Festa et al. 2001; Poitou et al. 2006; Chiellini et 
al. 2004). This could indicate that the pigs had not developed obesity-induced low-grade inflammation, 
even though the obese minipigs weighed significantly more than the lean. However, as shown in Table 10, 
the obese Ossabaw minipigs had higher levels of cholesterol (p=0.03) and triglycerides (p=0.02) in the blood 
than the lean minipigs, which indicate that the obese pigs are showing signs of metabolic perturbations, 
even if those perturbations are not yet evident in the innate immune factors in the blood.   
 
6.3 Study III 
A comparison between the 3 breeds of pig was difficult for all the reasons mentioned previously, such as 
the difference of age in the pigs, difference of diets, the genomic contamination of the samples from the 
Ossabaw minipigs and the differences in quality of RNA between the breeds and tissues. However, when 
investigating ORM, the NTC and –RT sample showed no contamination in either of the breeds, which 
indicates that, the ORM1 primers were not affected by the contamination.  
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All breeds and tissues had samples that showed no ORM1 expression as the ORM1 levels were below 
detection level. Of the samples of the adipose tissues in the obese Göttingen minipigs, as well as the lean 
and obese Ossabaw minipigs, about half were removed due to expression below detection level (Paper IV 
p. 95, Figure 2). Therefore, it is difficult to know for sure whether it is the pigs with no ORM1 expression or 
with ORM1 expression that are outliers, as the normal response could be no expression in the adipose 
tissues of these pigs. To further investigate this, larger groups are needed to obtain statistical power.  
When comparing lean and obese domestic pigs (Paper II p. 39, Figure 3A, C, E and G) with lean and obese 
Göttingen minipigs (Paper III p. 70, Figure 1A-D), it is clear that a higher number of genes in the Göttingen 
minipigs are affected by obesity, especially in the adipose tissues. In the adipose tissues of the domestic 
pigs 1-5 genes are differentially regulated in obesity, and in the Göttingen minipigs 8-12 genes are 
differentially regulated in obesity. This is despite the fact that the obese Göttingen minipigs were fed a 
standard diet and the domestic pigs were fed a high energy diet (Table 9) which is expected to have an 
impact on the metabolism of the pigs, and therefore on the obesity-response. However, the differences in 
the number of genes affected by obesity in the two breeds could be due to the difference in age between 
the breeds, as the domestic pigs are 7-9 months old and the Göttingen minipigs are 41-47 months.  
More genes are differentially regulated in the RPAT of the Göttingen minipigs than in the abdominal SAT of 
the domestic pigs (Paper III p. 70, Figure 1B and Paper II p. 39, Figure 3C, respectively). The RPAT is part of 
the intra-abdominal adipose tissue as is the VAT, and differs from abdominal SAT in some respects, such as 
having a higher lipid uptake (Mårin et al. 1992). In other regards, RPAT is more similar to abdominal SAT 
than VAT, for example in correlations between lipid uptake and fasting insulin as well as fasting glucose 
(Mårin et al. 1992), and RPAT has been shown to be drained by the inferior vena cava, as does abdominal 
SAT, where VAT is drained by the portal vein (Björntorp 1990; Abate et al. 1994). The drainage into the 
portal vein exposes liver cells directly to adipokines secreted from the VAT and this has been associated 
with systemic inflammation in obese humans (Fontana et al. 2007). For these reasons the abdominal SAT 
and RPAT have been grouped together in comparisons between the Göttingen minipigs and the other pigs. 
The Göttingen minipigs and the domestic pigs show the same response to obesity in the regulation of gene 
expression between the tissues (Paper II p. 39, Table 2 and Paper III p. 70, Table 2), as both breeds exhibit a 
lower number of differentially regulated genes between the abdominal adipose tissues (RPAT/abdominal 
SAT and VAT) and the neck SAT in the obese pigs compared to lean. A total of 16 genes are differentially 
regulated in the abdominal adipose tissues in the lean domestic pigs and Göttingen minipigs compared to 
neck SAT, where 12 and nine genes are differentially regulated in the abdominal adipose tissues in the 
obese Göttingen minipigs and domestic pigs, respectively.  
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7 Conclusions and perspectives  
Based on the results presented in this thesis it is not possible to determine a completely human-like innate 
immune response to obesity in any of the three breeds of porcine obesity-models studied.   
Cloning did not reduce the inter-individual phenotypic variation, as variability was found to be the same 
between the cloned and control domestic pigs, in all 4 tissues, and in serum proteins, except for the protein 
ORM in both the lean and obese clones.  
Obesity altered the expression of the innate immune genes, as fewer genes were differentially regulated in 
the obese controls and clones as compared to the lean controls and clones. Furthermore, cloning induced a 
differentiated response to obesity in innate immune genes in liver and three types of adipose tissue as 
fewer genes were differentially regulated in the lean and obese clones than in the lean and obese controls. 
The effect were additive, making the obese clones the group with fewest differentially regulated genes in 
the four tissues investigated. However, two of the measured serum proteins showed increased 
concentrations in the obese cloned pigs compared to the lean cloned pigs, and the protein concentrations 
were unchanged between the lean and obese control pigs.    
The abdominal tissue from the abdomen; abdominal SAT and VAT, did not show a higher number of 
affected innate immune response genes than the neck SAT, except in the VAT of the obese clones.  
As a method to reduce group sizes of animal models, by lowering the inter-individual phenotypic variation, 
cloning may not be the way forward. The results from this thesis is supported by other investigations into 
the variation between the cloned pigs having shown that cloned pigs does not show less inter-individual 
phenotypic variation than controls (Clausen et al. 2011; Hwang et al. 2009; Park et al. 2011; Whyte et al. 
2011). Furthermore, other studies have shown deviant phenotypes of cloned animals (Clausen et al. 2011; 
Christensen et al. 2012; Whyte et al. 2011; Park et al. 2011; Archer et al. 2003; Jiang et al. 2007). Coupled 
with the low efficiency of the method, with increased mortality perinatally, the method is time-consuming 
and expensive, and perhaps it is time to focus on other animal models until the method has been improved.  
Even though the Göttingen minipigs show a varied differential response to obesity in all tissues, the 
response does not translate to the serum protein expression, which is not as expected and different from 
the human responses to obesity. This could possibly be due to the feed, which was not high calorie feed, 
but a standard chow fed ad libitum. Because of the lack of differential expression in serum proteins, it is not 
possible, with the standard chow, to establish the Göttingen minipig as a suitable model for human obesity-
induced innate immune responses. However, it is possible that a different feed with high calories or that 
using pigs which had not been subjected to pharmacological treatments, would change this conclusion. 
The metabolic activity of the neck SAT was found to be lower than that of the other two adipose tissues in 
especially the lean Göttingen minipigs. However, the difference in differential expression was expected to 
increase in obesity, which is not the case for these pigs. Therefore the conclusion in regards to this must be 
that the access to ad libitum feeding of a standard diet could have a positive effect on the effects of 
obesity-induced low-grade inflammation.   
The Ossabaw minipigs show little response to obesity in both gene and serum protein expression, even 
though blood parameters and body weights show signs of metabolic perturbations. As the lack of response 
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is very different from what has been found in humans, it is not possible to establish the Ossabaw minipig as 
a suitable model for human obesity-induced innate immune responses. As the results of this study are 
limited due to small group sizes it would be very interesting to obtain more samples to enlarge the group 
sizes and to hopefully obtain RNA of higher quality, and to repeat the investigations. 
The response of the Göttingen minipigs is more human-like than the response of the domestic pigs in terms 
of the gene expression of the four tissues. In terms of the serum protein expression, the Ossabaw minipigs 
shows a more human-like response than the other two breeds as it shows an elevated concentration of the 
APP ORM, which has been shown to be elevated in obese humans.  
The gene expression of ORM1 in the liver and three adipose tissues was unchanged between the lean and 
obese pigs in all three breeds, although bigger groups of the Göttingen and Ossabaw minipigs will be 
needed to confirm this result. It would be of great interest to investigate whether humans exhibit a 
differential expression of ORM1 in the adipose tissues in obesity, as has been found in mice (Lee et al. 
2010). It is possible, even if the response of rodent obesity models to obesity has been found to be 
different from humans, that the differential expression of ORM1 in the adipose tissues is more similar to 
the expression of mice than the expression of pigs.     
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9 Appendix 
9.1 Preprocessing steps – Study I 
Using Fluidigm Real-Time PCR Analysis software (Fluidigm, CA, USA), GeNorm software (Vandesompele et 
al, 2002), and GenEx5 software (MultiD, Göteborg, Sweden). 
1. Check efficiency for all primers (between 0.8-1.1 is accepted) 
2. Check correlation for all primers (>0.98 is accepted) 
i. Should have been more diluted: FIB, HP and ORM1 
ii. Problems with serial dilution (efficiency set to 100%): IL8(b), IL1b, IL6, IL8(a), TNF in 
liver and IL10(b) in adipose tissues 
iii. Due to low efficiencies MUC1, DEFB1 and IL12 is removed 
3. Check melting curves (differences inside 1°C is accepted) 
4. Interrun calibrate 
5. Cutoff values off scale (Cq value >26 – due to primer dimer) 
6. Check for missing values; if less than 15% missing values pr primer, replace with max Cq+2 
i. Removed due to >15% missing samples: SPA1 from abdominal SAT and neck SAT, 
and LBP from VAT. 
7. Correct data for efficiency for each primer set 
8. Select reference genes on the basis of evaluation using GeNorm 
i. Liver: HPRT1 and GAPDH – M=0.3 
ii. Adipose tissues: HPRT1 and B2M – M=0.55 
iii. All tissues combined: RPL13A and GAPDH – M=0.8 
9. Normalize data with geometric means from reference genes; liver, adipose tissues and combined 
10. Check standard deviation of the technical replicates (variation of more than 1 cq value is removed) 
i. The samples: If variation between the technical replicates is >30% the samples are 
removed: Tissues combined; an obese clone from Group 1 is removed from liver 
(9601), a lean control from Group 3 is removed from VAT (3149), and a lean clone 
is removed from neck SAT (3297). Single tissues; a lean clone from Group 3 is 
removed from neck SAT (3297). 
ii. The genes: If variation between the technical replicates is >15% the genes are 
removed: Tissues combined; IL8(b) and IL6 in liver, FIB, IFNG, LBP, IL1RN and ORM1 
in adipose tissues. Single tissues; IL8(b) and IL6 in liver, FIB, IFNG, LBP, IL1RN, ORM1 
and IL10(b). 
11. Average technical replicates 
12. Convert Cq values to relative quantities; lowest number (highest expression) is set to 1 
13. Log2 transform data    
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9.2 Preprocessing steps – Study II 
Using Fluidigm Real-Time PCR Analysis software (Fluidigm, CA, USA), GeNorm software (Vandesompele et 
al, 2002), and GenEx5 software (MultiD, Göteborg, Sweden). 
1. Check efficiency for all primers (between 0.8-1.1 is accepted) 
2. Check correlation for all primers (>0.98 is accepted) 
i. Should have been more diluted: TNF and C3 
3. Check melting curves (differences inside 1°C is accepted) 
4. Interrun calibrate 
5. Cutoff values off scale (Cq value >26 – due to primer dimer) 
6. Check for missing values; if less than 15% missing values pr primer, replace with max Cq+2 
i. Removed due to >15% missing samples: Both breeds, adipose tissues; LBP, AOAH, 
SPA1, ORM1(a) and ORM1(b), Göttingen adipose tissues; SPA1 and ORM1(a), both 
breeds, liver: ADIPOQ 
7. Correct data for efficiency for each primer set 
8. Select reference genes on the basis of evaluation using GeNorm 
i. Both breeds combined, adipose tissue: RPL13A and GAPDH – M=0.96 
ii. Both breeds combined, liver: RPL13A and GAPDH – M=0.55 
iii. Göttingen, adipose tissues: GAPDH, B2M, RPL13A, ACTB and HPRT1 – M=1.26 
iv. Göttingen, liver: GAPDH, B2M, RPL13A and ACTB – M=0.6  
v. Göttingen, all tissues combined: RPL13A and ACTB – M=0.62 
vi. Ossabaw, adipose tissues: GAPDH – M=1.05 
vii. Ossabaw, liver: GAPDH, B2M and RPL13A – M=0.55 
viii. Ossabaw, all tissues combined: RPL13A and GAPDH – M=1.43 
9. Normalize data with geometric means from reference genes: for both breeds; liver, adipose tissues 
and combined, as well as both breeds combined 
10. Check standard deviation of the technical replicates (variation of more than 1 cq value is removed) 
i. The samples: If variation between the technical replicates is >30% the samples are 
removed: Ossabaw all tissues combined – two lean pigs was removed from VAT 
(1390 and 1371); Ossabaw adipose tissues – 2 lean pigs were removed from VAT 
(1390 and 1371) and a lean pig from abdominal SAT (1393); Göttingen and 
Ossabaw adipose tissues combined – three lean pigs from VAT was removed (1390, 
1371 and 1393)  
ii. The genes: If variation between the technical replicates is >15% the genes are 
removed: Göttingen and Ossabaw liver- IL6(a), IL8(a), IFNG, AOAH, TNF, SPA1 and 
ORM1(b); Göttingen and Ossabaw adipose tissues – FIB, IL1B and IFNG; Ossabaw all 
tissues combined – CRP, IL1B, IL6(a), SPA1, COX2, IL6(B), IL8(a), ITIH4(b), IL18, 
ORM1(a), IL10(b), ADIPOQ, IFNG, TNF, AOAH, CD36 and ORM(b); Ossabaw adipose 
tissues – CD40, CRP, DEF2, FIB, IL10(b), IL1B, ITIH4(b), IL18, IFNG, TNF, ORM1(b), 
TLR4, AOAH, CXCL10, CCL3, COX2 and IL6(b); Göttingen all tissues combined – IL1B, 
IL8(a), AOAH, SPA1, ORM1(a), ORM1(b), ADIPOQ and LBP; Göttingen adipose tissue 
(accepted variation set to 22%, as SD was high due to a cDNA-synthesis with low 
 126 
 
efficiency that was removed) – FIB, IL8(b), IL1B, IL8(a), IFNG, AOAH, IL10(b) and 
ORM1(b). 
11. Average technical replicates 
12. Convert Cq values to relative quantities; lowest number (highest expression) is set to 1 
13. Log2 transform data    
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9.3 Purification of RNA from non-adipose tissues  
Materials: 
RNase-Free DNase set (Qiagen, #79254) 
RNeasy Lipid Tissue Midi (Qiagen, #75842) 
QIAzol Lysis Reagent (200 ml) (Qiagen #79306) 
Chloroform (Merck #1.02445.1000) 
M Tubes for GentleMACS (Fisher #mil-130-093-458) 
 
Method: 
• Approximately ½ g of tissue is transferred to a M Tube with 5 mL Qiazol Lysis Reagent. Homogenize 
sample on GentleMACs dissociater, on program: 02.01 Frozen M.Tube 
• Transfer homogenized sample to nunc tube supplied in the kit, and place the sample at room 
temperature (15-25° C) for 5 minutes. 
• Add 1 mL chloroform (0,2 mL pr 1 mL QIAzol Lysis Reagent). Shake the tube vigorously for 15 
seconds, and place the sample at room temperature for 2-3 minutes. 
• Centrifuge tubes for 15 minutes at 4500 rpm at 4° C. 
• Homogenate is now divided into three phases. Transfer approximately 2.75 mL from the upper 
phase to a new 15 mL nunc tube, and add approximately 2.75 mL of 70% ethanol (1:1). Mix 
homogenate with the pipette.  
• Transfer up to 4 ml of homogenate to a RNeasy Maxi Spin Column. Centrifuge tubes for 5 minutes 
at 4500 rpm at 20-25° C. Discard flow-through. Repeat step and discard flow-through. 
• Transfer 2 mL Buffer RW1 to column and centrifuge for 5 minutes at 4500 rpm at 20-25° C. Discard 
flow-through. 
• Mix DNase I Incubation mix: 20 µL of DNase I Stock Solution is added to 140 µL Buffer RDD pr tube. 
Mix carefully with the pipette. Transfer 160 µL DNase I Stock Solution to the RNeasy silica-gel 
membrane and place at room temperature for a minimum of 15 minutes. 
• Add 2 mL Buffer RW1 to the column and centrifuge for 5 minutes at 4500 rpm at 20-25° C. 
• Add 2.5 mL Buffer RPE to the column and centrifuge for 5 at 4500 rpm at 20-25° C. Discard flow-
through. Repeat step. The column is now ethanol-free. 
• Transfer column to new nunc tube, and add 150 µl RNase-free water to the membrane. Place at 
room temperature for 1 minute and centrifuge for 3 minutes at 4500 rpm at 20-25° C. 
• Re-use flow-through on the membrane and centrifuge for 5 minutes at 4500 rpm at 20-25° C.  
• Add further 150 µL RNase-free water to the membrane and centrifuge for 5 minutes at 4500 rpm at 
20-25° C. 
• Measure concentration on Nanodrop. 
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9.4 Purification of RNA from adipose tissues (domestic pig) 
Materials: 
RNase-Free DNase set (Qiagen, #79254) 
RNeasy Maxi kit (Qiagen #75162) 
QIAzol Lysis Reagent (200 ml) (Qiagen #79306) 
Chloroform (Merck #1.02445.1000) 
M Tubes for GentleMACS (Fisher #mil-130-093-458) 
 
Method: 
• Approximately 1 g of tissue is transferred to a M Tube with 10 mL Qiazol Lysis Reagent. 
Homogenize sample on GentleMACs dissociater, on program: 02.01 Frozen M.Tube 
• Transfer homogenized sample to nunc tube supplied in the kit, and place the sample at room 
temperature (15-25° C) for 5 minutes. 
• Add 4 mL chloroform (0,2 mL pr 1 mL QIAzol Lysis Reagent). Shake the tube vigorously for 15 
seconds, and place the sample at room temperature for 2-3 minutes. 
• Centrifuge tubes for 15 minutes at 4500 rpm at 4° C. 
• Homogenate is now divided into three phases. Transfer approximately 11 mL from the upper phase 
to a new 50 mL nunc tube, and add approximately 11 mL of 70% ethanol (1:1). Mix homogenate 
with the pipette.  
• Transfer up to 15 ml of homogenate to a RNeasy Maxi Spin Column. Centrifuge tubes for 5 minutes 
at 4500 rpm at 20-25° C. Discard flow-through. Repeat step and discard flow-through. 
• Transfer 7.5 mL Buffer RW1 to column and centrifuge for 5 minutes at 4500 rpm at 20-25° C. 
Discard flow-through. 
• Mix DNase I Incubation mix: 30 µL of DNase I Stock solution is added to 210 µL Buffer RDD pr tube. 
Mix carefully with the pipette. Transfer 240 µl DNase I Stock Solution to the RNeasy silica-gel 
membrane and place tube at room temperature for a minimum of 15 minutes. 
• Add 7.5 mL Buffer RW1 to the column and centrifuge for 5 minutes at 4500 rpm at 20-25° C. 
Discard flow-through. Repeat step. 
• Add 10 mL Buffer RPE to the column and centrifuge for 2 minutes at 4500 rpm at 20-25° C. Discard 
flow-through. 
• Add another 10 mL Buffer RPE to the column and centrifuge for 10 minutes at 4500 rpm at 20-25° 
C. Discard flow-through. 
• Transfer column to new nunc-tube and add 800 µL RNase-free water to the membrane. Place tube 
at room temperature for 10 minutes and centrifuge at 4500 rpm at 20-25° C. 
• Re-use flow-through on the membrane and centrifuge for 5 minutes at 4500 rpm at 20-25° C. 
• Measure concentration on Nanodrop. 
 
  
 129 
 
9.5 Purification of RNA from adipose tissues (optimized - domestic pig) 
Materials: 
QIAzol Lysis Reagent (200 ml) (Qiagen #79306) 
Isopropanol (2-propanol, Merck #1.09634.1000) 
Chloroform (Merck #1.02445.1000) 
M Tubes for GentleMACS (Fisher #mil-130-093-458) 
 
Method: 
• Approximately ½ g of tissue is transferred to a M Tube with 10 mL Qiazol Lysis Reagent. 
Homogenize sample on GentleMACs dissociater, on program: 02.01 Frozen M.Tube 
• Transfer homogenized sample to a 15 mL nunc tube, and place the sample at room temperature 
(15-25° C) for 5 minutes. 
• Add 2 mL chloroform (0,2 mL pr 1 mL QIAzol Lysis Reagent). Shake the tube vigorously for 15 
seconds, and place the sample at room temperature for 2-3 minutes. 
• Centrifuge tubes for 20 minutes at 4500 rpm at 4° C. 
• Homogenate is now divided into three phases. Transfer approximately 2.2 mL from the upper 
phase to a new nunc tube, and add 1.4 mL of Isopropanol (1:0.625). Place the tube at room 
temperature for 5 minutes. Centrifuge tubes for 10 minutes at 4500 rpm at 4° C. 
• Aspirate carefully and discard the supernatant. 
• Washing step: Add 10 mL of cold 75% ethanol (1 mL pr 1 mL Lysis Reagent) and make sure the 
pellet is properly washed. Centrifuge for 5 minutes at 3300 rpm at 4° C.  
• Repeat the washing step 2 times, with 5 ml of cold 75% ethanol. Discard the supernatant between 
each washing step. 
• Remove the supernatant completely and let the RNA pellet air dry for 30 minutes. 
• Dissolve pellet in 100 µL RNase-free water, place sample at room temperature for 5-10minutes and 
then vortex. 
• Measure concentration on Nanodrop. 
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9.6 Purification of RNA from adipose tissues (optimized - Göttingen and 
Ossabaw minipigs) 
Materials: 
QIAzol Lysis Reagent (200 ml) (Qiagen #79306) 
Isopropanol (2-propanol, Merck #1.09634.1000) 
Chloroform (Merck #1.02445.1000) 
M Tubes for GentleMACS (Fisher #mil-130-093-458) 
 
Method: 
• Approximately ½ g of tissue is transferred to a M Tube with 4 mL Qiazol Lysis Reagent. Homogenize 
sample on GentleMACs dissociater, on program: 02.01 Frozen M.Tube 
• Transfer homogenized sample to two 2 mL eppendorf tubes, and place the sample at room 
temperature (15-25° C) for 5 minutes. 
•  Centrifuge the tubes for 10 minutes at 12000xg at 4° C. Transfer the pink phase to new eppendorf 
tubes (avoid pellet and fatty layer on top) 
• Add 400 µL chloroform (0.2 mL pr 1 mL QIAzol Lysis Reagent). Shake the tube vigorously for 15 
seconds, and place the sample at room temperature for 3 minutes. 
• Centrifuge tubes for 15 minutes at 12000xg at 4° C. 
• Homogenate is now divided into three phases. Transfer approximately 900 µL from the upper 
phase to a new eppendorf tube, and add 1 mL of Isopropanol. Vortex and place the tube at room 
temperature for 5 minutes. Centrifuge tubes for 10 minutes at 12000xg at 4-25° C. 
• Aspirate carefully and discard the supernatant. 
• Wash the sample 2 times: Add 1 mL of cold 75% ethanol and vortex to make sure the sample is 
properly washed. Centrifuge for 8 minutes at 8000xg at 4-25° C. Discard the supernatant between 
each washing step. 
• Remove the supernatant completely and dry the RNA pellet in a thermoblock at 55° C for 2 
minutes. 
• Dissolve pellet in one of the tubes in RNase-free water (30-100 µl, depending on the size of pellet), 
and mix. Transfer the water to the other tube and mix. 
• Place tube on thermoblock at 55° C for 10 minutes to dissolve the pellet completely. 
• Measure concentration on Nanodrop. 
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9.7 cDNA-synthesis 
Materials 
QuantiTect Reverse Transcription Kit (Qiagen #205311) 
 
Methods 
• Add 2 µl gDNA Wipeour Buffer (7x) to a 0.2 mL mini-eppendorf tube. Add a mix of 12 µL RNase-free 
water and RNA (final concentration 500 ng total RNA), to a total of 14 µL 
• Incubate in Thermocycler (Qiagen) for 2 minutes at 42°C -> 4°C 
• Make Master mix for all samples (+10%) : 
 For 1 reaction : 1 µL Reverse Transcriptase 
1 µL RT Primer Mix 
4 µL RT buffer 
• Add 6 µL Master mix to each tube with RNA 
• Incubate in Thermocycler for 15 minutes at 42°C -> 3 minutes at 95°C -> 4°C 
• The 20 µL of cDNA can be stored at -20°C until use 
• For Fluidigm: measure cDNA concentrations on the NanoDrop and dilute cDNA to approximately 
200 ng/µL in low EDTA TE-buffer before preamplification (all samples are diluted with the same 
amount of low EDTA TE-buffer) 
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9.8 qPCR with Rotor-Gene Q 
Materials 
Sybr Green Jumpstart Taq Readymix without MgCl2 (Sigma # S5193) 
 
Method 
• Make the dilution series: 
  
Koncentration 
(μg/5μl) 
cDNA 
(μl) H2O (μl)    
Koncentration 
(μg/5μl) cDNA (μl) H2O (μl) 
1 0,667 6 39  1 10 30 0 
2 0,222 15 (fra 1) 30  2 1 3 (fra 1) 27 
3 0,0741 15 (fra 2) 30  3 0,1 3 (fra 2) 27 
4 0,0247 15 (fra 3) 30  4 0,01 3 (fra 3) 27 
5 0,00823 15 (fra 4) 30  5 0,001 3 (fra 4) 27 
6 0,00274 15 (fra 5) 30  6 0,0001 3 (fra 5) 27 
7 0,000914 15 (fra 6) 30  7 0,00001 3 (fra 6) 27 
8 0,000305 15 (fra 7) 30  8 0,000001 3 (fra 7) 27 
 
• Dilute primers: 10 µl F + 10 µl R + 180 µl H2O => 10 µM (final concentration – 300 µM) 
• Make the Mix according to table over qPCR-setup 
• Add 20 µL Mix to each 0.1 mL mini-eppendorf tube (end with NTC) 
• Add 5 µL of sample cDNA to each 0.1 mL mini-eppendorf tube and 5 µL RNase-free water in the 
NTC 
• Place on the Rotor-Gene Q Instrument 
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9.9 Preamplification before Fluidigm 
Materials 
Man PreAmp Master Mix (Applied Biosystems, PN 4391128) 
Low EDTA TE-buffer (VWR, APLIA8569.0500) 
 
Method 
• Prepare primer mix (max 100 primers), all primers are shaken and centrifuged before use  
 Make 20 µM-dilution of all primer pars (10 µL F primer (100 µM) + 10 µL R primer 
(100 µM) + 30 µl low EDTA TE-buffer) 
 Primer Mix: Mix 5 µL 20 µM primer-dilution from all primers and add low EDTA TE-
buffer for a final dilution of 500 µL (200 nM).  
• Defrost the cDNA and vortex briefly 
• Prepare the PreAmp mix: 
 For 1 reaction: 5 µL TagMan PreAmp Master Mix  + 200 nM primer mix  
• Add 7.5 µL PreAmp mix to 0.2 mL mini-eppendorf tubes, and add 2.5 µL diluted cDNA 
• Incubate in Thermocycler for 10 minutes at 95°C -> 15 seconds at 95°C -> 4 minutes at 60°C for 16 
cycles -> 4°C 
• Dilute preamplified cDNA in 30 µL low EDTA TE-buffer and store at -20°C (undiluted preamplified 
cDNA are used for dilution series) 
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9.10 qPCR with Fluidigm (EvaGreen) 
Materials 
TaqMan Gene Expression Master mix (Applied Biosystems, PN 4369016) 
EvaGreen 20X (VWR, BTIU31000)  
Low EDTA TE-Buffer (VWR, APLIA8569.0500)  
BMK-M-48.48 B (Fluidigm)  
85000800 sample and assay loading kit (Fluidigm), 100-0388 DNA binding Dye (Fluidigm) 
 
 
Method 
• Turn on the MX IFC controller 
• Make Assay Master mix: 
Assay mastermix x 1 x 60 
2X Assay loading Reagent 2.5 µl 150 µl 
1X low EDTA TE-Buffer 0.25 µl 15 µl 
 
• Dispense 2.8 µL Assay Master mix (6x8) into a microtiter-plate, and then add 2.3 µL 20 µM (final 
volume 5.1 µL) of specific primer pars A1-6, B7-12, C13-18 and so forth. Put film on plate and place 
in refrigerator until use.   
• Make Pre-sample mix: 
 
Pre-sample mix x 1 x 60 
2X TaqMan Gene Expression 
Mastermix 3 µl 180 µl 
20X DNA binding Dye 0.3 µl 18 µl 
EvaGreen 20X 0.3 µl 18 µl 
1 x low EDTA TE-Buffer 0.9 µl 54 µl 
 
• Dispense 4.6 µL Pre-sample mix (6x8) to another microtiter-plate (to avoid contamination), and add 
1.5 µL preamplified cDNA to all wells. Put film on plate and place in refrigerator until use. 
• Add Control Line Fluid to the chip. 
• Remove protection-film from chip (is saved) and prepare the chip in the MX IFC Controller on the 
Chip Prime 113x-program (11 minutes). The chip is to be used within an hour of priming. 
• Place the chip with the severed corner on the top left. The two microtiter-plates are vortexed and 
centrifuged at 1000 rpm for 30 seconds at 21°C.  
• 4.9 µL of the Assay mix is added to the left side of the chip, and 4.9 µL of the sample mix is added to 
the right side of the chip. 
• Checks for bobbles! 
• The chip is placed in the MX IFC controller on the Load Mix 113x-program (1 hour). 
• Turn on BioMark, turn on computer and start “data collection” and “turn on lamp”. 
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• After loading and mixing remove dust from the surface of the crip with tape and place the chip in 
the BioMark. Start new run with the following parameters: 
 Application type: Gene expression 
 Passive ref: ROX 
 Single probe 
 Probe type: EvaGreen 
 Thermal cycling protocol: 48x48 qPCR (10 min…) 
• When the run has completed, the file is opened in the Chiprun Extractor and is divided into a PCR 
cycle file and a melt curve file 
  
 136 
 
9.11 Detailed composition of experimental diets 
Domestic pigs 
 
Information of the diet is from (Christensen et al. 2012), where further information of the content of 
vitamins and minerals in the diet can be found. 
 
Ossabaw minipigs 
 
Information of the diets are from (Lee et al. 2009). 
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Göttingen minipigs 
Altromin 9023 (lean pigs) 
 
 
Altromin 9033 (obese pigs) 
 
 
Information is from altromin.com, where further information of the content of vitamins and minerals in the 
diet can be found. 
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9.12 Biochemical characteristics of domestic pigs 
 
 
The table of characteristics of the domestic pigs are from (Christensen et al. 2012). 
